Zur Totalsynthese von Hexacyclinsäure by Stelmakh, Andriy

 
  
 
 
 
Zur Totalsynthese von Hexacyclinsäure 
 
Von der Naturwissenschaftlichen Fakultät 
der Gottfried Wilhelm Leibniz Universität Hannover 
 
 
zur Erlangung des Grades eines 
Doktors der Naturwissenschaften 
Dr. rer. nat. 
 
 
genehmigte Dissertation 
 
 
 
von 
 
 
 
Magistr Chimii Andriy Stelmakh 
geboren am 08. Dezember 1980 
in Tschernihiw, Ukraine 
 
 
2007 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referent:   Prof. Dr. Markus Kalesse 
Korreferent:   Prof. Dr. Andreas Kirschning 
Tag der Promotion:  07. März 2007 
 Hiermit versichere ich an Eides statt, die vorliegende Dissertation selbständig durchgeführt 
und keine unerlaubte Hilfe in Anspruch genommen zu haben. Die aus fremden Quellen 
übernommenen Gedanken sind als solche kenntlich gemacht. Diese Arbeit wurde nicht bereits 
als Diplom- oder ähnliche Prüfungsarbeit verwendet. 
 
 
Hannover, Januar 2007 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kurzfassung 
 
Stelmakh, Andriy 
 
Zur Totalsynthese von Hexacyclinsäure 
 
Schlagwörter: Totalsynthese, Naturstoffchemie, Hexacyclinsäure, FR182877. 
Hexacyclinsäure ist ein komplexes Polyketid, welches von Streptomyces cellulosae subsp. 
griseorubiginosus (Stamm S1013) produziert wird. Die Isolierung und Strukturaufklärung des 
Naturstoffs wurde im Jahr 2000 von Zeeck et al. veröffentlicht. Aufgrund seiner Komplexität 
und strukturellen Ähnlichkeit zu (-)-FR182877, einem Naturstoff mit vielversprechenden 
antineoplastischen Eigenschaften, stellt Hexacyclinsäure eine interessante synthetische 
Herausforderung dar. 
Im Mittelpunkt des ersten Teils dieser Arbeit stand die Untersuchung des stereochemischen 
Verlaufs der Tandem-Michael-Addition/Aldol-Reaktion als einen Schlüsselschritt im Aufbau 
des C-Rings von Hexacyclinsäure. Infolge dieser Studien wurde festgestellt, dass die Reaktion 
unter kinetischen Bedingungen ein Siloxycyclobutan mit einer Selektivität von 7:1 liefert, 
dessen relative Stereochemie mit dem Naturstoff identisch ist. Die Aufklärung der relativen 
Stereochemie wurde mit Hilfe von NOE-NMR-Experimenten durchgeführt. 
Darauf folgende Untersuchungen der Retroaldol-Reaktion haben gezeigt, dass das kinetische 
Siloxycyclobutan-Produkt bei tiefen Temperaturen (-30 °C, TBAF) in das gewünschte 
Methylketon ohne Epimerisierung überführt werden kann. Im Gegenteil dazu lieferte die 
Reaktion bei Raumtemperatur das epimerisierte Produkt. Dieser Befund erklärt die Tatsache, 
dass laut der Röntgenstrukturanalyse des vollständig entschützten ABC-Fragments eins von 
neun Stereozentren die falsche Stereochemie besaß (T. Stellfeld, Dissertation, Freie 
Universität Berlin, 2004). Dies war das Resultat einer Epimerisierung während der 
Entschützung mit TBAF bei Raumtemperatur. 
Die Addition des Grignard-Reagenzes aus 1-(Benzyloxy)-3-brompropan an das Methylketon 
lieferte das unerwünschte Felkin-Produkt mit einer Selektivität von 1:5. Die Aufklärung der 
relativen Stereochemie wurde mit Hilfe von ROESY-NMR-Experimenten durchgeführt. 
Im zweiten Teil der Arbeit wurden Studien zur Entwicklung eines synthetischen Zugangs zum 
DEF-Fragment des Naturstoffs durchgeführt. Entsprechend dem synthetischen Plan sollte der 
Aufbau des DEF-Fragments ausgehend von einem 9-gliedrigen Lacton mit Hilfe einer 
Dieckmann-Kondensation als Schlüsselschritt erfolgen. 
Die zur Synthese des 9-gliedrigen Lactons durchzuführende Ringschluß-Metathese war mit 
verschiedenen Zyklisierungs-Vorläufern und Katalysatoren nicht erfolgreich. Eine 
Umstellung des retrosynthetischen Ansatzes führte schließlich zur erfolgreichen Synthese des 
9-gliedrigen Lactons mit Hilfe einer Grignard-Reaktion, einer Evans-Aldol-Reaktion und 
einer Yamaguchi-Macrolactonisierung. Trotz erfolgsversprechender Modellstudien der 
Dieckmann-Kondensation mit einem Acetat- und Propionat-Vorläufer konnte die Reaktion 
nicht erfolgreich auf den fortgeschrittenen 9-gliedrigen Lacton-Vorläufer übertragen werden. 
Eine plausible Erklärung für diese Tatsache wurde vorgeschlagen und die synthetische 
Strategie zum Aufbau des trizyklischen DEF-Fragments wurde entsprechend überarbeitet. 
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Hexacyclinic acid is a complex polyketide, produced by the Streptomyces cellulosae subsp. 
griseorubiginosus (strain S1013). The isolation of the natural product and elucidation of its 
structure was reported by Zeeck et al. in 2000. Due to the complex structure and similarity to 
(-)-FR182877, a natural product with promising antineoplastic properties, hexacyclinic acid 
presents a challenging synthetic target. 
In the first part of this work the stereochemical outcome of the Tandem Michael 
Addition-Aldol reaction as a key step in the construction of the C-ring of hexacyclinic acid 
was studied. As a result of this investigation it was found that under kinetic conditions the 
reaction furnishes a siloxycyclobutane product with a selectivity of 7:1, and the relative 
stereochemistry identical to that of the natural product. Elucidation of the relative 
stereochemistry was performed using NOE NMR experiments. 
The following study of the retroaldol reaction has shown that the kinetic siloxycyclobutane 
product could be converted into the desired methylketone without epimerization at low 
temperature (TBAF, -30 °C). In contrast, conducting the reaction at rt afforded epimerized 
product. This experimental finding explained the wrong stereochemistry of one out of the nine 
stereocenters in the X-ray structure analysis of the totally deprotected ABC fragment 
(T. Stellfeld, Dissertation, Freie Universität Berlin, 2004). This was a result of the 
epimerization that took place during deprotection with TBAF at room temperature. 
Addition of a Grignard reagent generated from 1-(benzyloxy)-3-brompropane to the 
methylketone furnished the undesired Felkin product with a selectivity of 1:5. The elucidation 
of the relative stereochemistry was conducted using ROESY NMR experiments. 
In the second part of the thesis the studies were aimed at the elaboration of a synthetic 
approach towards the DEF fragment of the natural product. According to the synthetic plan 
the construction of the DEF cyclic fragment had to be straightforward from a 9-membered 
lactone precursor using the Dieckmann condensation as a key step. 
The ring closing olefin metathesis reaction, that we intended to use for the synthesis of the 
9-membered lactone, proved to be not successful with a set of catalysts and different 
substrates. A new, reconsidered retrosynthetic approach, featuring a Grignard reaction, an 
Evans aldol reaction and a Yamaguchi macrolactonization led to the successful synthesis of 
the 9-membered lactone. Despite the promising model studies of the Dieckmann condensation 
with acetate and propionate precursor, the reaction could not be successfully transferred to the 
advanced 9-membered lactone precursor. A reasonable explanation for this fact has been 
proposed and the synthetic approach towards the tricyclic DEF fragment has been 
reconsidered. 
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List of Abbreviations 
 
Ac acetyl 
AcOEt ethyl acetate 
AcOH acetic acid 
ACP acetyl carrier protein 
Ar aryl or aromatic 
AT acetyl transferase 
atm Atmosphere (unit); 1 atm = 101325 Pa  
Bn benzyl 
bp boiling point 
Bu butyl 
cat. catalytic 
COSY homonuclear correlation spectroscopy, usually H,H-COSY 
CSA camphorsulfonic acid 
dba dibenzylideneacetone or 1,5-diphenylpenta-1,4-dien-3-one 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DDQ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DEAD diethylazodicarboxylate 
DEPT distortionless enhancement by polarization transfer 
DH dehydratase 
DIBAL diisobutylaluminium hydride (DiBAlH, DIBAL-H or DIBALH) 
DMAP 4-N,N-dimethylaminopyridine 
DMF N,N-dimethylformamide 
DMSO dimethyl sulfoxide 
dppf 1,1’-bis(diphenylphosphino)ferrocene 
dr diastereomeric ratio 
equiv equivalent(s) 
Et ethyl 
GI50 median growth inhibition concentration 
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h hour(s) 
hexane n-hexane 
HMDS hexamethyldisilazane, bis(trimethylsilyl)amine 
HMPA hexamethylphosphoramide (HMPT, hempa, hexametapol) 
HPLC high performance liquid chromatography 
HRMS ESI high resolution mass spectroscopy (electrospray ionization) 
IC50 the half maximal inhibitory concentration 
inhib. inhibitor 
IR infrared 
KHMDS potassium bis(trimethylsilyl)amide, potassium hexamethyldisilazide 
KR ketoreductase 
KS ketoacetyl synthase 
LA Lewis acid 
LDA lithium diisopropylamide 
LiHMDS lithium bis(trimethylsilyl)amide 
Lit. or lit.  literature 
mCPBA meta-chloroperoxybenzoic acid 
Me methyl 
Mes mesityl, 2,4,6-trimethylphenyl 
MOM methoxymethyl 
mp melting point 
MTBE methyl tert-butyl ether 
MTM methylthiomethyl 
NAD+ nicotinamide adenine dinucleotide 
NADP+ nicotinamide adenine dinucleotide phosphate 
NaHMDS sodium bis(trimethylsilyl)amide 
NBS N-bromosuccinimide 
NMO N-methylmorpholine N-oxide 
NMP N-methyl-2-pyrrolidone 
NMR nuclear magnetic resonance 
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NOE nuclear Overhauser effect 
NOESY nuclear Overhauser enhancement and exchange spectroscopy 
Nu nucleophiles 
PG protecting group 
Ph phenyl 
PKS polyketide synthase 
PMB p-methoxybenzyl 
PPTS pyridinium p-toluenesulfonate 
Py pyridine 
rt room temperature 
TBAF tetrabutylammonium fluoride 
TBAI tetrabutylammonium iodide 
TBS tert-butyldimethylsilyl 
TES triethylsilyl 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TMS trimethylsilyl 
Ts p-toluenesulfonyl, tosyl 
UV ultraviolet light, usually 254 nm 
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1 Introduction 
1.1 Natural products in drug discovery 
The ability of small organic molecules to interact with specific macromolecules of living 
organisms makes them useful, both as tools to understand biological processes, and as 
valuable agents to treat health disorders. The most remarkable feature of natural products is 
the diversity of chemical structures, which reflects the diversity of enzymes and genes 
responsible for their biosynthesis. Natural products, which can be identified in screens of 
extracts, possess useful and often specific macromolecule-perturbing properties. These are 
reasons why natural products have become the target of new drug discovery. Cholesterol-
lowering drugs (1), immunosuppressors (2 and 4), antibiotics (3 and 5) and antitumor agents 
(6) are representative examples (Figure 1). 
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Figure 1. Selected polyketides that have found application as medicines 
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Once an active natural product has been identified, the compound often becomes a target for 
chemical synthesis. Growing demand for the cost effective synthesis of complex substances 
results in the development of new synthetic methods and the perfection of spectroscopic and 
analytical techniques. 
1.2 From fatty acids to polyketides 
Polyketides (or acetogenines) were named in 1890s to refer to a structurally diverse group of 
natural products that contain carbonyl and alcohol functional groups, separated by methylene 
groups.1 
The term “polyketide” may be used in different senses.2 One covers a wide range of 
compounds including fatty acids while the other is limited to non-fatty acid natural products, 
biosynthetically derived from fatty acids. Common fatty acids are primary metabolites. Non-
fatty acid polyketides are secondary metabolites and they are the subject of the study for 
natural products chemists. 
Investigations on the molecular biology of polyketide biosynthesis have demonstrated that 
genes of fatty acid synthases (FAS) and microbial polyketide synthases (PKSs) have a 
significant homology and they are recognized to have evolved from the same prototype gene. 
The chain elongation mechanism in the biosynthesis of such polyketides as erythromycin A 
(3) and rapamycin (4) is basically the same as that for FAS. It is therefore reasonable that fatty 
acids are included within polyketides when their biosynthesis is discussed at the enzyme and 
gene levels. At the same time there are significant differences in the biosynthesis of 
polyketides in microorganisms, fungi and plants. 
For E. coli. bacteria, for example, the synthesis of fatty acids involves eight enzymes. 
Important for the biosynthesis are coenzyme A (CoA) (7) and acyl carrier protein (ACP) (8), 
both possessing a terminal –SH function, crucial for the biosynthetic process (Figure 2). 
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Figure 2. Phosphopantetheine in coenzyme A and acyl carrier protein (ACP) 
The CoA activates a carboxylate anion towards nucleophilic substitution by its conversion 
into a thioester. This process is catalyzed by acyl-CoA synthase and can be considered as the 
first stage of the fatty acid synthesis (Scheme 1). It is worth to note, that four different acyl-
CoA synthases are found in cells, with specificities for fatty acids whose chains are short 
(<C6), medium (C6-12), long (C12-16), or very long (>C16). 
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Scheme 1. Mechanism of the formation of acyl-CoA, catalyzed by acyl-CoA synthase 
The second stage consists of the carboxylation of acetyl CoA to form malonyl CoA in a 
reaction catalyzed by the biotin-dependent enzyme acetyl-CoA carboxylase. This process is 
the key regulatory step of fatty acid synthesis (Scheme 2). 
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Scheme 2. Mechanism of acetyl-CoA carboxylase 
In Escherichia coli, three separate protein subunits carry out this transformation: a carrier 
protein called biotin carboxyl carrier protein (BCCP) and two enzymes, a biotin carboxylase 
and a transcarboxylase. In animals and yeast, all these functions are combined and performed 
by a single modular protein. 
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Assembly of fatty acids may be divided into five stages: (1) loading, (2) condensation, (3) 
reduction, (4) dehydration and (5) a further reduction (Scheme 3). 
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Scheme 3. Stages in the biosynthesis of fatty acids from acetyl CoA and malonyl CoA in E. 
coli 
1. Loading: two enzymes, acetyl CoA:ACP transacylase and malonyl CoA:ACP transacylase, 
are required for the loading steps, in which acetyl CoA and malonyl CoA are transesterified 
with ACP. 
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2. Condensation: ketoacyl-ACP synthase (KS), also called condensing enzyme, accepts an 
acetyl group from acetyl-ACP, and ACP-SH is released. KS then catalyzes transfer of the 
acetyl group to malonyl-ACP, evolving CO2 and forming acetoacetyl-ACP. 
3. Reduction: the ketone of acetoacetyl-ACP is converted to an alcohol, forming D-β-
hydroxybutyryl-ACP, in an NADPH-dependent reaction catalyzed by ketoacyl-ACP 
reductase. 
4. Dehydration: a dehydrase catalyzes the removal of water, with formation of a double bond. 
5. Further reduction: the product of dehydration, trans-butenoyl-ACP, undergoes reduction 
to form butyryl-ACP, in a reaction catalyzed by NADPH-dependant enoyl-ACP reductase. 
Steps 2-5 are repeated until a C16 palmitoyl group is formed. A thiolase enzyme catalyzes 
hydrolytic cleavage of palmitoyl-ACP and furnishes palmitate.  
Complex polyketides are synthesized by the essentially the same basic mechanism that was 
discussed in above. A series of decarboxylative condensation reactions between small 
carboxylic acid units and malonate proceed under enzymatic catalysis with the so called 
polyketide synthases (PKSs).a,3 
1.3 Biosynthesis of polyketides by modular synthases 
Known PKSs have been classified into three main types.4 Type I PKSs (or noniterative PKS) 
are multifunctional enzymes, organized into modules. Each module is responsible for a set of 
certain non-iteratively acting activities in a single cycle of the chain-elongation sequence, as 
exemplified in a simplified form by the biosynthesis of erythromycin A (3) (Scheme 4).5 Type 
II PKSs are multienzyme complexes that carry a single set of iteratively acting activities, as 
exemplified by the tetracenomycin C (9) biosynthesis (Scheme 4). Type III PKSs,b are 
homodimeric enzymes. A single III PKS catalyzes iterative condensation of small fatty acids, 
as exemplified by the biosynthesis of flavolin (10) (Scheme 4). 
Type I and II PKSs use acyl carrier protein (ACP) to activate the acyl CoA substrates whereas 
type III PKSs act directly on the acyl CoA substrates without ACP involvement. Despite these 
mechanistic differences, biosynthesis catalyzed by any PKSs proceeds through sequential 
decarboxylative condensation of acyl CoA precursors, and the ketoacetyl synthase (KS) 
catalyzes the C-C bond-forming step. 
                                                 
a) PKSs are large multienzyme systems (Mr = 100-10000 kDa). 
b) Also known as chalcone synthase-like PKSs. 
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Scheme 4. The three types of PKSs in the biosynthesis of polyketides 
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Since the first reports of bacterial type I PKS in 1990,5 type II PKS in 19846 and type III PKS 
in 19997 the PKS paradigms have helped the scientific community to classify and explain the 
vast structural diversity observed for polyketide natural products, and the biotechnological 
platform to produce ‘unnatural’ natural products by combination of biosynthetic methods with 
engineered PKSs.8 
There are about 7,000 identified polyketides, but this represents only a small fraction of what 
nature is capable of producing.8 Current and future research on polyketide biosynthesis will be 
driven by the unparalleled biological activities and commercial valuec of natural products, 
which remain the most promising candidates for new drug discovery. Remarkable versatility 
and amenability of PKSs allow the synthesis of novel compounds, difficult to access by 
conventional synthetic methods, by combinatorial biosynthesis.8 Integration of biological 
tools with chemical knowledge will evidently open new frontiers both for science and 
industry. 
1.4 Secondary metabolites and the OSMAC methodology 
It has been long known that cultivation conditions have strong influence on the production of 
microbial products. In nature, a changing environment results into changes in transcriptome, 
proteome, and finally metabolome. In the course of evolution these changes allow an 
organism to adapt to the new conditions and to survive. One can speculate on the function of 
secondary metabolites.9 Some may bring clear advantage for a living organism, others – not. 
In fact, any change of a cultivating parameter may influence every single biosynthetic step. 
Since there is a huge number of such steps on translational, transcriptional or enzymatic 
levels, the approach provides an endless number of possible combinations that results into a 
vast number of microbial products produced in this way. Systematic alteration of cultivating 
parameters (media composition, pH, temperature, addition of enzyme inhibitors, salts, oxygen 
supply even the type of culture vessel etc.) is a simple and natural approach to influence the 
production of secondary metabolites and, probably, to obtain new ones.10 This way of 
releasing nature’s chemical diversity has been termed by Zeeck et al. an OSMAC (One Strain 
– MAny Compounds) approach, which resulted from the observation that small changes in 
the cultivation conditions can completely shift the metabolic profile of microorganisms.11,12 
                                                 
c) The market of polyketides is estimated to exceed $10 billion per annum 
(http://www.bio.cam.ac.uk/~pflgroup/research.htm). 
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1.5 Hexacyclinic acid - a polyketide from the Streptomyces 
In 2000 Zeeck et al. described the isolation of hexacyclinic acid (11, Figure 3), a new natural 
product with an unusual structure, from Streptomyces cellulosae subsp. griseorubiginosus 
(strain S1013).12 
Following the OSMAC approach strain S1013 has been cultivated in different culture vessels, 
using a rolled oats medium. In the extract of culture filtrate from a 10 L fermenter a new 
metabolite has been detected. The substance was identified by TLC (Rf = 0.3 in CHCl3/MeOH 
9:1) as an intensive blue spot when anisaldehyde/H2SO4 was used as a staining reagent. 
Unfortunately, low yields obtained did not allow the complete structure elucidation. 
Optimization of the fermentation process was conducted. The influence of different alkali 
metal halides on was investigated. It was found that sodium bromide present in a 
concentration of 1 g·L-1 in the cultivating medium resulted in 10-20 fold increased production 
of the unknown metabolite. In special fermentation vessels the yield of the compound rose to 
13 mg·L-1. Additional optimization of the C-source allowed to obtain up to 56 mg·L-1 of the 
natural product. These efforts allowed the isolation of the substance in reasonable quantities, 
and structure elucidation using spectroscopic methods (1H and 13C NMR, HRMS ESI, COSY, 
HSQC, HMBC, NOESY and X-ray structural analysis).13 Absolute stereochemistry could be 
defined using advanced Mosher’s ester methodology.14 
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H3C
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H H
H H
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COOH
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B C D
E
F
O H
CH3       
hexacyclinic acid (11) 
Figure 3. Hexacyclinic acid (11), a new polyketide from Streptomyces cellulosae subsp. 
Griseorubiginosus (strain S1013)d 
Hexacyclinic acid showed weak cytotoxicity towards three tested cell lines (HM02, HEPG2 
and MCF7) with GI50 values as low as 14.0 µmol·L-1. 
In order get insight into the biosynthesis of 11, feeding experiments were conducted.15 
Feeding of the growing strain with [1-13C] acetate and comparing 13C NMR of the so obtained 
                                                 
d) 3D structure of hexacyclinic acid representing a minimum of potential energy was created and optimized 
(MM2 method, RMS gradient = 0.01) using Chem3D® software (CambridgeSoft Corp.). 
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metabolite with the original sample revealed signal enhancement for C-1, C-3, C-8, C-16, C-
18 and C-27. The increment of values for specific incorporations of C-5 and C-12 was within 
the experimental error. Another feeding experiment with [1-13C] propionate showed strong 
enrichment of C-5, C-10, C-14 an C-22. Combination of these two experiments led to the 
conclusion that hexacyclinic acid is a polyketide built by seven acetate and four propionate 
units (Figure 4). 
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Figure 4. The polyketide nature of hexacyclinic acid was revealed from the labeling pattern 
At this stage hexacyclinic acid was believed to arise from a single polyketide chain precursor 
built by a modular type I polyketide synthase (see Section 1.3). The transformations that could 
lead from this precursor to 11 were not clear. It was nevertheless proposed that these could be 
an intramolecular Diels-Alder reaction, aldol reaction, lactonization and ketalization. 
Since more understanding of the biosynthetic pathways leading to 11 was desired Zeeck et al. 
conducted advanced feeding experiments.15 This time the strain was fed with [1-13C, 18O2] 
labelled propionate. 
O HOH
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COOH
18O label
NO 18O label found
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5
14
22
1018O label H
 
Position Incorporation 13C (%) 18O/16O (%) 
C-5 31.9 70.1 
C-10 25.5 - 
C-14 32.7 71.3 
C-22 22.8 - 
Figure 5. Results of the feeding experiments with [1-13C, 18O2] propionate 
As a result of this experiment, it was found that C-5 and C-14 were directly connected to an 
18O enriched oxygen (Figure 5.). Interestingly, no 18O incorporation was found near to C-7 
suggesting that hemiketal OH was 18O enriched. 
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Based on these results Zeeck et al. suggested that the D-ring of hexacyclinic acid was 
probably not formed in a hetero Diels-Alder reaction, as was proposed for a related natural 
product, (-)-FR182877 (12) (Scheme 5),51a otherwise there should have been an 18O label at 
C-7. 
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Scheme 5. Proposed biosynthetic approach towards (-)-FR182877 (WS9885B) that features 
transannular hetero Diels-Alder reaction (Sorensen et al.) 
Zeeck et al. proposed a biosynthesis featuring a vinylogous Prins reaction in the formation of 
the C-ring. In this transformation the trisubstituted alkene acts as a nucleophile adding to the 
Michael acceptor followed by addition of water (Scheme 6). 
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Scheme 6. Possible pathway in the biosynthesis of hexacyclinic acid (Zeeck et al.) 
Especially interesting and valuable for the understanding of the biosyntheses of both (-)-
FR182877 (12) and hexacyclinic acid (11) could be a feeding experiment of the Streptomyces 
strain producing (-)-FR182877 with [1-13C, 18O2] labelled propionate. Investigation of the 18O 
label incorporation could support or reject the proposed biosynthesis of hexacyclinic acid. To 
the best of our knowledge such experiment has not hitherto been described. 
1. Introduction 
 
27
1.6 Structurally related compounds 
Bicyclo[4.3.0]nonane structural fragment found in hexacyclinic acid (11) and (-)-FR182877 
(12) is often found in metabolites produced by the Streptomyces bacteria. Selected examples 
are presented in Figure 6. 
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Figure 6. Selected natural products from the Streptomyces 
The macquarimicins A-C (13a-13c, Figure 6) were isolated from Micromonospora chalcea by 
researchers at Abbott Laboratories in 1995.16 
Macquarimicin A (13a) was isolated as a very weak antibacterial agent, while macquarimicins 
B (13b) and C (13c) were found to exhibit cytotoxicity against the P388 leukemia cell line 
(IC50 is 0.3 and 30.0 µg/mL, respectively).16a In 1999, researchers at Sankyo Co. disclosed 
that 13a is a selective inhibitor of membrane-bound neutral sphingomyelinase (N-SMase).17 
An improved understanding of SMase-dependent signaling may provide novel strategies for 
the treatment of inflammatory and neurodegenerative diseases, as well as cancer. Thus, 
selective inhibitors of N-SMase are used to gain insight into the enzyme mechanism, which is 
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currently unknown, and more importantly into the experimental therapy of such diseases. The 
total synthesis of macquarimicins inspired by a biosynthetic pathway and using an 
intramolecular Diels-Alder approach was successfully accomplished by Tadano and co-
workers.18 
Another natural product of this family, cochleamycin A (14a, Figure 6), was isolated from 
Streptomyces DT136 in 1992 by Shindo and co-workers.19 In addition to displaying 
antimicrobial activity against gram-positive bacteria, cochleamycin A is cytotoxic toward a 
variety of tumor cell lines.e,20 The total synthesis of the compound was described by the group 
of W. Roush in 2004.21 
In 1995, stawamycin (16),22 a new natural product from the pyrroloketoindane family was 
isolated by Miao et al. from a liquid culture of Streptomyces sp. and displayed moderate 
inhibitory activity against the binding of the Epstein-Barr virusf BZLF1 transcription factor to 
DNA with IC50 = 50 µM in a DNA binding assay (Figure 6). 
(-)-FR182877 or cyclostreptin, a substance formerly known as WS9885B and described by 
Fujisawa Pharmaceutical Company,23 has been identified in screens as an agent that binds and 
stabilizes cellular microtubules.24 Formation of microtubules involves polymerization of 
heterodimeric α/β-tubulin subunits which is regulated by several microtubule-associated 
proteins and involves a hydrolysis of guanosine 5'-triphosphate.25 Intact microtubule function 
is required for the formation and functioning of the mitotic spindle. That is why cells treated 
with agents that bind either tubulin subunits or polymerized microtubules exhibit alterations in 
spindle formation leading to arrest at the G2/M phase of the cell cycle, which is associated 
with the induction of apoptosis.26 Compounds that target microtubules are potent cytotoxic 
agents, exemplified by a variety of plant and marine natural products. Representative 
examples are epothilones,27 discodermolide,28 eleutherobins,29 dolastatins,30 cryptophycins,31 
indanocine,32 halicondrin B,33 peloruside A,34 laulimalide35 and paclitaxel.38 Inhibitors of 
microtubule assembly may also show prominent anti-tumor activities, as exemplified by 
vinblastine.36 Important that not all compounds that affect microtubule function are useful as 
anticancer drugs (e.g., colchicine). Furthermore, recent data suggest that at least a part of the 
anticancer activity exhibited by this class of drugs involves antiangiogenic effects on 
tumorassociated endothelial cells.37 
Preclinical studies indicated that FR182877 binds and stabilizes microtubules in a manner 
similar but not identical to that of paclitaxel38 and the epothilones.39 
                                                 
e) IC50 = 1.6 µg/mL for P388 leukemia cells. 
f) A human herpes virus that infects lymphocytes and epithelial cells. See Dimmock, N. J.; Primrose, S. B. In 
Introduction to Modern Virology, 4th ed.; Blackwell Science: Oxford, 1994, Chapter 17, p. 266-267. 
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The molecule of (-)-FR182877 features a strained anti-Bredt bridgehead olefin that is believed 
to be the active site for the covalent binding to tubulin. 
In 2004 the scientists from the Fujisawa Pharmaceutical Company, reported on the isolation 
and structure elucidation of FR182876 (12a), a new water soluble natural product, produced 
by the Streptomyces.40 3-Methylhistidine moiety found in FR182876, is believed to contribute 
to both solubility in water and activity in promoting tubulin polymerization. 12a showed 
potent cytotoxicity against a panel of cancer cells at concentrations of 28-75 ng/mL. 
Natural products 11-16, possessing bicyclo[4.3.0]nonane skeleton may share a biosynthetic 
pathway that involves intramolecular Diels-Alder (IMDA) reaction of polyketide 
intermediates.19d,50,41 
Oikawa et al. proposed that Diels-Alder reactions may be involved in the biosynthesis of 
more than a hundred of natural products.41b However, to date, only three natural enzymes, 
solanapyrone synthase (SPS),42 lovastatin nonaketide synthase (LNKS),43 and macrophomate 
synthase (MPS),44 have been shown to catalyze Diels-Alder reactions in purified or partially 
purified form.45 At the same time, definitive proof that MPS and the other two enzymes 
catalyze the Diels-Alder reaction remains somewhat elusive.46 
In 2003, the group of Tanaka and Oikawa elucidated the structure of Diels-Alderase for the 
first time by X-ray crystallography of MPS.47 
Artificial ribozymes that catalyze the Diels-Alder reaction have been described.48 
Details of the biosyntheses of 11 and 12 are still unclear. Therefore, the development of a 
synthetic methodology may help to elucidate the details by supplying synthetic probes. This 
intriguing feature of this class of natural products, combined with biological activities and a 
formidable molecular architecture, makes them highly attractive targets for synthetic 
chemists. 
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2 Discussion 
2.1 Synthetic progress towards hexacyclinic acid and related substances 
In 1998 scientists of the Fujisawa Pharmaceutical Company reported on the discovery of a 
novel microtubulin stabilizing agent, WS9885B (12), later called as FR182877.23 Fujisawa 
scientists originally incorrectly assigned 12 with the opposite absolute configuration to that 
shown in Figure 6. Their assignment based on the Mosher ester method was later corrected.49 
In 1999, Sorensen and co-workers reported the first synthetic study towards FR182877 (12) 
and proposed the biosynthetic pathway for the antibiotic.50 The first total synthesis of 
FR182877 by Sorensen was actually that of the non-natural enantiomer.51 Later the group 
elaborated an optimized synthesis to the naturally occurring enantiomer, (-)-FR182877.52 
Soon after the synthesis of Sorensen, synthetic investigations towards hexacyclinic acid (11) 
and FR182877 (12) were reported by the groups of Evans,53 Prunet,55 Armstrong,61 Nakada,57 
Clarke,54,59 Roush,58 Landais72 and Kalesse.69 These synthetic contributions will be discussed 
in this section. 
2.2 Synthesis of the A-ring of hexacyclinic acid and (-)-FR182877 by Prunet et. al. 
In the course of the studies towards the synthesis of (-)-FR182877 Prunet and co-workers55 
reported on the construction of the A-ring of the natural product exploiting the ring closing 
olefin metathesis (RCM) (Scheme 7). 
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(a) CH≡CMgBr, 75%; (b) HF/CH3CN, 82%; (c) DIBAL, 89%; (d) TBSOTf, 2,6-lutidine, 82% or BnBr, NaH, 
TBAI, 90%; (e) Grubbs' II catalyst, CH2Cl2, 0.03 M, ethylene. 
Scheme 7. RCM in the construction of the A-ring of (-)-FR182877 (Prunet et al.) 
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A synthetic approach towards the ABC cyclic fragment of FR182877 featuring a Diels-Alder 
reaction as the key step was also proposed (Scheme 8).56 
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(a) Olefin migration; (b) retro Diels-Alder reaction; (c) Diels-Alder reaction. 
Scheme 8. Retrosynthetic approach towards the ABC fragment of (-)-FR182877 (Prunet et 
al.) 
2.3 Synthesis of the bicyclic AB-fragment of (+)-FR182877 by Nakada et al. 
Nakada and co-workers57 found that the intramolecular Diels-Alder reaction (IMDA) of the 
all-trans substituted precursor 21 proceeds through the endo- transition state furnishing the 
cycloadduct with the relative stereochemistry corresponding to that of the AB cyclic fragment 
of (+)-FR182877 (Scheme 9). 
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(a) 2,6-di-tert-butyl-4-methylphenol (BHT), 80 °C, 24 h. 
Scheme 9. Synthesis of the AB cyclic fragment of (+)-FR182877 (Nakada et al.) 
2.4 Construction of the C-ring of (-)-FR182877 by Roush et al. 
Roush58 recognized that the C-ring of (-)-FR182877 may be constructed utilizing an 
intramolecular vinylogous Morita-Baylis-Hillman Reaction. Indeed, treatment of the acrylate 
24 with PMe3 (4 equiv) in THF/H2O 3:1 resulted in the formation of 25a and 25b with 84% 
yield and 6:1 dr with the desired diastereomer favored (Scheme 10). 
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(a) 4 equiv PMe3, 0.03 M tert-amyl alcohol, 20 h. 
Scheme 10. Intramolecular vinylogous Morita-Baylis-Hillman reaction in the construction of 
the C-ring of (-)-FR182877 (Roush et al.) 
A retrosynthetic approach towards (-)-FR182877 based on the vinylogous Baylis-Hillman 
reaction has been proposed (Scheme 11). 
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Scheme 11. Retrosynthetic approach towards the ABC fragment of FR182877 (Roush et al.) 
2.5 Synthesis of the DEF-cores of FR182877 and hexacyclinic acid by Clarke et al. 
Clarke and co-workers proposed a universal approach to the DEF-ring fragments of both 
FR182877 and hexacyclinic acid utilizing a transannular cationic cyclization of a β-ketoester 
26 to an appropriately positioned double bond (Scheme 12).59 
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Scheme 12. Construction of the DEF cores of hexacyclinic acid (11) and FR182877 (12) 
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Carbocyclic precursor 26 was synthesized in six steps starting from nerol. The key step in the 
sequence is the intramolecular C-alkylation of a β-ketoester with a π-allyl Pd-complex.60 
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(a) DMAP, Ac2O, Py, 18 h 100%; (b) mCPBA, 2 h, CH2Cl2, 0 °C, 85%; (c) HIO4, THF/H2O, 2 h, 0 °C, 81%; (d) 
TiCl4, CH2Cl2, -78 °C, 3 h, 79%; (e) TBSOTf, Py, -35 °C, 8 h, 97%; (f) NaH, 5 mol% Pd(PPh3)4, 10 mol% dppf, 
THF, reflux. 
Scheme 13. Construction of the nine-membered β-ketoester 26 
When 26 was treated with iodine and silver acetate in AcOH at rt transannular iodocyclization 
occurred (Scheme 14). Four products 34, 35, 36 and 37 were obtained. It is noteworthy that 34 
embodies the DF-ring fragment of hexacyclinic acid whereas 37 – the DF cyclic fragment of 
FR182877. 
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Scheme 14. Transannular iodocyclization of β-ketoester 26 
After the removal of the protecting groups the lactonization was conducted under acidic 
conditions furnishing the DEF cyclic fragment of hexacyclinic acid (38) with excellent yield 
(Scheme 15). 
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(a) HF, CH3CN, rt, 18 h, 97%; (b) TFA, CH2Cl2, rt, 4 days, 100%. 
Scheme 15. Construction of the DEF core of hexacyclinic acid 
Though the construction of the DEF core of FR182877 was straightforward from 37, it was 
not possible to influence the course of the iodocyclization to favor the formation of 37. The 
conversion of 34 into the DEF cyclic fragment of hexacyclinic acid (41) required 4 additional 
synthetic steps (Scheme 16). 
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(a) Pd(PPh3)4, Bu3N, HCO2H, DMF, 23%; (b) DBU, CH3CN, reflux, 93%; (c) 40% aqueous HF, CH3CN, 100%; 
(d) TFA, CH2Cl2, 100%. 
Scheme 16. Construction of the DEF core of FR182877 
Though a universal approach towards the DEF-cyclic fragment of both 12 and 11 has been 
achieved, no synthetic strategy towards these natural products based on the transannular 
iodocyclization has been proposed. 
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2.6 Studies towards the DE fragment of FR182877 by Armstrong et al. 
Armstrong and co-workers envisioned that the synthesis of the DE core of FR182877 may be 
achieved in one step starting from commercially available compound 42 (Scheme 17).61 
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(a) LDA, R2C(O)R3, -22 °C overnight then aqueous workup. 
Scheme 17. Synthesis of the DE core of FR182877 by Armstrong and co-workers 
Reaction of a carbonyl compound with the γ-enolate generated from 42 furnished the product 
43 in a yield of 40-80% after a standard aqueous workup. Aromatic and aliphatic aldehydes, 
ketones, cyclohexanone, acrolein and diethyl ketomalonate were successfully used as 
carbonyl components. 
No synthetic approach towards the natural product was proposed by Armstrong et al. 
2.7 The total syntheses of (+)-FR182877 and (-)-FR182877 by Sorensen et al. 
Sorensen et al. recognized that four of the six rings of the target molecule and seven of its 
stereocenters may be constructed in a sequence of two cycloadditions starting form 
polyunsaturated precursor 44 (Scheme 18). If 44 initially participated in an intramolecular 
Diels-Alder (IMDA) reaction with endo-selectivity to furnish 45, subsequent intramolecular 
Knoevenagel condensation could then provide 47, a substrate suitable for the transannular 
hetero-Diels-Alder reaction between the enone and the trisubstituted olefin that would provide 
48. Alternatively, 44 could first participate in a Knoevenagel condensation to afford the 19-
membered cyclic pentaene 46 poised to undergo a tandem of a transannular Diels-Alder 
reaction (TADA) and the hetero-Diels-Alder reaction to furnish 48. In either routes, a final 
lactonization would complete the target molecule 12. 
2. Discussion 
 
36
HO
OO
CH3
OH
CH3 CH3
OH
CH3OHC
OH
Intramolecular 
Diels-Alder 
Reaction
HO
OO
CH3
OH
CH3 CH3
OH
CH3HO
OHC
H
H
H
Knoevenagel
Condensation
Knoevenagel
Condensation
O H3C
OHHO
H
CH3
H
O
O
H
H3C
H3C
HO H
O H3C
OHHO
CH3
O
O
H
H3C
H3C
HO
Transannular 
Diels-Alder 
Reaction
Transannular 
Hetero-Diels-Alder 
Reaction
O
H3C
OHHO
H
CH3
H
CH3
H3C
HO H
H
H
OHO
O
H3C
OHHO
H
CH3
H
H3C
O
H
H
H
O
Lactonization
H3C
H
H
(-)-FR182877 (12)
44 45
46 47
48  
Scheme 18. Biomimetic retrosynthetic approach to (-)-FR182877 by Sorensen et al. 
Early investigations revealed that compounds such as 45 could, indeed, be synthesized with 
the help of the intramolecular Diels-Alder reaction. Unfortunately, all attempts to accomplish 
intramolecular or intermolecular Knoevenagel condensation failed (Scheme 19).50 
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Scheme 19. Attempted intra- and intermolecular Knoevenagel condensation 
Sorensen and co-workers decided access the 19-membered pentaene precursor 46 omitting the 
Knoevenagel condensation.62 A new retrosynthetic approach to that end has been proposed 
(Scheme 20). 
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Scheme 20. Sorensen’s retrosynthetic analysis of (-)-FR182877 (12) 
Cyclic tetraene 54 was recognized to be a suitable precursor for the pentaene 46 (Scheme 18). 
Sorensen and co-workers expected to introduce the missing double bond via a selenation-
elimination sequence.63 Compound 54 had to be synthesized according to the Tsuji-Trost 
protocol64 starting from the acyclic carbonate 55, which may be accessible from the Weinreb 
amide 56. This compound was divided into two precursors 57 and 58 of approximately equal 
size that have to be merged using the Pd-catalyzed π-allyl Stille reaction.65 Both 57 and 58 
were effectively constructed utilizing the Evans aldol protocol (Scheme 21 and Scheme 22).66 
H
O
OAc a-c N
O
O
CH3
OTMS
CH3
OAc
5759  
(a) (R)-4-phenyl-N-propionyloxazolidin-2-one, n-Bu2BOTf, i-PrNEt2, CH2Cl2, -78 °C, 1 h; -25 °C, 18 h; 0 °C, 
MeOH, 100%; (b) NH(OCH3)CH3 · HCl, Me3Al, THF, -15 °C; (c) TMSCl, imidazole, CH2Cl2, 25 °C, 25 min; 
87% overall yield. 
Scheme 21. Synthesis of the Weinreb amide 57 
 
 
2. Discussion 
 
38
TBSO
H
O
a-c TBSO
OTMS
CH3
N O
O
d TBSO
OTMS
CH3
O
P
O O
O
e, f
HO
OH
CH3
O
I
g, h
TESO
OTES
CH3
OTES
I
CH3
i
TESO
OTES
CH3
OTES
Me3Sn
CH3
58
60 61 62
63 64
 
(a) (R)-(-)-4-benzyl-N-propionyloxazolidin-2-one, n-Bu2BOTf, i-Pr2NEt, CH2Cl2, 0 °C, -78 → 0 °C, 74%; (b) 
NH(OCH3)CH3 · HCl, Me3Al, THF, 0 °C, 98%; (c) TMSCl, imidazole, DMAP, CH2Cl2, 23 °C; (d) 
LiCH2P(O)(OMe)2, THF, -78 °C; (e) Ba(OH)2, THF, then (E)-β-iodomethacrolein, THF/H2O, 0 °C; (f) PPTS, 
MeOH, 23 °C, 83% over four steps; (g) Et2BOMe, NaBH4, THF/MeOH, -78 → 0 °C; (h) TESCl, imidazole, 
DMAP, CH2Cl2, 90% over two steps; (i) Me3SnSnMe3, Pd(Ph3P)4, i-Pr2NEt, PhH, 80 °C, 95%. 
Scheme 22. Synthesis of the vinylstannane 58 
According to the retrosynthetic plan the Stille coupling of 57 and 58 proceeded smoothly to 
provide the product 65 in 91% yield (Scheme 23). 
2. Discussion 
 
39
5857 +
a
OTES
OTES
CH3
TESO
H3C
H3C
TMSO
N
O
O
b, c
OH
OTES
CH3
TESO
H3C
H3C
HO O
Ot-Bu
O
d, e
O
OTES
CH3
TESO
H3C
H3C
TMSO O
Ot-Bu
O
OCH3
O
f
O H3C
ORRO
CH3
O
t-Bu
H3C
H3C
TMSO
68: R = TES
O H3C
ORRO
CH3
O
t-Bu
H3C
H3C
TMSO
R = TES
g X
X = SePh
h
O
H3C
ORRO
H
CH3
H
H3C
OTMS
H
H
H
OH3C
H
H O t-Bu
71: R = TES
i
O
H3C
OHHO
H
CH3
H
H3C
OH
H
H
H
OH3C
H
H O t-Bu
O
H3C
OHHO
H
CH3
H
H3C
OH
H
H
H
OH
H3C
H
H O
O
H3C
OHHO
H
CH3
H
H3C
O
H
H
H
H3C
H
H
O
j k
(-)-FR182877 (12)
65 6766
seco-acid 75
O O
69:
74  
(a) Pd2dba3, LiCl, i-Pr2NEt, NMP, 40 °C, 91%; (b) LDA, t-BuOAc, THF, -78 → 25 °C, 85%. (c) TBAF, THF, 
-30 → -10 °C; (d) MeOCOCl, pyridine, CH2Cl2, 25 °C; (e) TMSCl, imidazole, CH2Cl2, 25 °C, 82% over three 
steps; (f) 10 mol% Pd2dba3, THF (0.05 M), 45 °C, 60-85%; (g) NaHMDS, PhSeBr, Et2O, 25 °C, < 1 min, 89%, 
10:1 dr; (h) mCPBA, CH2Cl2, -78 °C, 1 min (E:Z = 2.2 : 1); NaHCO3, CH3Cl, 45 °C, 4 h, 61-66%; (i) PPTS, 
MeOH, 0 → 25 °C, 2 h, 100%; (j) TFA/CH2Cl2 9:1, 0 °C, 1 h, 96%; (k) Mukaiyama’s reagent, Et3N, 
CH2Cl2/CH3CN 9:1, 25 °C, 76%. 
Scheme 23. Completion of the total synthesis of (-)-FR182877 by Sorensen and co-workers 
The Weinreb amide 65 was transferred into the keto ester 66 and the deprotected primary 
allylic alcohol was converted into carbonate 67 needed for the Tsuji-Trost reaction. 
Fortunately, when a diluted THF solution of 67 was stirred at 45 °C for 24 h with 10 mol% of 
Pd2dba3, product 68 was obtained in a 60-85% yield. 
To introduce the double bond required for the tandem Diels-Alder/hetero-Diels-Alder 
sequence, 68 was treated with NaHMDS followed by PhSeBr providing a 10:1 diastereomeric 
mixture of products 69. When this mixture was treated with mCPBA at -78 °C, oxidation-
elimination sequence provided a 2.2:1 mixture of (E)- and (Z)-olefins 70. Tandem 
transannular Diels-Alder/hetero-Diels-Alder reaction proceeded when the above 
diastereomeric mixture was heated in CH3Cl/aqueous NaHCO3 to furnish the cycloadduct 71 
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in 61-66% yield along with 72 (8-15%) and 73 (8-15%) (Scheme 24). Both products are 
believed to derive from the (Z)-olefin obtained after the selenation - elimination sequence. 
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Scheme 24. The tandem transannular Diels-Alder/hetero-Diels-Alder reaction 
In order to complete the synthesis, the TMS protected alcohol was deprotected to give 74 and 
the tert-Bu ester was hydrolyzed to furnish the seco-acid 75. The lactonization was 
accomplished when 75 was treated with the Mukaiyama’s reagent to yield the (-)-FR182877 
(12) (Scheme 23). 
2.8 The total synthesis of (-)-FR182877 by Evans et al. 
In 2002, the Evans group from Harvard university reported a successful completion of the 
total synthesis of (-)-FR182877. In its strategy the synthesis is similar to that of the Sorensen 
group, featuring the key sequence of a tandem transannular Diels-Alder/hetero-Diels-Alder 
reaction. 
Instead of the Stille coupling used by Sorensen et al. Evans and co-workers utilized Pd-
catalyzed Miyaura-Suzuki coupling to merge fragments 76 and 77 (Scheme 25). Weinreb 
amide 78 was reduced with DIBAL to the aldehyde and converted to the β-ketoester 79 
according to the Roskamp protocol.67 The primary allylic alcohol was deprotected with TBAF 
and transformed into allyliodide 79. Intramolecular alkylation of the β-ketoester, promoted by 
Cs2CO3 furnished the 19-membered macrocycle 80. 
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 (a) Pd(PPh3)4, Tl2CO3, 84%; (b) DIBAL, THF; (c) ethyl diazoacetate, SnCl2 (cat.); (d) TBAF, AcOH; (e) I2, 
PPh3; (f) Cs2CO3, 49% over six steps; (g) (PhSeO)2O, SO3·Py, Et3N, THF, 25 °C, 2 h, 50 °C, 6 h, 63%; (h) 
HF/CH3CN (1:20); (i) Me3B3O3, Pd(dppf)Cl2, Cs2CO3, 80 °C; (j) TMSOK, THF; (k) Mukaiyama’s reagent, 44% 
over four steps. 
Scheme 25. The synthesis of (-)-FR182877 by Evans et al. 
To introduce the unsaturation needed for the tandem cycloaddition step, the group of Evans 
utilized (PhSeO)2O with SO3·Py. Remarkably the desired E- olefin was obtained exclusively 
and underwent subsequent tandem transannular Diels-Alder/hetero-Diels-Alder reaction at 
50 °C to provide 81 in 63% yield. 
The silyl protecting groups were removed with HF in CH3CN. The vinylic bromine was 
substituted with a methyl group in a Pd-catalyzed Suzuki reaction with Me3B3O3.68 The ethyl 
ester was saponificated with TMSOK and the lactonization was successfully effected with the 
Mukaiyama’s reagent to provide (-)-FR182877 (12). 
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2.9 Synthesis of the ABC cyclic fragment of hexacyclinic acid by Kalesse et al. 
Kalesse et al. reported on the synthesis of the ABC cyclic fragment of hexacyclinic acid.69 
The synthesis started with the alcohol 82 (Scheme 26, Scheme 27). 
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(a) TBSCl, imidazole, DMF; (b) O3, Me2S, CH2Cl2; (c) (E)-(EtO)2P(O)CH2CH=CHCOOEt, LDA, THF, 0 °C → 
rt, 70% over three steps; (d) DIBAL, CH2Cl2, -78 °C, 98%; (e) MnO2, CH2Cl2, 94%; (f) 4(S)-benzyl-3-
propionyloxazolidin-2-one, n-BuBOTf, Et3N, CH2Cl2, -78 °C, 99%; (g) NHMe(OMe)·HCl, Me3Al, CH2Cl2, 
78%; (h) TBSOTf, lutidine, CH2Cl2, -78 °C, 86%; (i) DIBAL, THF, -78 °C, 90%; (j) HC≡CMgBr, CH2Cl2, 
-78 °C → rt, 95%; (k) Dess-Martin, CH2Cl2, 99%; (l) toluene, 80 °C, 78%; (m) CH2=CHMgBr, CuBr·Me2S, 
THF, Me2S, -78 °C, 84%; (n) LiAlH4, THF, -100 °C, 96%, dr 20:1. 
Scheme 26. The synthesis of the ABC-cyclic fragment of hexacyclinic acid 
After TBS protection and ozonolysis, aldehyde 83 was subjected to the HWE olefination with 
(E)-(EtO)2P(O)CH2CH=CHCOOEt to give the (E)-, (E)- diene selectively. This was 
converted to the aldehyde 84 through reduction with DIBAL and reoxidation of the allylic 
alcohol with MnO2. The boronate aldol reaction according to the Evans protocol furnished the 
aldol in 99% yield. This was treated with NMe(OMe)·HCl and Me3Al to give the Weinreb 
amide 85. After the protection of the secondary alcohol as a TBS ether, the amide function 
was reduced with DIBAL to the aldehyde and reacted with HC≡CMgBr. Reoxidation of the 
secondary alcohol with the Dess-Martin reagent furnished alkynone 86 (Scheme 26). 
The Diels-Alder reaction took place when 86 was heated in toluene to give 87 in 78% yield. 
Substrate controlled conjugate addition of vinylmagnesium bromide to 87 provided 88. It was 
found that the reduction of the ketone functionality in the A-ring with LiAlH4 at -100 °C 
furnished the desired diastereomeric alcohol 89 with excellent selectivity (Scheme 26). 
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(o) 4 equiv methyl acrylate, 5 mol% Grubbs II catalyst, CH2Cl2, 80%; (p) TBDPSCl, i-Pr2EtN, DMAP, 5d, 98%; 
(q) CSA, CH2Cl2, MeOH, 0 °C, 82%; (r) TPAP, NMO, CH2Cl2, 99%; (s) TMSI, HMDS, 1,2-dichloroethane, 
30 min, 0 °C then 2 h at rt; (t) TBAF, THF, -20 °C, 10 min, 68%.; (u) TBAF, THF, rt, 3 h. 
Scheme 27. The synthesis of the ABC-cyclic fragment of hexacyclinic acid 
Alkene cross-metathesis with methyl acrylate gave acrylate 90. The hydroxy function in the 
A-ring was protected as a TBS ether. The secondary alcohol in the side chain was deprotected 
and oxidized to furnish methylketone 91. When 91 was treated with TMSI and HMDS in 1,2-
dichloroethane the tandem Michael-aldol reaction took place to give an inseparable mixture of 
four diastereomers 92. When this was treated with TBAF at -20 °C over 10 min at THF a 
retroaldol reaction took place yielding the methyl ketone 93 as 4:1 diastereomeric mixture 
(Scheme 27). 
The relative stereochemistry of the major diastereomer was determined with the aid of 
NOESY experiments. A cross peak between H20 and H16 suggested the desired configuration 
at C19. Ha at C9 was observed as a quartet with J = 12.2 Hz in 1H NMR, suggesting that the 
desired configuration at C8 (Scheme 27). 
When 93 was subjected to the action of TBAF (THF, rt, 3 h), total deprotection took place. 
The diol 94, which was obtained as 6:1 mixture of diastereomers, was crystalline making it 
thus possible to obtain an X-ray crystal structure. According to the X-ray structure analysis 
(Figure 7), eight out of nine stereocenters were constructed correctly, leaving only the 
configuration at C8 to be opposite to the natural product.70 
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Figure 7. X-ray structure analysis of 94 
2.10 Synthesis of the ABC cyclic fragment of hexacyclinic Acid by Landais et al. 
Landais et al. reported the synthesis of the ABC core of hexacyclinic acid utilizing the free-
radical 5-exo-trig cyclization71 of a chiral 3-silylhepta-1,6-diene 99 (construction of the A-
ring) followed by the Pauson-Khand cyclization (construction of rings B and C) (Scheme 
28).72 
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(a) LDA, THF, 0.5 h, -78 °C 98/97 65:35, 40%, chromatographic separation; (b) TsONa, Pd(PPh3)4, E/Z 95:5, 
94%; (c) 0.15 equiv TsSePh, CH2Cl2, -25 °C, hν, 2 h, 77%, > 95:5; (d) DIBAL; (e) MOMCl, i-Pr2EtN, 60% over 
three steps; (f) n-BuLi, t-BuOK, THF, -78 °C, TMSC≡CCH2Br, 35% conversion, 65% corrected yield, 4:1; (g) 
Co(CO)8, TMANO, THF, 74%. 
Scheme 28. The synthesis of the ABC core of hexacyclinic acid (Landais et al.) 
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Aldol reaction between 95 and 96 furnished the desired diene 98 along with 97. Pd-catalyzed 
allylation of TsONa gave tosylate 99. Radical 5-exo-trig cyclization of 99 was conducted 
under irradiation with a sun lamp (300W) at -25 °C using catalytic amounts of p-TsSePh and 
AIBN and yielded cyclopentane 100 in 77% yield and > 95:5 dr. After the reduction of the 
carbomethoxy group with DIBAL and MOM protection of the diol, 101 was obtained. 
Deprotonation of the sulfonate 101 with Schlosser base and reaction with 1-TMS-3-
bromopropyne-1 furnished 102 in 65% corrected yield and 4:1 dr. The Pauson-Khand reaction 
provided 103 with 74% yield and completed the synthesis of the ABC cyclic core of 
hexacyclinic acid in seven steps starting from the readily available β-silyl ester 96. 
The strategy towards the natural product based on the elaborated approach (5-exo-trig 
cyclization/alkylation/intramolecular Pauson-Khand reaction) has not been proposed. 
2.11 Biomimetic approach in the construction of the C-ring of hexacyclinic acid 
As was discussed in Section 1.2 feeding experiments conducted by Zeeck et. al. led to the 
assumption that the C-ring of hexacyclinic acid may be biosynthetically constructed in a 
process that mimics cationic π-cyclizations of alkenes. 
Inspired by the findings of Zeeck we proposed a biomimetic approach towards the C-ring of 
hexacyclinic acid (Scheme 29). 
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Scheme 29. Biomimetic construction of the C-ring of hexacyclinic acid 
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The acid-catalyzed intramolecular reactions of α,β-unsaturated ketones with aromatic rings 
has been studied by Stork et. al., Dutta et. al. in the 1950s and by Ziegler et al. in the 1970s.73 
Andersen et al. studied the application of cationic cyclizations of α,β-unsaturated aldehydes 
in the synthesis of hydroazulenic sesquiterpenes (guaiol, bulnesol).74 It was found that 
treatment of aldehydes 107a-c with a mixture of perchloric acid and acetic anhydride in 
AcOEt75 at rt resulted into formation of the products of a stereospecific cationic cyclization 
108a-d (Scheme 30). 
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 (a) HClO4, Ac2O in AcOEt at rt. 
Scheme 30. Stereospecific cationic cyclizations of α,β-unsaturated aldehydes (Andersen et 
al.) 
The first example of direct cationic olefin cyclization of a simple unsaturated ketone was 
reported by Cooper and Harding (Scheme 31).76 When 109 was treated with perchloric acid in 
a mixture of acetic anhydride and acetic acid, furnished the ketoalcohol 110 in 50% overall 
yield (trans-110 : cis-110 4:1) together with the ketone 111 in 12 % yield. 
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(a) HClO4, AcOH and Ac2O in AcOEt, 1.5 h at rt; (b) BF3·Et2O in AcOEt, rt. 
Scheme 31. Cationic olefin cyclization of an α,β-unsaturated ketones 
Interestingly, when treated with a variety of protic and Lewis acids (HCO2H, CH3CO2H, 
CF3CO2H, HClO4 in acetic acid, SnCl4, BF3·Et2O in acetic acid) 109 could be recovered 
unchanged, and with (p-toluene)-sulfonic acid the reaction was sluggish. 
Dienone 112 underwent cyclization to keto acetate 113 in good yield when treated with boron 
trifluoride etherate in AcOH at rt.77 At the same time 109 was unreactive under same reaction 
conditions (Scheme 31). 
Another example of a cationic cyclization of an α,β-unsaturated ketone was published by 
Dastur.78 The cyclization of 114 proceeds at rt in formic acid to furnish 115 (Scheme 32). 
O O
OH
a, b
114 115  
(a) HCOOH, rt, 1 h; (b) aqueous NaOH, 50% yield. 
Scheme 32. A cationic cyclization of α,β-γ,δ-unsaturated ketone (Dastur et al.) 
Barry Snider et al.79 investigated Lewis acid catalyzed reactions of alkynyl and alkenyl esters 
and alkynyl ketones with alkenes 117 (Scheme 33). 
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Scheme 33. Intermolecular cationic addition of α,β-unsaturated ketones to alkenes (Snider et 
al.) 
The first intermolecular addition of an enone, as an electrophile, to an alkene was described 
by the same group. Remarkable are specific termination of the reaction by a series of alkyl 
and hydride shifts and the absence of polymerization. 
In order to investigate cationic alkene cyclizations as a tool for the biomimetic construction of 
the C-ring of hexacyclinic acid a model compound 120 was proposed and synthesized 
(Scheme 34). 
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Scheme 34. Investigation of cationic alkene cyclization in the construction of the C-ring on a 
model compound 120 
Details on the synthesis of 120 and the investigation of cationic alkene cyclizations are 
discussed in the synthetic part, Section 3.4. 
 
3. Synthetic Part 
 
49
3 Synthetic Part 
3.1 Retrosynthetic analysis of 25-decarboxy hexacyclinic acid 
Remarkable structural features of the target molecule are the combination of 6 fused rings and 
its 14 stereocenters. To simplify the synthetic target and to focus on the construction of the 
polycyclic backbone we worked on a synthetic approach towards 25-decarboxy hexacyclinic 
acid 123 (Scheme 35). 
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Scheme 35. Hexacyclinic acid (11) and 25-decarboxy hexacyclinic acid (123) 
We divided the molecule into two parts: the ABC and the DEF cyclic fragments. The 
retrosynthetic analysis of the ABC cyclic fragment has been previously elaborated and 
supported by a successful synthesis of 93 (Section 2.9) is presented in Scheme 36. 
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Scheme 36. Retrosynthetic analysis of the ABC cyclic fragment 
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The strategy for the construction of the DEF cyclic fragment should not only provide access 
to the target fragment but also be compatible with the previously elaborated approach towards 
ABC cyclic fragment 9369,70 (Scheme 37). 
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Scheme 37. Retrosynthetic analysis of 25-decarboxy hexacyclinic acid (123) 
The key step of our approach was the Dieckmann condensation of the imide 124 that would 
provide access to 1,3-dicarbonyl compound 125. Subsequent deprotection of the tert-alcohol 
and the formation of the hemiketal should furnish the complete cyclic framework of the 
natural product. 
3.2 Synthetic goals 
Though the synthesis of the ABC cyclic fragment was successfully completed, the X-ray 
structure analysis of the totally deprotected ABC fragment 94 suggested that eight out of nine 
stereocenters were constructed correctly leaving the configuration at C8 to be opposite to that 
of the natural product. The following explanations were proposed to explain this 
observation:70 
1) formation of a trans-fused bicyclo[3.2.0]heptane derivative as the product of the 
tandem Michael-aldol reaction; 
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2)  epimerization under basic deprotection conditions (4 equiv TBAF, THF, rt); 
3) epimerization under storage in CDCl3. 
 
Finding out the reason for the wrong configuration at C8 was a pivotal goal for the further 
elaboration of the synthesis of the natural product. 
 
Another goal was the elaboration of the synthetic approach towards the DEF cyclic fragment 
of hexacyclinic acid. Importantly, this approach had to be compatible with our approach for 
the construction of the ABC cyclic fragment. 
3.3 The model study of the tandem Michael-aldol reaction 
In order to understand the stereochemical outcome of the tandem Michael-aldol reaction and 
to establish the conditions of the retro-aldol reaction that avoid epimerization, we studied 
these transformations on model methyl ketone 130. 
Compound 173 was synthesized in five steps starting from cyclohexene-1-carbaldehyde (126) 
(Scheme 38). Conjugate addition80,81 of 12782 to the aldehyde 126 in the presence of TMSCl 
and HMPA yielded 128. Silyl ether 128 was treated with TBAF to give aldehyde 129 which 
was subjected to equilibration using SiO2 in hexane/AcOEt 6:1 at rt to establish the desired 
trans substituted cyclohexane derivative with 8:1 selectivity. Subsequently, the 
α,β−unsaturated ester was introduced according to the Horner-Emmons protocol. The 
1,3-dioxolane protecting group was removed in refluxing aqueous acetone with 0.3 equiv of 
PPTS to provide methyl ketone 130 as mixture of the cis- and trans-diastereomer (1:7) which 
were separated by HPLC.g 
CHO CHO
O
O
CH3
O
O MgBrCH3
OTMS
O
O
CH3
O
CH3
CO2Et
126 127 129 130
a
128
 dr = 1 : 8 cis : trans dr = 1 : 7 cis : trans
128
129
trans-129
b
c
trans-129
130
d
e
129a
 
 (a) HMPA, CuBr2⋅Me2S, Me3SiCl, THF, -78 °C, 80%; (b) 1.2 equiv TBAF, THF, 12 h, rt; (c) SiO2, 
hexane/AcOEt 6:1, 24 h, rt, 54%; (d) 1.7 equiv (EtO)2POCH2CO2Et, NaH, THF, 46%; (e) 0.3 equiv PPTS, 3 h, 
reflux in aqueous acetone, 92%. 
Scheme 38. The synthesis of the model compound 130 
                                                 
g) See Experimental part for the details on the separation. 
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The key step in the sequence is the conjugated addition80 of 12782,83,84 to the α,β-unsaturated 
aldehyde in the presence of Me3SiCl,81 HMPA and CuBr·Me2S. The reaction proceeded with 
good yield and no 1,2-addition product isolated. 
The deprotection of the TMS-enol ether 128 turned out to be a problematic step. A number of 
reaction conditions were screened (Table 1). A selectivity of 1:7 (cis : trans) could be 
achieved (entries 1, 2, 3, 4, 5). 
Table 1. Deprotection of the TMS enol ether 128. 
OTMS
O
O
CH3
H
O
O
CH3
CHO
O
O
CH3
CHO
128 trans-129 cis-129
a
 
entry (a) conditions Yield, % trans-129 : cis-129 
1 2.3 equiv TBAF, THF, 5.5 h, rt 54 7:1 
2 1.2 equiv TBAF, THF, 30 min, rt 49 7:1 
3 1.2 equiv TBAF, THF, 12 h, rt 53 7:1 
4 EtONa, EtOH, 1.5 equiv TBAF, THF, 15 h, rt 52 6:1 
5 1.2 equiv TBAF, THF, 18 h, rt 49 6:1 
6 1.2 equiv TBAF, THF, -10 °C 50 3.4:1 
7 1.2 equiv TBAF, MeOH, 2 h, rt 61 1:2 
8 10% aqueous H2SO4, THF, 5.5 h, rt 15 1:2 
9 1.7 equiv KF in MeOH, 8 h, rt 53 1:2.5 
10 2.3 equiv TBAF, EtOH, THF, 5.5 h, rt 75 1:3 
11 0.6 equiv H2C2O4, H2O, THF, 8 h, rt 34 1:3.2 
12 silica gel, hexane/AcOEt 7:3, 5 days, rt no reaction 
13 37% aqueous HCl/EtOH, 1 min CH2Cl2, rt no reaction 
14 37% aqueous HCl/THF, 1 h, rt no reaction 
 
The trans-acrylate moiety was introduced according to the Horner-Emmons protocol (Scheme 
38). The yield of 129a appeared to be proportional to the excess of the diethyl 
ethoxycarbonylmethanephosphonate and NaH used: 38% with 1.05 equiv and 46% with 
1.7 equiv of the phosphonate. According to the 1H NMR the trans- olefin was obtained with a 
selectivity better than 9:1. The Wittig protocol was tested as well. Though the reaction with 
methoxycarbonyl methylidenetriphenylphosphorane was rather slow at rt, after 100 h 64% of 
the product could be obtained. 
The 1,3-dioxolane protection of the keto functionality was removed by reflux of 129a in wet 
acetone in the presence of 30 mol% of PPTS85 to provide 130 with 92% yield. 
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With 130 in hands, the diastereoselectivity of the tandem Michael-aldol86 reaction (Scheme 
39) was studied. The results are summarized in Table 2. 
CO2Et
CH3
O
H
H
CO2Et
CH3
OTMS
H
H
HH
H
CO2Et
CH3
OTMS
H
H
H
H
H
130 131a (kinetic) 131b (thermodynamic)
+
a
 
a) 1.5 equiv HMDS, 1.3 equiv TMSI, in ClCH2CH2Cl, for details see Table 2. 
Scheme 39. Tandem Michael-aldol reaction 
When the reaction was carried out at 0, -20 or -30 °C the kinetic product 131a was obtained as 
the major product. On the other hand, when the reaction was performed at rt for more than 
1 h, the thermodynamic product (131b) was formed selectively. In general, longer reaction 
times favor the thermodynamic product with better yields, whereas shorter reaction times 
favor the kinetic product (Table 2). 
Table 2. TMSI-HMDS mediated tandem Michael-aldol reaction 
entry conditionsb dr  131a : 131bc Yield (%)d 
1 rt, 6 h 1.0  : 17.5 78 
2 rt, 3 h 1.0  : 14.3 79 
3 rt, 60 min 1.0  :   4.4 82 
4 rt, 10 min 1.8  :   1.0 87a 
5 0 °C, 6 h 1.0  :   1.7 77a 
6 0 °C, 3 h 1.5  :   1.0 82a 
7 0 °C, 60 min 5.4  :   1.0 81a 
8 0 °C, 10 min 8.2  :   1.0 83a 
9 -20 °C, 6 h 8.2  :   1.0 70a 
10 -20 °C, 60 min 12.4  :   1.0 81a 
11 -20 °C, 10 min 16.2  :   1.0 49a 
12 -30 °C, 3 h 16.2  :   1.0 79a 
13 -30 °C, 60 min 17.6  :   1.0 71a 
 
aIncomplete reaction. bFor all entries in Table 2 the concentration of 130 was 0.1 M. cdr was determined by GC. 
Other products were also detected (up to 6), but not listed in Table 1. Analysis were done on crude products. The 
composition of crude products was also controlled by the intensity of the signals corresponding to OSi(CH3)3 
group (δ 0.26-0.15 ppm) in 1H NMR spectra (in C6D6). dFor the mixture of diastereomers after chromatographic 
purification (hexane-AcOEt 50:1, Rf = 0.10-0.15). 
Both 131a and 131b were isolated in pure form and analyzed with NOE experiments in order 
to assign the relative stereochemistry. 
3. Synthetic Part 
 
54
NOESY spectra of 131a support the structure shown in Figure 8 with cis-fusion between the 
cyclopentane and the cyclobutane rings and trans-orientation between H5 and H6 as in 
hexacyclinic acid. 
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Figure 8. Stereochemistry assignment for 131a using NOESY and for 131b with the help of 
NOE. 
In the case of the 131b, a NOE between H4 and H11 is a strong argument to support the 
proposed structure (Figure 8). 
With 131a in hand we performed the retro-aldol reaction putting our particular focus on the 
potential epimerization. 
When 131a was treated with TBAF (1.0 equiv, -30 °C, 30 min), the corresponding methyl 
ketone 132a was obtained in 80% yield. The relative stereochemistry of 132a was assigned 
using NOESY NMR experiments (Scheme 40). 
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(a) 1.0 equiv TBAF 30 min, -30 °C; (b) TBAF 3 h, rt. 
Scheme 40. Retroaldol reaction of 131a 
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When methyl ketone 132a was treated with TBAF at rt (Scheme 40), epimerized compound 
133a could be isolated as the sole product. Again, the relative stereochemistry was assigned 
with the help of NOE NMR experiments (Figure 9). 
H CO2CH2CH3
CH3O
HH
H
CO2CH2CH3
CH3O
H
irrad. at 2.56 ppm irrad. at 2.83 ppm
46 6
13 13
133a: NOE  
Figure 9. Assignment of the relative configuration of 133a using NOE experiments 
When 131b was treated with TBAF for 30 min at -30 °C, a 2.8:1 diastereomeric mixture of 
two methyl ketones 132b and 133b respectively was isolated. After treatment of this 
diastereomeric mixture with TBAF at rt (3 equiv, 3 h), only isomer 133b could be isolated 
(Scheme 41). 
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(a) 1.0 equiv TBAF, 30 min, -30 °C; (b) TBAF, 3 h, rt. 
Scheme 41. Retroaldol reaction of 131b and epimerization of 132b into 133b 
The structure of 133b was studied with the help of ROESY NMR experiments (Figure 10). 
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Figure 10. Assignment of the configuration of 133b by ROESY experiment 
With the results obtained, we can explain the unexpected epimerization at C8 center of 93 
(Section 2.9) under the conditions for silyl deprotection with TBAF and provide a reliable 
path for the further elaboration of the total synthesis of hexacyclinic acid. Additionally, we 
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provided a method which allows the diastereoselective synthesis of 1,2-disubstituted 
octahydroindene derivatives, with four diastereomers accessible through either the kinetic or 
thermodynamic product and subsequent epimerization. 
3.3.1 The Grignard reaction with a model methylketone 
The selectivity of the Grignard reaction of methyl ketones 93 and 132a can be predicted87 in 
terms of the Felkin-Anh model as shown in Scheme 42. The Felkin transition state will lead to 
the undesired addition product, whereas the anti-Felkin transition state will furnish the desired 
tert-alcohol. 
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Scheme 42. Predicting the selectivity of the Grignard reaction of methyl ketones 93 and 132a 
With compound 132a in our hands its Grignard reaction with 
(3-(benzyloxy)propyl)magnesium bromide was investigated. When the reaction was 
conducted at 25 °C the product was obtained as a 5:1 diastereomeric mixture that could be 
separated by chromatography. 
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Scheme 43. The Grignard reaction of a model methylketone 132a 
We expected to distinguish between the two products of the Grignard reaction with the help of 
the ROESY NMR spectra for both compounds. In order to be able to interpret the results of 
the ROESY experiments, a better understanding of conformational preferences of 134 and 135 
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was required. Molecular modeling was conducted using Schrödinger MacroModel (ver. 8.1)88 
and Schrödinger Maestro interface (ver. 5.1.020) under SuSE Linux OS (ver. 10). 
Energy minimization was carried out for 134 and 135 by 500 steps of steepest descent until 
the RMS gradient of the potential energy was less than 0.05 kJ mol-1Å-1. The calculation was 
simulated in CHCl3 as the solvent. 
The searching of favorable conformations was conducted using MCMM conformational 
search protocol. The Monte Carlo Multiple Minimum (MCMM)89 method implemented in 
MacroModel is highly efficient in performing global searching, exploring close, as well as 
distant areas of the potential energy surface. The search proceeds by random changes in 
torsion angles. Automatic setup of torsions was performed and the calculation was simulated 
in CHCl3 as above. The method consisted of 1,000 conformational search steps with 
MMFF94s force field.90 Other parameters were left by default. Only unique structures within 
a 50 kJ mol-1 energy window above the found global minimum were saved. If a found 
structure was not converged it was subjected to MMFF94s minimization (in CHCl3) until the 
RMS of the conjugate gradient was less than 0.05 kJ mol−1Å−1. So obtained structures 134a, 
134b, 135a, 135b and their potential MMFF94s energies are presented in Scheme 44. 
  
134a, 206.10 kJ mol-1 134b, 204.19 kJ mol-1 
  
 
 
135a, 206.06 kJ mol-1 135b, 201.92 kJ mol-1 
  
Scheme 44. Favorable conformations 134a, 134b, 135a, 135b and their potential energies 
(hydrogen atoms and bond order are not shown) 
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It is worth to note that according to the modeling results, conformations with a “bigger” 
CH2CH2CH2OCH2Ph substituent in a pseudo-axial position are energetically preferred over 
those conformations where this substituent takes a pseudo-equatorial position. 
Results of molecular modeling and the results of the ROESY experiments were compared 
(Scheme 45). 
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Scheme 45. Elucidation of the relative stereochemistry of 134 and 135 with the help of 
ROESY 
In the ROESY spectrum of the major product 134 a cross peaks between the methyl group and 
H3 proton (specific for conformation 134a) strongly supports the proposed structure (Scheme 
45). In the ROESY spectrum of the minor diastereomer 135 a cross peak between the methyl 
group and H4 (specific for the conformation 135a) support the relative stereochemistry 
presented in Scheme 45. 
The relative stereochemistry of the lactone 135 corresponds to that of hexacyclinic acid (11). 
In agreement with the Felkin-Anh model the Grignard reaction afforded the undesired product 
134 selectively. 
It is worth to note that unreacted methylketone, isolated after the Grignard reaction was 
identical with the starting material 132a according to TLC and 1H NMR, suggesting that no 
epimerization of 132a takes place during the Grignard reaction. 
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Lactone 134 was converted to the corresponding tert-alcohol 134c when treated with NaOMe 
in MeOH (Scheme 46). 
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(a) 0.22 M NaOMe in MeOH, 48 h at rt; (b) H3O+, PPh3, DAED, PhCOOH. 
Scheme 46. Reaction of lactone 134 with NaOMe in MeOH 
It is worth to note that 134c was prone to undergo spontaneous cyclization (during workup 
and purification by chromatography) furnishing the starting lactone 134. One should to point 
on the possibility to convert the undesired tert-alcohol 134c to the desired 135c according to 
the Mitsunobu protocol.91 
3.4 The C-Ring via a nucleophilic addition of an alkene to the Michael acceptor 
In order to investigate cationic alkene cyclizations as a tool for the biomimetic construction of 
the C-ring of hexacyclinic acid, a model compound 120 was chosen (Scheme 34, Section 
2.11). Compound 120 was synthesized in five steps starting from cyclohexanone. Alkylation 
of the lithium enolate of cyclohexanone with neryl bromide afforded 2-nerylcyclohexnone 
(136). Methylvinylether 137 was prepared according to the Wittig olefination protocol 
(Scheme 47). 
O
a
O
b
MeO
c
d
O O
e
COOEt
120
137
138 trans-138
136
 
(a) LDA, THF, -78 °C; neryl bromide, 50%; (b) MeOCH=PPh3, THF, -78 °C, 68%; (c) 5% HCl/THF 4:1, reflux 
10 min, 35%; (d) KOH, MeOH, reflux, 92%; (e) (EtO)2P(O)CH2COOEt, NaH, THF, 52%. 
Scheme 47. The synthesis of the model compound 120 
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Unfortunately, the acid catalyzed hydrolysis of methylvinylether 137 gave two byproducts 
together with the desired aldehyde 138 in low yields. In order to optimize the yield of 138 a 
number of reaction conditions was tested. Best results were obtained when 137 was briefly 
refluxed (5 min) in a 4:1 mixture of THF and 5% aqueous HCl, furnishing 138 as a 1:1 
mixture of the cis- and trans- isomers as suggested by 1H NMR. The desired trans-138 could 
be selectively obtained when the 1:1 mixture was subjected to reflux in aqueous KOH/MeOH. 
A cis : trans selectivity of 1:7 was achieved. 
The HWE olefination and the Wittig protocol were two alternative methods to introduce the 
required acrylate moiety. Whereas the HWE olefination furnished the trans-acrylate with 52% 
yield, the Wittig olefination afforded the product in 79% yield. 
With the compound 120 in hand, we investigated cationic alkene cyclizations. A set of 
Brønsted and Lewis acids was tested for the ability to induce cationic alkene cyclizations of 
120 (Table 3). 
Table 3. Investigation of cationic alkene cyclization of 120 
CH3
CH3
CH3
OEt
O
conditions
120
CH3 CH3
CH3
O
OEt
R
122a: R = OH
122b: R = Hal  
entry conditions notesh 
1 15 equiv F3COOH, 50h in CH2Cl2, rt the starting material and a new product, Rf = 0.35-0.31 
2 4 equiv BF3⋅Et2O, 24 h in CH2Cl2, -78 °C to rt starting material 
3 2 equiv Me2AlCl, 24 h in CH2Cl2, -78 °C to rt starting material 
4 4 equiv TPPB, H2O , 24 h in THF, -78 °C to rt starting material 
5 2 equiv SnCl4, 24 h in CH2Cl2, -78 °C to rt starting material 
6 4 equiv Sc(OTf)3, 24 h in THF/H2O 9:1, 0 °C starting material 
7 160 equiv aqueous H2SO4, 24 h in THF, 0 °C starting material 
8 4 equiv TiCl4, 18 h in CH2Cl2 at -78 °C products with Rf = 0.40-0.35; Rf = 0.33-0.29, decomp. 
9 2.5 equiv TiCl4, 9 h in CH2Cl2 at -78 °C product with Rf = 0.40-0.35 
10i 2.5 equiv TiCl4, 9 h in CH2Cl2 at -78 °C two products, Rf = 0.40-0.35; Rf = 0.33-0.29 
11 1.2 equiv TiCl4, 9 h in CH2Cl2 at -78 °C two products, Rf = 0.40-0.35; Rf = 0.33-0.29 
 
 
                                                 
h) The progress of the reaction was monitored by TLC in hexane/AcOEt 15:1. 
i) Reversed addition: the solution of 120 was added to the Lewis acid. 
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Reaction of 120 with an excess of trifluoroacetic acid was rather slow even at rt (entry 1). A 
new product, obtained in pure form after chromatographic purification, was assigned a 
structure of 139 (Scheme 48). According to 1H NMR 139 possessed one olefinic proton less 
compared to the starting material while both acrylate protons were retained. Strong IR 
absorption at 1167 (C-F) and 1770 cm-1 (CF3-CO) supported the proposed structure. 
CH3
CH3
CH3
OCH3
O
CH3
CH3CH3
OCH3
O
CF3COOH
O
CF3
O
120 139  
Scheme 48. Reaction of 120 with an excess of CF3COOH 
Such Lewis acids as BF3⋅Et2O, Me2AlCl, TPPB, SnCl4, Sc(OTf)3 and aqueous H2SO4 failed to 
promote any transformation of 120. To the contrary, when TiCl4 was used, the formation of 
up to 4 new products could be observed. Two of these new products were isolated in pure 
form and analyzed by 1H NMR. In both cases the two acrylate protons could be identified 
with their usual chemical shifts suggesting that the new compounds are not the result of the 
desired transformation but are the side-products. 
3.5 First generation approach towards the DEF fragment 
Compound 93 is accessible in twenty synthetic steps from alcohol 82 with an overall yield of 
less than 8% (see Scheme 26, Section 2.9). That is why for the elaboration of the synthetic 
approach towards the DEF-core we decided to start form an easily accessible model 
compound. This had to have the same arrangement of functional groups as in 93 in order to 
make the synthesis of the DEF-core applicable to 93 (Scheme 49). 
Compound 132a can be a suitable model as it is structurally closely related to 93 and is 
accessible in only seven steps from cyclohexene-1-carbaldehyde (126) (see Scheme 38, 
Scheme 39 and Scheme 40, Section 3.3). 
Alternatively, methyl 5-oxohexanoate (140) can be a suitable model compound (Scheme 49). 
It posses the same set of functional groups as 93 does, separated by a chain of three carbon 
atoms. Importantly, 140 is a commercially available substance that is also available in a single 
step starting from methyl acrylate and acetylacetone.126 
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Scheme 49. Model compounds 132a and 140 for the elaboration of the synthetic approach 
towards the DEF core of hexacyclinic acid 
Our first generation approach towards the DEF core of hexacyclinic acid is shown in Scheme 
50. We decided to construct the target fragment starting from the readily available 140. Our 
retrosynthetic approach features the Grignard reaction (g) furnishing 144, the Evans aldol 
reaction (f), esterification (e), the ring closing olefin metathesis (d) the catalytic 
hydrogenation (c), the Dieckmann condensation (b) and the formation of the hemiketal 141 
(a). 
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Scheme 50. First generation approach towards the DEF core of hexacyclinic acid 
We considered an asymmetric synthesis of 144a using the Sharpless asymmetric 
epoxidation92 as the key step (Scheme 51). 
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144a: R = -CH=CH2 147 148 149  
Scheme 51. Asymmetric approach to 144a 
The major disadvantage of such synthesis is that it can not be transferred to the ABC fragment 
93 (Scheme 49). 
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A simple addition of common organometallic nucleophiles to 140 will produce racemic 
mixture of the addition products. The major drawback of conducting the synthesis with 
racemic 144 is the formation of diastereomeric mixtures e.g. of 143 after the esterification 
step. This means complication of the spectroscopic characterization by NMR and the need of 
separation(s) at later synthetic steps. In order to investigate the proposed approach and to 
reveal the optimal sequence of synthetic transformations we decided to conduct the synthesis 
with racemic 144. 
The synthesis of the Weinreb amide 145 was conducted according to a described procedure 
(Scheme 52).99 
O N
O O
CH3
O N
O O OH
N
O OH
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(a) 1) n-Bu2BOTf, i-Pr2EtN, CH2Cl2, 0 °C, 2) acrolein, -78 °C → rt, 30 min, 75%; (b) NH(OCH3)CH3 · HCl, 
Me3Al, CH2Cl2, -20 °C → rt, 15 h, 87%. 
Scheme 52. The synthesis of the Weinreb amide 145 
The Evans aldol reaction with acrolein furnished diastereomerically pure hydroxy imide 146 
with a 75% yield. Transamination with N,O-dimethyl hydroxylamine hydrochloride and 
Me3Al afforded 145 in 87% yield. Weinreb amide 145 was used in a 6 step synthesis of 143a 
(Scheme 53). 
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(a) Methylvinylketone, MeONa, 66%; (b) vinylmagnesium bromide, CeCl3, 64%; (c) Et3N, MeOH, 95%; (d) 
TESOTf, 2,6-lutidine, 75%; (e) LiOH, 0 °C, THF/MeOH/H2O, quant.; (f) 2,4,6-trichlorbenzoylchloride, THF, 
then 152, 80%. 
Scheme 53. Synthesis of the Weinreb amide 143a 
3. Synthetic Part 
 
64
As was mentioned above, methyl-5-oxohexanoate (140) was synthesized from methylacrylate 
and acetylacetone according to a published procedure.126 With 140 in hand we studied its 
reactions with organometallic nucleophiles in order to obtain the tert-alcohol 151. 
Reaction of 140 with vinylmagnesium bromide afforded a mixture of 151 together with the 
corresponding lactone 150 in a 42% yield while the reaction with vinyllithium provided the 
product in 34% yield. The relatively low yields can be explained by the low chemoselectivity 
of the highly reactive Grignard and organolithium reagents when a keto and a carbomethoxy 
functions are present in the substrate. Surprisingly, when the reaction was conducted in the 
presence of equimolar amount of CeCl3, the product was obtained in a 64% yield.93 After the 
so obtained lactone-alcohol mixture was treated with Et3N in MeOH, tert-alcohol 151 was 
obtained in excellent yield. Its hydroxy function was protected as a triethylsilyl ether and the 
carbomethoxy function was saponificated using LiOH in THF/MeOH/H2O mixture affording 
acid 152. Compound 143a was obtained according to the Yamaguchi esterification protocol94 
from the acid 152 and the Weinreb amide 145. 
3.5.2 RCM in the construction of the 9-membered lactone 
According to the retrosynthetic plan (Scheme 50), the 9-membered lactone 142 should be 
accessible from a linear precursor 143a via a ring closing olefin metathesis (RCM) followed 
by hydrogenation of the double bond. Having 143a in hand we studied the RCM reaction 
(Table 4) using different ruthenium catalysts (153-157) (Scheme 54). 
Table 4. Attempted ring closing olefin metathesis of 143a 
O
N
O
CH3
O
O ORH3C
143a: R = OSiEt3
143b: R = H
catalyst
O
N
O
CH3
O
O
H3C
OSiEt3
 
entry substrate conditions notes 
1 143b 5 mol% 154, toluene, 80 °C, 24 h (c = 2.9 µmol/mL) no reaction 
2 143b 5 mol% 154, CH2Cl2, reflux, 24 h no reaction 
3 143a 5 mol% 157, toluene, 90 °C, 24 h (c = 4.7 µmol/mL) no reaction 
4 143a 5 mol% 155, toluene, 90 °C, 24 h (c = 3.4 µmol/mL) no reaction 
5 143a 5 mol% 156, CH2Cl2, rt, 24 h no reaction 
6 143a 5 mol% 157, toluene, reflux, 24 h no reaction 
7 143a 10 mol% 157, toluene, reflux, 24 h no reaction 
8 143a 25 mol% 154, CH2Cl2, reflux, 24 h (c = 1.64 µmol/mL) no reaction 
9 143a 10 mol% 153, CH2Cl2, reflux, 24 h (c = 1.64 µmol/mL) no reaction 
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Unfortunately none of the tested catalysts (Scheme 54) was able to induce the ring closing 
olefin metathesis of 143a under the conditions tested. We believed that the proximity of the 
sterically demanding silyl protecting group to the reacting double bond might prohibit the 
desired reaction. The triethylsilyl protecting group was removed by treatment 143a with acetic 
acid in THF furnishing the tert-alcohol 143b. Attempts to induce the RCM of 143b using the 
Grubbs II catalyst were not successful. 
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157: Grubbs III156: p-nitro-Hoveyda-Grubbs II
 catalyst (Grela catalyst)  
Scheme 54. Ru- catalysts tested for the ring closing olefin metathesis of 143a 
We then reconsidered our approach towards the 9-membered lactone 142 by changing the 
order of synthetic steps: we expected to be able to conduct a cross metathesis (CM) between 
158 and 144a followed by macrolactonization reaction and hydrogenation. 
The CM reaction between 158 and 144a was studied in the presence of 5-10 mol% of 154, 
155 or 157 as catalysts (Scheme 55). Catalyst 157 was not effective, while 154 and 155 
resulted in the consumption of only one of the reaction partners, compound 158, from the 
reaction mixture and the formation of a homodimerization product 159, as suggested by 
HRMS ESI ((M + Na)+: 573.2195 found). 
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(a) 5 mol% 154 or 155, PhCH3, reflux 6 h. 
Scheme 55. Attempted olefin cross metathesis between 158 and 144a 
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3.5.3 Dieckmann condensation 
N-methoxy-N-methylamides (Weinreb amides) are known to react with C-nucleophiles 
affording ketones.95 Enolates derived from ketones, esters, acetonitrile and acetone 
dimethylhydrazone react with N-methoxy-N-methylbenzamide to produce β-dicarbonyl 
compounds in moderate yields.96 At the same time there are several reports on inefficient 
condensations of N-methoxy-N-methylamides with ester enolates.97 Sibi reported 
chemoselective Dieckmann-like condensations using N-methoxy-N-methylamides (Scheme 
56).98 
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Scheme 56. Dieckmann condensation of N-methoxy-N-methylamides 160. 
Depending on the base and the reaction conditions it was possible to selectively obtain one of 
the two possible reaction products 161 or 162. 
We investigated the Dieckmann condensation of two model substrates, acetate 163 and the 
propionate 164, easily and directly available from the aldol product 146. 
O N
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164: R = CH3
R
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R
165: R = H
166: R = CH3 
Scheme 57. Dieckmann condensation of 163 and 164. 
The acetate 163 underwent the Dieckmann condensation when 3 equiv of LiHMDS were used 
as the base and the reaction was conducted for 3 h at -78 °C, furnishing 1,3-diketone 165 in a 
19% yield after chromatographic purification. The Dieckmann condensation of 164 furnished 
166 as a mixture of diastereomers in 23% yield when the propionate was treated with 4 equiv 
of KHMDS for 3 h at -78 °C. 
With these positive results we expected to conduct the Dieckmann condensation with the 
more complex substrates 143a and 143c. A number of bases was investigated (Table 5). 
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Table 5. The Dieckmann Condensation of 143a 
N
O
CH3
Et3SiOO
CH3O
143c
conditions
CH3
O
O
167
O
H3C
OSiEt3
O
O
Ph
N
O
CH3
Et3SiOO
CH3O
143a
O
or
 
entry substrate conditions notes 
1 143a 3.0 equiv LDA, 18 h at -78 °C in THF no reaction 
2 143a 1.2 equiv LiHMDS, 16 h at -78 °C, THF no reaction 
3 143a 1.2 equiv KHMDS, 16 h at -78 °C, THF no reaction 
4 143c 4.0 equiv KHMDS, 16 h at -78 °C, THF no reaction 
 
3.6 Second generation approach towards the DEF fragment 
Since the synthesis of the 9-menmbered lactone 142, required for the construction of the DEF 
fragment, was not achieved using olefin metathesis, a new synthetic approach was proposed 
(Scheme 58). 
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Scheme 58. The second generation approach to the DEF fragment of hexacyclinic acid 
Such key steps as the Dieckmann condensation in the construction of the E-ring, the 
hemiketalization and the macrolactonization of the seco-acid 168 to access 142 remained the 
same. The seco-acid 168 should be accessible from the aliphatic aldehyde 169 utilizing the 
Evans aldol protocol. 
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To synthesize the aldehyde 169 we started from the precursor, mentioned in Section 3.5, the 
methyl 5-oxo-hexanoate (140) (Scheme 59). The Grignard reaction of 140 with a known 
organomagnesium reagent 175 followed by the opening of the lactone should provide the 
methyl ester 173. 
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(a) See Table 6 for reaction conditions; (b) Et3N in MeOH or NaOMe in MeOH; (c) TESOTf, 2,6-lutidine; (d) 
acetone, PPTS. 
Scheme 59. The synthesis of the aldehyde 169 
After the tert-alcohol is protected as a triethylsilyl ether the selective removal of the dioxolane 
protecting group should afford the desired aldehyde 169. These synthetic transformations will 
be discussed in this section. 
3.6.1 Grignard reaction 
The Grignard reagent 175 was prepared from 2-(2-bromoethyl)-1,3-dioxolane82 (171) 
according to a published procedure. When the reaction of 140 and 175 was conducted under 
described reaction conditions, only a poor yield of the desired product was obtained, 
suggesting that an optimization of the reaction conditions was required. 
The tested reaction conditions are summarized in Table 6. When THF/Et2O 1:1 or THF/PhH 
2:1 were used as solvent and the reaction was conducted at 0 to -5 °C, yields of 87 and 77% 
respectively, could be obtained. 
Under the conditions of the Grignard reaction, alcohol 173 partly underwent cyclization 
giving lactone 172. To obtain the desired tert-alcohol 173 the crude reaction product was 
treated with NaOMe in MeOH at rt. 
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Table 6. Optimization of the Grignard reaction 
OHH3C
OCH3
O
O
O
173
H3C OCH3
OO
CH3
O
O
O
O
O
O MgBr
+
172 (lactone)140
175
 
entry conditions yield,j % notes 
1 1 equiv 175, THF, -78 °C 20 incomplete reaction 
2 2 equiv 175, THF, -90 °C 30 incomplete reaction 
3 2 equiv 175, THF, -78 °C 37 incomplete reaction 
4 2 equiv 175, THF, 0 - -5 °C 32 complete reaction 
5 2 equiv 175, THF, rt 30 complete reaction 
6 1 equiv 175, rt; then NaOMe in MeOH 60 incomplete reaction 
7 1.3 equiv 175, “One-pot”, THF, rt - incomplete reaction 
8 1.3 equiv 175, THF/Et2O 1:1, 0 to -5 °C; then MeOH, NaOMe 87 almost complete reaction 
9 1.3 equiv 175, THF/PhH 2:1, 0 to -5 °C; then MeOH, NaOMe 77 almost complete reaction 
 
The protection of the tert-alcohol 173 as a triethylsilyl ether also required the optimization of 
the reaction conditions (Scheme 60). The temperature control appeared to be important for the 
desired outcome of the reaction. 
OSiEt3H3C
OCH3
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O CH3
OCH3
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Et3SiO 177
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OCH3
O
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O
Elimination products, 
decomposition
173
a
b
c
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OHH3C
OCH3
O
O
O 173
OHH3C
OCH3
O
O
O 173  
(a) 2.0 equiv TESOTf, 3.0 equiv 2,6-lutidine, CH2Cl2, rt; (b) 1.5 equiv TESOTf, 2.0 equiv 2,6-lutidine, CH2Cl2, 
-78 °C, quenched while cold, 80% after flash; (c) 2.0 equiv TESOTf, 1.7 equiv 2,6-lutidine, CH2Cl2, -78 °C → 
rt, 30%. 
Scheme 60. Reaction of the tert-alcohol 173 with TESOTf and 2,6-lutidine 
Conducting the reaction at rt resulted in the formation of a complex mixture of products. 
When the addition of TESOTf was performed at -78 °C followed by warming the reaction 
                                                 
j) For the mixture of the lactone 172 and the tert-alcohol 173. 
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mixture to rt, the undesired product 177 was obtained with 30% yield. The desired silyl ether 
174 could be obtained in a yield of 80% when 1.5 equiv of TESOTf and 2.0 equiv of 2,6-
lutidine were used and the reaction mixture was stirred for 6 h at -78 °C followed by 
quenching while cold. 
3.6.2 1,3-Dioxolane deprotection 
A number of different reagents and reaction conditions was tested in order to selectively 
cleave the dioxolane protecting group of 174 in the presence of the triethylsiloxy group and to 
obtain the aldehyde 169 (Table 7). 
Table 7. Cleavage of the 1,3-dioxolane protection in the presence of the TES-ether 
OSiEt3H3C
OCH3
O
O
O
OSiEt3H3C
OCH3
O
O
conditions
174 169  
entry conditions notes 
1 30 mol% PPTS, acetone/H2O 10:1, reflux, 5 h no reaction 
2 30 mol% PPTS, wet acetone, reflux, 2 h no reaction 
3 1 equiv PPTS, MeOH, rt deprotection of the TES group 
4 cat. p-TsOH·H2O, acetone simultaneous TES and dioxolane deprotection 
5 1.3 equiv p-TsOH, acetone/H2O 15:1, reflux, 4 h simultaneous TES and dioxolane deprotection 
6 3.75 equiv FeCl3, CH2Cl2, rt simultaneous TES and dioxolane deprotection 
7 50 mol% PdCl2(CH3CN)2, wet acetone, rt, dark, 3d decomposition 
3.6.3 Protection of the tert-alcohol as MTM ether 
As it was not possible to find reaction conditions that allowed the deprotection of the 
aldehyde function leaving the TES group intact, we decided to check if MTM protection of 
the tert-alcohol 173 allow the chemoselective cleavage of the 1,3-dioxolane moiety. To 
introduce the MTM protecting group, the alcohol 173 was treated with the mixture of DMSO 
and acetic anhydride at -78 °C to afford the desired MTM ether 178 in an 85% yield. The 
mechanism of this transformation resembles the Pummerer rearrangement with the difference 
that in the last mechanistic step the alcohol acts as a nucleophile instead the acetate anion 
(Scheme 61). 
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(a) DMSO, Ac2O, 30 h at 25 °C, 85%. 
Scheme 61. MTM protection of the tert-alcohol 173 
We tested a set of reaction conditions in order to selectively deprotect the 1,3-dioxolane in the 
presence of the MTM protecting group (Table 8, compare with Table 7). Unfortunately, the 
desired aldehyde 169 could not be obtained. 
Table 8. Cleavage of the 1,3-dioxolane protection in the presence of the MTM ether 
OH3C
OCH3
O
O
O
OSiEt3H3C
OCH3
O
O
conditions
178 169
SCH3
 
entry conditions notes 
1 48 mol% TsOH, acetone, 12 h, rt decomposition 
2 3.75 equiv FeCl3, CH2Cl2/acetone 4:1, rt, 2 h decomposition, traces of the product 
3 30 mol% PPTS, acetone, 12 h, rt no reaction 
4 45 mol% PPTS, acetone, 48 h, 40-50 °C decomposition 
5 30 mol% PPTS, reflux in wet acetone, 12 h decomposition 
6 conc. AcOH, acetone no reaction 
7 50% aqueous AcOH, acetone no reaction 
3.6.4 Protection of the tert-alcohol as a benzyl ether 
It is well known that alkyl ethers are less prone to cleavage under acidic conditions compared 
to silyl, and especially triethylsilyl ethers. We decided to protect the tert-alcohol 173 as a 
benzyl ether, since that would allow to use strong acids (aq. HCl) for the chemoselective 
cleavage of the 1,3-dioxolane. 
The reaction of 173 with BnBr in the presence of KH unexpectedly gave compound 179 as the 
product (Scheme 62). 
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(a) KH, BnBr in THF, 0 °C → rt. 
Scheme 62. Reaction of 173 with BnBr and KH 
Since the reaction with BnBr under basic conditions led to the formation of the lactone 179 
we investigated the possibility to protect alcohol 173 as PMB ether under acidic conditions 
(Scheme 63). 
173
H3C OH
OCH3
O
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O a
H3C O
OCH3
O
O
O
OCH3
180  
(a) PMBOC(=NH)CCl3, 0.3 mol% TfOH, 20 mol% CSA in two portions, Et2O, 30 h, 88% yield. 
Scheme 63. Protection of the alcohol 173 as a PMB ether 
The crude reaction product required extensive chromatographic purification, that resulted in a 
diminished yield of 180 (36% after two chromatographic separations). 
3.6.5 Grignard reaction with 3-(benzyloxy)-propylmagnesium bromide 
Having investigated a number of different groups (TES, MTM, Bn and PMB) for the 
protection of the tert-alcohol 173 and have not found a suitable one we considered the 
possibility of masking the aldehyde group of 169 with such a function which can be removed 
under neutral conditions that tolerate a tert-triethylsilyl ether. For example, aldehyde 169 is 
directly accessible by the oxidation of the corresponding primary alcohol, which in turn can 
be temporarily protected as a Bn ether 184 (Scheme 64). Important, that the deprotection of a 
Bn ether and the oxidation of a primary alcohol can be conducted under neutral conditions, 
compatible with a TES group. 
The synthesis of 184 started from 1,3-propanediol (Scheme 64). Alkylation of one of the two 
hydroxy groups with BnCl furnished alcohol 181. This alcohol was converted to the 
corresponding bromide 182 by treatment with PPh3 and NBS. 
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(a) Na, BnCl, o-xylene, 65%; (b) NBS, Ph3P, 64%; (c) 3 equiv Mg, methyl 5-oxo-hexanoate; (d) NaOMe, 
MeOH, 83%; (e) TESOTf, 2,6-lutidine, 80%. 
Scheme 64. Synthesis of the methyl ester 184 
Bromide 182 was required for the synthesis of 3-(benzyloxy)-propylmagnesium bromide,134 
the Grignard reagent, which was reacted with the methyl 5-oxohexanoate (140) (compare with 
Section 3.6.1). The crude product of the Grignard reaction was treated with NaOMe in MeOH 
affording the tert-alcohol 183 in 80% yield. As we did with 173 (see Section 3.6.1), the 
alcohol 183 was converted to the triethylsilyl ether 184 (Scheme 64) by treatment with a 
slight excess of TESOTf and 2,6-lutidine at -78 °C. 
A number of conditions was tested to selectively cleave the primary Bn-ether of 184 as 
summarized in Table 9. Catalytic hydrogenation with Pd/C and Pd/CaCO3 catalysts, transfer 
hydrogenation using 1,4-cyclohexadiene as a hydrogen donor and Pd/C catalyst as well as the 
Birch reduction protocol did not afford the desired alcohol 185. 
Table 9. Hydrogenolytic cleavage of the Bn-ether 184 
COOMe
H3C OSiEt3
BnO
184
COOMe
H3C OSiEt3
HO
185
conditions
 
entry conditions notes 
1 10% Pd/C, H2, 1 atm, MeOH, rt cleavage of both Bn and TES groups 
2 5% Pd/CaCO3, Et3N (inhib.), H2, 1 atm, MeOH, rt starting material 
3 10% Pd/C, 1,4-cyclohexadiene, EtOH, 12 h, rt  cleavage of both Bn and TES groups 
4 Na in liquid NH3 decomposition 
5 Ni Raney W2 catalyst, H2, 1 atm, MeOH, rt 98% yield 
 
Fortunately, 185 was obtained with an excellent yield of 98% when the reaction was 
conducted using Ni Raney W2 catalyst (Scheme 65).135 
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Oxidation of the primary alcohol 185 was conducted according to the Swern protocolk and 
afforded aldehyde 169 in an 86% yield (Scheme 65). 
COOMe
H3C OSiEt3
BnO COOMe
H3C OSiEt3
HO COOMe
H3C OSiEt3
O
169184 185
a b
 
(a) H2, Raney Ni "W2"; MeOH, rt, 12 h, 98%; (b) DMSO, (COCl)2, -78 °C, CH2Cl2, 86%. 
Scheme 65. Completion of the synthesis of the aldehyde 169 
3.6.6 The Evans aldol reaction 
With the aldehyde 169 in hand the Evans aldol reaction was studied. When the reaction was 
conducted under the published reaction conditions,99 no aldol product could be isolated since 
most of the aldehyde was isolated unchanged. In order to obtain the required aldol product 
with a suitable yield the reaction conditions were optimized as summarized in Table 10. 
Table 10. The optimization of the Evans aldol reaction 
+ O N
O O
Ph
n-Bu2BOTf, i-Pr2NEt
O N
O O
CH3
Ph
OH
DCMO COOMeH3C OSiEt3 H3C OSiEt3
COOMe
169 170 186  
170 Bu2BOTf i-Pr2EtN 169 entry 
equiv equiv mmol/Ll 
conditions yield, % notes 
1 1 1.2 1.3 0.97 25.8 30 min at -78 °C, then to rt 0 no reaction 
2 1 1.2 1.3 0.97 41.8 40 min at -78 °C and 1 h at 0 °C traces not reaction 
3 1 1.2 1.3 0.97 68.0 2 h at 0 °C and 15 h at rt 40 
33% of 169 left, a 
few side-products 
4 2 2.4 2.6 0.97 81.2 2 h at 0 °C and 15 h at rt 44 
incomplete, 
byproducts 
5 1 1.2 1.3 0.97 57.1 0 °C, 2 h < 30 complete, byproducts 
6 1 1.2 1.3 0.97 34.8 2 h at 0 °C and 5 h at rt < 30 incomplete 
7 1 1.2 1.3 0.97 57.6 2 h at 0 °C and 15 h at rt < 30 
incomplete, 
byproduct 
8 2 2.2 2.5 0.97 19.8 2 h at -10 to -15 °C 84 complete, little byproduct 
9 2 2.2 2.5 0.97 56.8 6 h at -10 to -15 °C and 15 h at rt 60 
20% of 169 left, 
byproduct 
                                                 
k) Oxidation with TPAP-NMO was very slow. 
l) Concentration of the aldehyde 169 in the reaction mixture during the aldol reaction. 
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It was found that if the aldol reaction was conducted at -78 °C no or little aldol product was 
formed (entry 1, 2). When the reaction was conducted at 0 °C, the desired product could be 
isolated in 40% yield together with approx. 30% of the starting aldehyde (entry 3). When 
2 equiv of the boron enolate were used, a complex mixture of reaction products was obtained 
with a little improvement of the yield (entry 4). Fortunately, when the reaction was conducted 
at -10 to -15 °C with 2 equiv of the boron enolate, the desired aldol product 186 could be 
isolated with 84% yield. The aldehyde was almost completely consumed and only traces of 
byproducts were detected by TLC (entry 8). 
With the aldol product 186 in hand we considered two possible ways towards the construction 
of the 9-membered lactone 187, an analogue of 142 (Scheme 58). One possibility was to 
exploit the Yamaguchi macrolactonization94 protocol which required seco-acid 168a as the 
starting material and the other possibility was to conduct a direct intramolecular 
transesterification of the aldol product 186 (Scheme 66). We first decided to investigate the 
formation of the lactone 142 by an intramolecular transesterification since this pathway has 
the advantage of less synthetic steps. 
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Scheme 66. Two possible ways towards the construction of the 9-membered lactone 187 
3.6.7 Macrolactonization through intramolecular transesterification 
Transesterification has been carried out traditionally and most frequently using acidic or basic 
catalysts.100 When the substrate posses no labile functional groups, is cheap and available, 
strong mineral acids are probably best catalysts. For the substrates, which are not compatible 
with strong acids or bases, neutral transesterification catalysts are required. 
Several organotin compounds, which are neither strong acids nor strong bases, are known to 
catalyze transesterification reactions (Scheme 67).100,101 The activity of these catalysts can be 
attributed to the ability of tin to enhance the nucleophilicity of a heteroatom bound to it, 
making alcohols more reactive in a transesterification process. 
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Scheme 67. Organotin transesterification catalysts 
The first two catalysts, n-Bu2SnO and (n-Bu3Sn)2O, were tested under conventional reflux 
conditions. When 186 was refluxed in toluene in the presence of 10 mol% of the catalyst over 
48 h, the 9-membered lactone 187 could be obtained with a 20% yield. It is worth to note that 
(n-Bu3Sn)2O appeared to be more effective under the specified reaction conditions  (Scheme 
68). 
O N
O O
CH3
Ph
OH
H3C OSiEt3
COOCH3 O N
O O
CH3
Ph
O
a
O
H3C
OSiEt3
186 187  
(a) 10 mol% (n-Bu3Sn)2O, toluene, reflux 48 h, 20%. 
Scheme 68. (n-Bu3Sn)2O catalyzed intramolecular transesterification of 186 
The product 187 was obtained as a mixture of two diastereomers. Chromatographic separation 
on silica gel using hexane/AcOEt 10:1 proved to be difficult because of close Rf values of the 
products. Nevertheless each diastereomer of the 9-membered lactone 187 could be obtained in 
pure form and analyzed with the help of spectroscopic methods. Figure 11 and Figure 12 
present the 1H NMR and 13C spectra of both compounds. 
The use of microwave assisted heating allowed conducting the reaction at a temperature 
exceeding the boiling point of the solvent used. For n-Bu2SnO and (n-Bu3Sn)2O catalysts 
there was no yield enhancement when microwave heating was used. 
We investigated two other catalysts, [n-Bu2(OAc)Sn]2O]2 and [n-Bu2ClSn]2O using a 
combination of microwave heating and HPLC to analyze the reaction mixture. Results are 
summarized in Table 11. 
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Figure 11. 1H NMR spectra of the diastereomers of 187 
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Figure 12. 13C NMR spectra of the diastereomers of 187 
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Table 11. Intramolecular transesterification of 186 using organotin catalysts 
O N
O O
CH3
OH
OSiEt3H3C
O
O
CH3
MW 300W, 150 °C, catalyst
O N
O O
CH3
O
OSiEt3H3C
O
186 187
 
entry conditionsm 186, %n 187, %o 
1 2.5 mol% {[n-Bu2(OAc)Sn]2O}2, 150 °C, 1 h 61 19 
2 2.5 mol% {[n-Bu2(OAc)Sn]2O}2, 150 °C, 2 h 49 21 
3 2.5 mol% {[n-Bu2(OAc)Sn]2O}2, 150 °C, 3 h 45 21 
4 3.6 mol% [n-Bu2ClSn]2O, 150 °C, 1 h 39 29 
5 3.6 mol% [n-Bu2ClSn]2O, 150 °C, 2 h 23 28 
6 3.6 mol% [n-Bu2ClSn]2O, 150 °C, 3 h 21 33 
 
Having investigated a number of catalysts and reaction conditions we were able to obtained 
the desired 9-membered lactone 187 with yields up to 30%. Though direct transesterification 
has the advantage of less synthetic steps compared to the saponification/Yamaguchi 
macrolactonization approach (Scheme 66), we could not be satisfied with the low yields of 
187 and investigated the alternative synthetic way. 
3.6.8 Saponification of the methyl ester 
For the Yamaguchi macrocyclization the seco-acid 168a was required (Scheme 66). In order 
to selectively saponificate the methyl ester in the presence of the oxazolidine imide a number 
of reaction conditions was investigated (Table 12). 
 
 
 
 
 
 
                                                 
m) 25 mg of 186 were dissolved in PhCH3 (5 mL), c = 9.1·10-3 M. The catalyst was added and the reaction 
mixture was irradiated in the microwave oven at 300W for the indicated period of time. 
n) The yield was determined with the help of HPLC on a LiChrospher 250-4 RP18 (5 µm) column at 1 mL/min 
flow rate of MeOH/H2O 85:15. For the aldol 186 a 4-point calibration was conducted. 186 had a Rt = 10.61 min. 
o) As above. For the macrolactone a 5-point calibration was performed. Diastereomers of 187 had a Rt = 13.01 
min (diastereomer II) and 16.30 min (diastereomer I). 
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Table 12. Attempted saponification of the methyl ester 186 
O N
O O
CH3
Ph
OH
H3C OSiEt3
186
conditions
HO
O
CH3
OH
OSiEt3H3C
OCH3
O 188
HO HN
O
CH3
OH
OSiEt3H3C
OH
O 189
HO HN
O
CH3 OSiEt3H3C
OCH3
O 190
OH
CH3 OSiEt3H3C 191
OCH3
O
H3CO
O
OCH3
O
 
entry Conditions Product 
1 LiOOH, THF-H2O 4:1, 70% 188 
2 Ba(OH)2 ⋅ 8H2O, MeOH 189 
3 Me3SiOK, Et2O, 25% 190 
4 LiOH in THF/MeOH/H2O 2:2:1, rt, 34% 191 
5 240 units PLE, pH 7.0 phosphate buffer starting material 
 
None of the tested reaction conditions allowed a chemoselective cleavage of the methyl ester 
of 186, leaving the oxazolidine ring intact. 
We believe that the secondary hydroxy group of 186 facilities intramolecular cleavage of the 
Evans auxiliary as shown in the Scheme 69. 
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Scheme 69. Anchimerically assisted methanolysis of the oxazolidine auxiliary 
The seco-acid 168a was therefore not directly accessible from the aldol product 186. 
3.6.9 Synthesis of the seco-acid 
In order to get access to the seco-acid required for the Yamaguchi macrocyclization we 
decided first to convert imide 186 into the Weinreb amide 194 and then to saponificate 194 to 
the seco-acid 195 (Scheme 70). 
O N
O O
CH3
Ph
OH
H3C OSiEt3 O
N
O
CH3
OH
H3C OSiEt3
a b
O
N
O
CH3
OH
H3C OSiEt3
186 194 195
OCH3
O
OCH3
O
OH
O
 
(a) 3.4 equiv NHCH3(OCH3)⋅HCl, 3.4 equiv Me3Al, THF, 0 °C, 2.5 h, 75%; (b) 0.43 M LiOH in THF/MeOH 
1:1, 2.5 h at rt, 95%. 
Scheme 70. Synthesis of the seco-acid 195 
This approach proved to be successful. The transamination furnished the Weinreb amide with 
a yield of 75% when 186 was treated with NHCH3(OCH3)⋅HCl and Me3Al. The reaction of 
194 with LiOH in THF/MeOH 1:1 afforded the desired seco-acid 195 in 95% yield. 
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3.6.10 Yamaguchi macrocyclization 
With the seco-acid 195 in hand we could carry out the Yamaguchi macrocyclization.94,102 
First, the solution of the seco-acid 195 in THF was treated with 2,4,6-trichlorobenzoyl 
chloride and Et3N as the base to afford the mixed anhydride. The macrolactonization took 
place when the solution of the mixed anhydride was slowly added to a refluxing solution of 
DMAP in toluene. The 9-membered macrolactone 196 was obtained with yields of 75-90% 
after a simple extractive workup and a chromatographic purification (Scheme 71). 
O
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O
CH3
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(a) 1) 3 equiv 2,4,6-trichlorobenzoyl chloride, 3 equiv Et3N, THF; 2) add to 6 equiv of DMAP in toluene over 
8 h at reflux, 75-90% yield. 
Scheme 71. Yamaguchi macrolactonization of Weinreb amide 195 
3.6.11 Dieckmann condensation 
Having achieved some positive results with the Dieckmann condensation of two model 
substrates (Section 3.5.3) we investigated the reaction of 196 with strong bases. Reactions of 
196 with various bases are summarized in Table 13. No reaction took place when the solution 
of 196 was refluxed with NaH in toluene (entry 2). Also with KHMDS in THF at -78 °C no 
reaction progress was detected (entry 6). When the addition of KHMDS was done at -78 °C 
and then the reaction mixture was slowly warmed to rt, the starting material was consumed 
and a complex mixture of products was obtained (entry 7). 
Four new products could be isolated when the reaction was conducted with 2 equiv of LDA at 
-78 °C (entry 3). After chromatographic separation and thorough analysis using spectroscopic 
methods two of the products could be assigned structures 198 and 199 (Scheme 72). 
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(a) 2 equiv LDA, THF, -78 °C, 1.5 h, 55%. 
Scheme 72. Products of the reaction of 185 with LDA 
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Table 13. Attempted Dieckmann condensation of the Weinreb amide 196 
O
N
O
CH3
O
O
H3C
OSiEt3 O
CH3
O
O
H3C
Et3SiO
conditions
196 197  
entry conditions notes 
1 2 equiv NaHMDS, -78 °C → -30 °C, 12 h starting material 
2 2.5 equiv NaH, reflux in toluene starting material 
3 2 equiv LDA, -78 °C, 30 min 4 new spots, complete reaction 
4 4 equiv LiHMDS, -78 °C to rt starting material 
5 4 equiv LiHMDS, 3 equiv TMSI, -78 °C to rt starting material 
6 2 equiv KHMDS, 1 h at -78 °C, starting material 
7 2 equiv KHMDS, -78 °C → rt decomposition 
8 2 equiv, 78 °C → -30 °C then TBAF decomposition 
9 6.5 equiv KHMDS, 3 equiv TMSCl 4 unidentified products 
10 4 equiv KHMDS, reversed slow addition, -40 °C decomposition 
11 4 equiv Ph3CLi, rt, 14 h starting material, decomposition 
12 4 equiv Ph3CLi, 0 °C → rt, 14 h starting material 
 
Formation of 198 and 199 from 196 under the action of LDA was neither desired nor 
expected. Having studied the literature we have found that a similar, rather unusual, 
transformation of a Weinreb amide has been reported by Graham and Scholz.103 They 
observed the fragmentation of a Weinreb amide resulting into formation of an N-methylamide 
and formaldehyde. It was proposed that the reaction involves an E2-elimination (Scheme 73). 
Two other groups have made similar observations.104 
H3CO N
O
O
CH3
H
:NR2
H3CO N
O
O
CH3
H
H
+
200
H
 
Scheme 73. Fragmentation of Weinreb amides 
Unfortunately, it was not possible to find a base and reaction conditions that afforded the 
desired 1,3-dicarbonyl compound 197. We attribute the failure of the Dieckmann 
condensation of 196 to the hampered enolization of the desired 1,3-dicarbonyl compound 
(Scheme 74). 
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The ester condensation is a reversible, thermodynamically controlled reaction and the 
formation of a resonance-stabilized enolate of the 1,3-dicarbonyl compound is its driving 
force. If the enolization of the 1,3-diketone is not possible, such product is not formed.105 
The Bredt’s rule says that a bridged bicyclic hydrocarbon cannot have a double bond 
involving a bridgehead carbon unless one of the rings contains at least eight carbons atoms. 
Such a bridged double bond common for the two small ring is equal to a trans-double bond in 
a small ring, what obviously causes severe strain. 
In the case of the enol-197 we have a bridged [2.2.5]bicyclic alkene with a trans-double bond 
in a 9-membered ring (Scheme 74). Therefore, one may expect that enol-197 is higher in its 
energy compared to keto-197 making enolization unfavorable and resulting in the failure of 
the Dieckmann condensation. 
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O
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H
H
197 keto-form 197 enol-form  
Scheme 74. The hindered enolization of 197 
We attempted to carry out the Dieckmann condensation with three another substrates: 187, 
202 and 203, but, unfortunately, without success (Table 14, Table 15, Table 16). 
Table 14. Attempted Dieckmann condensation of the imide 187 
O N
O O
CH3
O
O
H3C
OSiEt3
187
O
CH3
O
O
H3C
Et3SiO
conditions
197
 
entry conditions notes 
1 1, 2, 3 equiv LDA, -78 °C → rt, 12 h starting material 
2 2.5 equiv LiHMDS, -78 °C → -30 °C starting material 
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Table 15. Attempted Dieckmann condensation of the Weinreb amide 202 
O
CH3
OH
O
H3C
Et3SiO
conditions
N
O
O
CH3
O
OCH3
OSiEt3H3C O
OCH3
202
OCH3
H
O
H3C
O
O
CH3
OSiEt3
OCH3
H
OCH3
204
 
entry conditions notes 
1 2.5 equiv t-BuOK, toluene, 0 °C, 2 h No reaction 
2 2.5 equiv t-BuOK, toluene, rt, 18 h No reaction 
3 5 equiv t-BuOK, toluene, reflux, 2 h No reaction 
4 1.2 equiv LDA, -78 °C No reaction 
5 1.2 equiv LDA, -78 °C to rt No reaction 
6 2 equiv LHMDS, -78 °C → rt, 1 h  No reaction 
7 2 equiv LHMDS, 0 °C → rt, 1 h No reaction 
8 1 equiv LHMDS, 0 °C → rt, 1 h No reaction 
 
Table 16. Attempted Dieckmann condensation of the imide 203 
CH3
O
OCH3
OSiEt3H3C O
OCH3
O N
OO
203
O
CH3
OH
O
H3C
Et3SiO
conditions OCH3
H
O
H3C
O
O
CH3
OSiEt3
OCH3
H
OCH3 204  
entry Conditions notes 
1 2.5 equiv t-BuOK, toluene, 0° C, 2 h No reaction 
2 2.5 equiv t-BuOK, toluene, rt, 24 h No reaction 
 
Though the Dieckmann condensation failed to afford 197 it was possible to trap the enolate of 
196 with I2 and to obtain the corresponding iodide (Scheme 75). 
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(a) 2.7 equiv Ph3CLi, -78 °C, then 6 equiv I2, warm to rt. 
Scheme 75. Trapping the enolate of 196 with iodine 
In addition it was possible to conduct the reduction of the Weinreb amide 196 to the aldehyde 
201 with DIBAL (Scheme 76). 
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(a) 4 equiv DIBAL, THF, -78 °C, 13%. 
Scheme 76. Reduction of the Weinreb amide 196 
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3.7 Conclusion and outlook 
Investigation of the stereochemical outcome of the Tandem Michael Addition - Aldol reaction 
together with the study of the retroaldol reaction and the epimerization provided insights into 
the reactions involved in the construction of the C-ring of hexacyclinic acid. It also helped to 
find the reason for the wrong stereochemistry of a C8 stereocenter in the X-ray structure 
analysis of the totally deprotected ABC fragment 94. 
It was shown that the reaction of a Grignard reagent generated from 1-(benzyloxy)-3-
brompropane with the methylketone 132a selectively furnishes the undesired Felkin product 
134. This finding will be of value for the work on the total synthesis of hexacyclinic acid. 
Several strategies towards the construction of the DEF core have been studied. The ring 
closing alkene metathesis using a number of catalysts and different substrates did not prove to 
be successful in the synthesis of the 9-membered lactone 196. 
A new, reconsidered retrosynthetic approach, featuring a Grignard reaction, an Evans aldol 
reaction and a Yamaguchi macrolactonization led to the successful synthesis of the 9-
membered lactone 196. 
Despite the promising model studies of the Dieckmann condensation with an acetate and a 
propionate precursor, the reaction could not be successfully transferred to the advanced 
substrate 196. The failure of the Dieckmann condensation we attributed to the hindered 
enolization of the desired product, the 1,3-dicarbonyl compound 197. 
Since the key step of our approach, the Dieckmann condensation, has failed, it is important to 
propose and to investigate other possibilities to access the DEF cyclic fragment. In this regard 
an approach featuring an intramolecular aldol reaction106 could be useful (Scheme 77). 
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Scheme 77. The construction of the DEF ring fragment via intramolecular aldol reaction 
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A possible complication associated with this approach may arise from the epimerization of 
201 (α-position to aldehyde function) under the conditions of the aldol reaction. 
According to another promising approach the construction of the E-ring can be achieved in an 
intramolecular Reformatsky reaction (Scheme 78). Since the classical method employing zinc 
dust as a reductant has been established, many improvements and modifications have been 
reported107 employing either alternative elemental reductants, such as Cd,108 Ni,109 Co,110 
Ce,111 Mn,112 Mg,113 Ge,114 Sn,115 In116 or low-valent organometallic species, such as Cr(II),117 
titanocene(III),118 TiCl2,119 and SmI2.120,121 
It is worth to note that the reaction may be investigated on an easily accessible model 
aldehyde 212 as shown in the Scheme 78. 
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(a) Ph3CLi, I2, THF, -78 °C; (b) DIBAL; (c) SmI2, THF, -78 °C; (d) Dess-Martin oxidation, DCM. 
Scheme 78. A model system to investigate the intramolecular Reformatsky reaction in the 
construction of the E-ring of hexacyclinic acid (11). 
If the reaction affords the lactone 214 in a diastereomerically pure form (without 
epimerization), it can be applied to the advanced lactone 215, furnishing the desired DEF 
fragment of the natural product (Scheme 79). 
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(a) SmI2, THF, -78 °C; (b) Dess-Martin oxidation, DCM. 
Scheme 79. Reformatsky reaction in the synthesis of the DEF fragment of hexacyclinic acid 
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We hope that a reliable strategy for the construction of the DEF cyclic fragment combined 
with the previously elaborated approach towards the ABC fragment will result in the 
successful synthesis of the hexacyclinic acid (11). 
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4 Experimental Part 
4.1 General Methods 
NMR spectra were recorded with Bruker AVS-500, AVS-400 or AM-200 spectrometers. 
Chemical shifts are reported in parts per million (ppm) relative to tetramethylsilane (0.00 
ppm) on δ-scale. Corresponding solvent signal served as an internal standard: for 1H NMR 
spectra in CDCl3 - the singlet of CHCl3 at δ7.26 ppm, in C6D6 - the singlet of C6D5H at δ7.16 
ppm; for 13C NMR spectra in CDCl3 - the triplet at δ77.00 ppm, in C6D6 - the triplet at 
δ128.40 ppm. Values of the coupling constant, J, are given in hertz (Hz). Following 
abbreviations are used in the experimental section for the description of 1H-NMR spectra: 
singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), doublet of doublets (dd), doublet 
of triplet (dt), doublet of quartets (dq), doublet of doublets of doublets (ddd), broad singlet 
(bs), broad doublet (bd) and broad triplet (bt). The chemical shifts of complex multiplets are 
given as the range of their occurrence. 
13C-Signals were assigned by means of standard DEPT 135 and DEPT 90 experiments and the 
following abbreviations are used in the experimental part: quaternary (Cq), methyne (CH), 
methylene (CH2) and methyl carbon atom (CH3) respectively. Further assignment of NMR-
signals was achieved using two-dimensional NMR experiments when appropriate (H,H-
COSY, HMQC and HMBC). 
Infrared spectra were recorded with Bruker 580 FT-IR photometer. Samples were solved in 
dichloromethane or applied neat according to the “Golden-Gate” ATR method. 
High-resolution electrospray-mass spectra (HRMS-ESI) were recorded with Waters 
Micromass LCT spectrometer with a Lock-Spray unit. 
Elemental analyses were conducted on an Elementar Vario EL device with acetanilide as a 
standard. 
Optical rotations were determined on a Perkin Elmer PE-241 instrument at 25 °C and using a 
light with 589 nm (D-line of sodium emission spectrum) and a cuvette of 10 cm length. 
Analytical gas chromatography (GC) was performed with HP 6890 device using Macherey-
Nagel “Optima 5” capillary column (30 m, 5% phenyl - 95% dimethylpolysiloxan) and a 
flame ionization detector. Nitrogen served as the carrier gas. According to the standard 
method used, the column temperature was maintained 50 °C for 1 min then rose to 300 °C at a 
20 °C/min rate and was maintained at 300 °C till the end of the run. The overall run time was 
20 min. 
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All air- and moisture sensitive reactions were performed under argon or nitrogen gas in heat 
gun-dried glassware. 
Microwave heating was carried out with a CEM Discover® LabMate™ single-mode device. 
Reactions were conducted in 10 mL sealed Pyrex vessels, with a maximum operating 
temperature of 150 °C and a maximum pressure of 8 bar. 
All experiments were monitored by thin layer chromatography (TLC) performed on Merck 60 
F-254 (0.2 mm thick) silica gel aluminium supported plates. Spots were visualized by 
exposure to ultraviolet light (254 nm) or by staining with a “Vanillin” (85 mL MeOH, 5 mL 
H2SO4, 10 mL AcOH, 0.5 g vanillin (added last)), “Cer reagent” (10 g Ce(SO4)2, 25 g 
molybdophosphoric acid, 80 mL H2SO4, H2O to 1000 mL), followed by heating or by 
“permanganate reagent” (3 g KMnO4, 20 g K2CO3, 5 mL 5% aqueous NaOH, 300 mL H2O). 
Flash chromatography was performed using J. T. Baker brand silica gel (40-60 µm, 60Å 
pores). Solvents for chromatography (usually n-hexane and ethyl acetate) were distilled prior 
to use and mixed in volumetric parts. 
Tetrahydrofuran (THF) was distilled under argon from sodium/benzophenone. 
Dichloromethane was distilled from calcium hydride under argon. 
Commercially available reagents were used as supplied.  
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4.2 Experimental procedures and spectral data 
2-(2-Bromo-ethyl)-2-methyl-[1,3]-dioxolane (127) 
O
O CH3
Br
C6H11BrO2
Mol. Wt.: 195,05 
Method a): 127 was obtained from methylviylketone (10.0 g), bromotrimethylsilane (24.9 g), 
ethylene glycol (10.6 mL) and p-toluenesulfonic acid hydrate (0.7 g) as a catalyst according to 
the reported procedure83 to give 17.5 g (57%) of the product after vacuum distillation at 85-
90 °C/19-23 mmHg. Lit.83 yield: 82%, bp 42-46 °C/0.4 mmHg; lit.122 bp 88-94 °C/27 mmHg. 
Method b): 127 was obtained from methylvinylketone (24.7 mL, 0.3 mol), 48% aqueous HBr 
solution (72 mL, 0.645 mol), ethylene glycol (25 mL, 0.45 mol) and p-toluenesulfonic acid 
hydrate (1.5 g) according to the reported procedure.83 Modification: 1.5 equiv of ethylene 
glycol were used; it is not necessary to wash the toluene solution after the addition of HBr to 
the methylvinylketone; the crude product was distilled under reduced pressure (61-70 °C/15 
mmHg) to give 23.9 g (46%) of 127 as a yellow liquid. Lit.83 yield: 54%, bp 88-94 °C/27 
mmHg. 
Analytical sample (5.0 g) was obtained by flash chromatographic purification on a 10×2 cm 
column with hexane/AcOEt 10:1 as eluent. Rf = 0.23-0.25, the spot is UV inactive but visible 
with “Vanillin” staining reagent. 
1H-NMR (CDCl3, 200 MHz): δ4.05-3.90 (m, 4H), 3.50-3.35 (m, 2H), 2.35-2.20 (m, 2H), 
1.33 (s. 3H). 
HRMS ESI: desired M+ was not found. 
Trimethyl-(2-(2-(2-methyl-[1,3]dioxolan-2-yl)-ethyl)-cyclohexylidene-methoxy)-silane 
(128) 
O
O
H3C
OTMS
C16H30O3Si
Mol. Wt.: 298.49 
Mg turnings (1.10 g, 46 mmol, 3 equiv) were ground in a mortar and transferred immediately 
to a Schlenk flask fitted with an argon-filled balloon. THF (3 mL) and 1,2-dibromoethane 
(200 mg, 1.3 mmol) were added. A solution of 2-(2-bromoethyl)-2-methyl-1,3-dioxolane 
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(2.92 g, 15 mmol, 1 equiv) in THF (2 mL) was added dropwise over 2 h to Mg turnings while 
stirring at 22-24 °C (water bath). After the addition was complete, the reaction mixture was 
diluted with THF (15 mL) and stirred for 1 h at rt. The resulting grey solution was transferred 
with a syringe into another 100 mL Schlenk flask fitted with an argon-filled balloon. The flask 
was cooled to -78 °C and the solution of CuBr·Me2S (0.107 g, 0.5 mmol, 3 mol%) in HMPA 
(3.8 mL, 22 mmol, 1.5 equiv) was added. After the resulting mixture was stirred for 1 h at 
-78 °C a mixture of 1-cyclohexene-1-carbaldehyde (929 mg, 8.44 mmol) and TMSCl 
(2.25 mL, 17 mmol) in THF (10 mL) was added within 8 h to the reaction mixture while 
stirring at -78 °C. After additional 6 h at -78 °C Et3N (3 mL) was added followed by hexane 
(30 mL) and H2O (30 mL). Organic layer was separated. Aqueous layer was treated with 
saturated aqueous NH4Cl solution (20 mL) and extracted with hexane (2×30 mL). Combined 
hexane extract was washed with water and brine, dried over MgSO4 and concentrated. Flash 
chromatography on silica gel with hexane/AcOEt/Et3N 100:10:1 furnished 128 (2.0 g, 80%) 
as a colorless oil. Rf = 0.55 in hexane/AcOEt 7:3. 
1H-NMR (C6D6, 400 MHz): δ6.19 (s, 1H), 3.57 (s, 4H), 2.60-2.45 (m, 1H), 2.20 (m, 1H), 
2.00-1.40 (m, 11H), 1.33 (s, 3H), 0.11 (m, 9H). 
13C-NMR (C6D6, 100 MHz): δ131.93 (CH), 125.03 (Cq), 111.02 (Cq), 65.35 (CH2), 65.34 
(CH2), 40.35 (CH), 38.66 (CH2), 34.93 (CH2), 28.49 (CH2), 27.13 (CH2), 24.84 (CH3), 24.27 
(CH2), 23.77 (CH2), 0.17 (3×CH3). 
Elemental Analysis: Anal. C, 63.26%; H, 9.94%; calcd. for C16H30O3Si: C, 64.38%; H, 
10.13%. 
HRMS ESI: desired M+ was not found. 
2-[2-(2-methyl-[1,3]dioxolan-2-yl)-ethyl]-cyclohexane carbaldehyde (129) 
O
O
CH3
O
C13H22O3
Mol. Wt.: 226.31  
1.0 M TBAF solution in THF (1 mL, 1.0 mmol, 2.3 equiv) was added to a solution of 128 
(130 mg, 0.44 mmol) in THF (4 mL). After the reaction mixture was stirred for 5 h at rt it was 
then quenched with H2O (10 mL) and extracted with MTBE (3×10 mL). Combined organic 
extract was washed with brine, dried over MgSO4, filtered and concentrated. Flash 
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chromatography on silica gel with hexane/AcOEt 7:3 as eluent furnished 129 as a colorless oil 
(53.2 mg, 54%). Rf = 0.3. 
1H-NMR (CDCl3, 200 MHz): δ9.82 (s), 9.55 (d, J = 3.9 Hz, 1H), 3.92 (m, 4H), 2.10-0.70 
(complex m, 17H). Signals at 9.82 (s) and 9.55 (d, J = 3.9 Hz, 1H) ppm correspond to the 
absorption of the CHO proton of the cis- and the trans- isomer respectively. According 1H 
NMR the product was obtained as a 1:7.1 cis : trans diastereomeric mixture. 
13C-NMR (C6D6, 100 MHz): for the cis : trans mixture: δ204.62 (CH), 204.39 (CH), 110.70 
(Cq), 110.69 (Cq), 65.35 (CH2), 65.32 (CH2), 56.12 (CH), 52.58 (CH), 38.35 (CH2), 38.32 
(CH2), 38.18 (CH), 37.14 (CH), 37.06 (CH2), 37.04 (CH2), 31.04 (CH2), 30.06 (CH2), 29.51 
(CH2), 26.67 (CH2), 26.33 (CH2), 25.99 (CH2), 25.60 (CH2), 25.17 (CH2), 24.82 (CH2), 24.68 
(CH3), 24.67 (CH3), 24.58 (CH2). 
HRMS ESI: Calcd. for [C13H22O3 + H]: 277.1623; found: 227.1640. 
trans-129: 
The solution of aldehyde 129 in hexane/AcOEt 6:1 was stirred with silica gel (100 mg) for 
24 h at rt. The reaction mixture was filtered through a plug of cotton and concentrated to give 
the product. According to 1H NMR the cis : trans ratio was 1:8. 
(E)-methyl 3-(2-(2-(2-methyl-1,3-dioxolan-2-yl)ethyl)cyclohexyl)acrylate 
O
O
CH3
COOCH3
C16H26O4
Mol. Wt.: 282,38  
A solution of Ph3P=COOMe (0.502 g, 1.504 mmol, 2 equiv) in CH2Cl2 (3 mL) was added at 
reflux to the solution of the aldehyde 129 (0.168 g 0.743 mmol) in CH2Cl2 (3 mL) in a two 
necked flask fitted with a reflux condenser and an argon balloon. 
The mixture was refluxed for 9 h. The solvent was removed under reduced pressure and the 
rest was triturated with hexane. After the solution was filtered and concentrated, the crude 
product was purified by flash chromatography to give 134 mg (0.475 mmol, 64%) of the 
desired acrylate. 
1H-NMR (CDCl3, 400 MHz): δ6.85-6.75 (dd, J = 9.46, 15.87 Hz, 1H), δ5.80-5.75 (dd, 
J = 0.61, 15.56 Hz, 1H), 3.95-3.83 (m, 4H), 3.71 (s, 3H), 1.90-1.76 (complex m, 2H), 1.75-
1.42 (complex m, 7H), 1.28-1.02 (complex m, 9H), 0.98-0.84 (complex m, 1H). 
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According to the 1H NMR spectrum the product obtained is a 1:7 mixture of diastereomers 
(cis- to trans- in relevance to the substituents on the cyclohexane ring). The olefinic protons 
of the minor (cis-) diastereomer are found at: δ7.17-7.09 (dd, J = 8.85, 15.56 Hz), δ5.84-5.79 
(dd, J = 1.22, 15.87 Hz). 
13C-NMR (100 MHz, CDCl3): δ167.16 (CO), 153.94 (CH), 120.30 (CH), 110.15 (Cq), 64.56 
(CH2), 64.51 (CH2), 51.31 (CH3), 46.93 (CH), 41.07 (CH), 35.66 (CH2), 32.71 (CH2), 31.00 
(CH2), 28.69 (CH2), 25.95 (CH2), 25.55 (CH2), 23.64 (CH3). 
Signals from olefinic protons of the minor isomer are found at 150.85 and 121.18 ppm. 
HRMS ESI: Calcd. for [C16H26O4 + H]: 283.1909, for [C16H26O4 + Na]: 305.1729; found: 
283.1921, 305.1742. 
(E)-ethyl 3-(2-(2-(2-methyl-1,3-dioxolan-2-yl)ethyl)cyclohexyl)-acrylate (129a) 
O
O
CH3
COOEt
C17H28O4
Mol. Wt.: 296,40  
A solution of diethyl ethoxycarbonylmethanephosphonate (688 mg, 3.01 mmol, 1.7 equiv) in 
toluene (3 mL) was added to a suspension of NaH in mineral oil (60%, 106 mg, 2.66 mmol, 
1.5 equiv) in toluene (4 mL) at rt forming a clear colorless solution which was additionally 
stirred for 20 min at rt. The solution was cooled to -20 °C and the solution of the aldehyde 129 
(400 mg, 1.77 mmol, 1 equiv) in toluene (4 mL) was added dropwise over 20 min. The 
reaction mixture was stirred for 30 min at -20 °C. When the reaction was complete (TLC with 
hexane/AcOEt 7:3, product Rf = 0.45, UV), the reaction mixture was diluted with MTBE 
(10 mL) and H2O (10 mL). The mixture was extracted with MTBE (3×10 mL) and the 
combined organic extract was washed with brine, dried over MgSO4, filtered and 
concentrated. Chromatographic purification on silica gel using hexane/AcOEt 8:2 as eluent 
furnished purified 129a as a colorless oil (240 mg, 46%). 
1H-NMR (CDCl3, 400 MHz): δ6.38-6.77 (dd, J = 9.5, 15.7 Hz, 1H), 5.78 (d, J = 15.7 Hz 
1H), 4.17 (q, J = 7.2 Hz, 2H), 3.90 (m, 4H), 1.90-1.40 (m, 8H), 1.30-1.00 (m, 11H), 1.00-0.80 
(m, 1H). According 1H NMR the product was obtained as a 1:6.6 cis : trans mixture of 
isomers (in respect to the substitution pattern on the cyclohexane ring). Olefinic protons of the 
minor cis isomer are observed at 7.20-7.07 (dd, J = 8.9, 15.7 Hz) and 5.82 (d, J = 15.7 Hz) 
ppm. 
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13C-NMR (CDCl3, 100 MHz): δ166.68 (O-C=O), 153.53 (CH), 120.62 (CH), 110.07 (Cq), 
64.47 (CH2), 64.42 (CH2), 59.99 (CH2), 46.84 (CH), 40.97 (CH), 35.53 (CH2), 32.62 (CH2), 
30.92 (CH2), 28.60 (CH2), 25.88 (CH2), 25.48 (CH2), 23.57 (CH3), 14.17 (CH3). 
HRMS ESI: Calcd. for [C17H28O4 + H]: 297.2066; found: 297.2070. 
IR (cm-1, neat): 2981 (m), 2924 (s), 2854 (m), 1716 (s), 1650, 1447, 1370, 1323, 1263, 1223, 
1174, 1039, 987, 947, 859, 720. 
(E)-3-[2-(3-oxo-butyl)-cyclohexyl]-acrylic acid ethyl ester (173) 
O
CH3
COOEt
C15H24O3
Mol. Wt.: 252,35  
A solution of 129a (253 mg, 0.86 mmol) and PPTS (64 mg, 0.256 mmol, 30 mol%) in 
aqueous acetone (5 mL, 0.5 mL H2O) was refluxed for 4 h. When the reaction was complete 
(TLC with hexane/AcOEt 7:3, product Rf = 0.35, UV) the excess of the solvent was removed 
under reduced pressure, MTBE (15 mL) was added and the mixture was washed with 
saturated aqueous NaHCO3 solution (15 mL) and brine (15 mL). The organic layer was dried 
over MgSO4, filtered and concentrated. The crude product was purified by flash 
chromatography on silica gel with hexane/AcOEt 8:2 as eluent to give 173 as colorless oil 
(199 mg, 92%). 
1H-NMR (CDCl3, 400 MHz): δ6.80-6.70 (dd, J = 9.6, 15.7 Hz, 1H), 5.81-5.72 (d, 
J = 15.6 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 2.51-2.25 (m, 2H), 2.11 (s, 3H), 1.58 (s, 3H), 1.90-
1.60 (m, 5H), 1.35-1.15 (m, 8H), 1.00-0.80 (m, 1H). According to 1H NMR the product was 
obtained is a 1:6. mixture of isomers (cis : trans- in respect to the substitution pattern on the 
cyclohexane ring). Olefinic protons of the minor cis isomer are observed at: 7.14-7.08 (dd, 
J = 8.8, 15.7 Hz) and 5.83 (d, J = 15.7 Hz) ppm. 
13C-NMR (CDCl3, 100 MHz): δ208.82 (C=O), 166.55 (O-C=O), 153.00 (CH), 120.94 (CH), 
60.04 (CH2), 46.83 (CH), 40.74 (CH2), 40.48 (CH), 32.56 (CH2), 30.80 (CH2), 29.73 (CH3), 
28.33 (CH2), 25.74 (CH2), 25.34 (CH2), 14.14 (CH3). 
HRMS ESI: Calcd. for [C15H24O3 + Na]: 275.1623; found: 275.1628. 
IR (cm-1, neat): 2925 (s), 2854 (m), 1712 (s), 1650 (m), 1447, 1367, 1324, 1266, 1225, 1161, 
1133, 1039, 986, 844, 734. 
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The cis-trans mixture was separated using HPLC on a 250×25 mm “Reprosil-Pur 120 C18 
AQ 5 µm” column with a 30×20 mm “Reprosil-Pur 120 C18 AQ 10 µm” precolumn and 
CH3CN/H2O 48:52 as eluent at 10 mL/min flow rate. Detection with L-7400 “LaChrome” UV 
detector at 254 nm. The minor diastereomer had a retention time of 57.0 min. The major one: 
59.9 min. In a single run 300 µL of the solution of the diastereomeric mixture in CH3CN, 
containing 60 mg of the substance, was injected. 
Siloxycyclobutane 131a (kinetic product) 
COOEt
CH3
OTMS
H
H
C18H32O3Si
Mol. Wt.: 324,53
H
H
COOEt
CH3
H
OTMS
H
HH
HH
H
H
H
Rac
 
TMSI (58 µL, 0.43 mmol, 1.3 equiv) was dropwise added to a stirred solution of 173 
(83.0 mg, 0.33 mmol, 1 equiv) and hexamethyldisilazane (104 µL, 0.49 mmol, 1.5 equiv) in 
1,2-dichloroethane (3.5 mL) at -30 °C. After the reaction mixture was stirred at this 
temperature for 3 h it was diluted with MTBE (10 mL) and saturated aqueous NH4Cl solution 
(10 mL) followed by the extraction with MTBE (3×10 mL). Combined organic extract was 
washed with brine (15 mL), dried over MgSO4 and concentrated. The crude product was 
purified by flash chromatography on silica gel (20×270 mm column) with hexane-Et2O 50:1 
as eluent to give 131a (56.6 mg, 53%) as a colorless oil. According to the 1H NMR the 
product is a 11:1 diastereomeric mixture. Rf = 0.45-0.52 in hexane/AcOEt 10:1; Rf = 0.17-
0.13 in hexane-Et2O 60:1. 
1H-NMR (C6D6, 400 MHz): δ4.03 (dq, J = 3.8, 7.2 Hz, 1H), 3.98 (dq, J = 3.6, 7.2 Hz, 1H), 
3.05-3.02 (d, J = 5.1 Hz, 1H), 2.45-2.31 (m, 2H), 1.98-1.91 (m, 1H), 1.87-1.81 (m, 1H), 1.75-
1.62 (m, 4H), 1.43 (s, 3H), 1.14-1.06 (m, 4H), 1.01-0.96 (t, J = 7.2 Hz, 3H), 0.21 (s, 9H). 
13C-NMR (C6D6, 100 MHz): δ172.70 (O-C=O), 74.26 (Cq), 60.12 (CH), 59.99 (CH2), 55.45 
(CH), 50.77 (CH), 49.40 (CH), 37.54 (CH), 32.95 (CH2), 31.93 (CH2), 31.92 (CH2), 27.27 
(CH2), 26.74 (CH3), 26.62 (CH2), 14.50 (CH3), 2.14 (3×CH3). 
HRMS ESI: Calcd. for [C18H32O3Si + H]: 325.2199, for [C18H32O3Si + CH3CN + Na]: 
388.2284; found: 325.2394, 388.2424. 
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Siloxycyclobutane 131b (thermodynamic product) 
COOEt
CH3
OTMS
H
H
C18H32O3Si
Mol. Wt.: 324,53
H
H
COOEt
CH3
H
OTMS
H
HH
HH
H
H
H
H
H
H
H
Rac
 
TMSI (52 µL, 0.383 mmol, 1.3 equiv) was added dropwise to a stirred solution of 173 
(74.3 mg, 0.294 mmol, 1.0 equiv) and TMS2NH (93 µL, 0.442 mmol, 1.5 equiv) in 1,2-
dichloroethane (3 mL) at 0 °C and the mixture was stirred at this temperature for 24 h. The 
reaction mixture was diluted with MTBE (5 mL), quenched with saturated aqueous NH4Cl 
solution (5 mL) and extracted with MTBE (3×10 mL). Combined organic extract was washed 
with brine (15 mL), dried over MgSO4 and concentrated. The crude product was purified by 
flash chromatography on silica gel (25×400 mm column) with hexane-Et2O 60:1 as eluent to 
give 131b (59 mg, 62%) as a colorless oil. The content of the fractions was judged by the GC. 
Rf = 0.45-0.50 in hexane/AcOEt 10:1, Rf = 0.15-0.12 in hexane/Et2O 60:1. 
1H-NMR (C6D6, 400 MHz): δ4.15 (dq, J = 10.9, 7.2 Hz, 1H), 4.08 (dq, J = 10.9, 7.2 Hz, 1H), 
3.01-2.97 (d, J = 6.8 Hz, 1H), 2.89-2.82 (m, 1H), 2.36-2.31 (t, J = 8.0 Hz, 1H), 2.20-2.13 (dd, 
J = 12.8, 6.3 Hz, 1H), 1.98-1.91 (m, 1H), 1.71-1.62 (m, 3H), 1.59-1.49 (m, 1H), 1.45 (s, 3H), 
1.16-1.12 (m, 5H), 1.02-0.97 (t, J = 7.2 Hz, 3H), 0.97-0.87 (m, 1H), 0.24 (s, 9H). 
13C-NMR (C6D6, 100 MHz): δ172.25 (O-C=O), 74.47 (Cq), 59.95 (CH2), 50.97 (CH), 48.97 
(CH), 48.71 (CH), 43.30 (CH), 37.16 (CH), 32.33 (CH2), 32.32 (CH2), 27.05 (CH2), 26.92 
(CH2), 26.90 (CH3), 26.58 (CH2), 14.49 (CH3), 2.14 (3×CH3). 
HRMS ESI: Calcd. for [C18H32O3Si + H]: 325.2199, for  [C18H32O3Si + CH3CN + Na]: 
388.2284; found: 325.2191, 388.2304. 
Methyl ketone 132a 
COOEt
CH3
O
H
H
H
H
C15H24O3
Mol. Wt.: 252,35  
1.0 M solution of TBAF in THF (0.214 mmol, 0.214 mL) was added to the solution of silyl 
ether 131a (69.6 mg, 0.214 mmol) in THF (5 mL) at -30 °C. The reaction mixture was stirred 
for 30 min at -30 °C, quenched with saturated aqueous NH4Cl solution (5 mL) and extracted 
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with MTBE (3×10 mL). The combined organic extract was washed with brine, dried over 
MgSO4 and concentrated. The crude product was purified by flash chromatography on silica 
gel (20×240 mm column) with hexane/AcOEt 20:1 as eluent to give 132a (43.2 mg, 80%) as a 
colorless oil. 
1H-NMR (CDCl3, 500 MHz): δ4.07 (q, J = 7.1 Hz, 2H), 3.36 (ddd, J = 8.7, 8.7 and 8.7 Hz, 
1H), 2.56 (dd, J = 16.9, 10.8 Hz, 1H), 2.41 (dd, J = 16.9, 4.7 Hz, 1H), 2.13 (s, 3H), 2.07 (ddd, 
J = 8.7, 11.7 and 6.0 Hz, 1H), 1.97 (ddd, J = 20.7, 11.1 and 4.7 Hz, 1H), 1.86-1.80 (m, 1H), 
1.79-1.70 (m, 3H), 1.22 (t, J = 7.1 Hz, 3H), 1.27-1.11 (m, 4H), 1.04 (dddd, J = 11.3, 11.2, 
11.3, 3.1 Hz, 1H), 1.05-0.96 (m, 1H), 0.90-0.81 (m, 1H). 
13C-NMR (CDCl3, 100 MHz): δ213.38 (Cq), 173.91 (Cq), 60.20 (CH2), 50.04 (CH), 49.88 
(CH), 45.53 (CH), 43.71 (CH), 36.33 (CH2), 33.40 (CH2), 32.04 (CH3), 31.51 (CH2), 30.09 
(CH2), 26.24 (CH2), 25.83 (CH2), 14.18 (CH3). 
HRMS ESI: Calcd. for [C15H24O3 + Na]: 275.1623, for [C15H24O3 + CH3CN + Na]: 
316.1889; found: 275.1636, 316.1883. 
Methyl ketone 133a 
COOEt
CH3
O
H
H
H
H
C15H24O3
Mol. Wt.: 252,35  
1.0 M solution of TBAF in THF (0.55 mL, 0.55 mmol) was added to the solution of methyl 
ketone 132a (27.9 mg, 0.111 mmol) in THF (5 mL) at rt. After 3 h the reaction mixture was 
quenched with saturated aqueous NH4Cl solution (5 mL) and extracted with AcOEt 
(3×10 mL). Combined organic extract was washed with brine, dried over MgSO4 and 
concentrated. The crude product was purified by flash chromatography on silica gel (160×15 
mm column) with hexane/AcOEt 10:1 as eluent to give 133a (15 mg, 54%) as a colorless oil. 
1H-NMR (CDCl3, 500 MHz): δ4.06 (q, J = 7.2 Hz, 2H), 2.76 (ddd, J = 11.5, 7.6, 3.0 Hz, 
1H), 2.49 (dd, J = 14.3, 4.3 Hz, 1H), 2.23 (dddd, J = 10.9, 7.3, 9.2 and 4.2 Hz, 1H), 2.17 (s, 
3H) 2.16 (dd, J = 14.4, 9.2 Hz, 1H), 1.85-1.75 (m, 2H), 1.75 (ddd, J = 12.7, 7.0 and 2.9 Hz, 
1H), 1.75-1.65 (m, 2H), 1.51 (ddd, J = 12.3, 12.1, 12.1 Hz, 1H), 1.29 (t, J = 7.2 Hz, 3H), 1.30-
1.20 (m, 1H), 1.20-1.10 (m, 2H), 1.10-1.00 (m, 1H), 0.85-0.99 (m, 1H), 0.83 (dddd, J = 11.1, 
11.1, 11.1 and 3.3 Hz, 1H). 
4. Experimental Part 
 
99
13C-NMR (CDCl3, 100 MHz): δ210.76 (Cq), 172.94 (Cq), 60.31 (CH2), 55.40 (CH), 51.72 
(CH), 44.52 (CH), 42.95 (CH), 37.87 (CH2), 34.71 (CH2), 31.49 (CH2), 29.86 (CH2), 29.07 
(CH3), 25.95 (CH2), 25.92 (CH2), 14.15 (CH3). 
HRMS ESI: Calcd. for [C15H24O3 + H]: 253.1798, for [C15H24O3 + Na]: 275.1618, for 
[C15H24O3 + CH3CN + Na]: 316.1889; found 253.1742, 275.1669, 316.1901. 
Methyl ketone 133b 
COOEt
CH3
O
H
H
H
H
C15H24O3
Mol. Wt.: 252,35  
1.0 M TBAF solution in THF (0.066 mL, 0.066 mmol, 1.0 equiv) was added to the solution of 
131b (21.5 mg, 0.066 mmol) in THF (5 mL) at -30 °C. The reaction mixture was stirred at 
-30 °C for 30 min, then quenched while cold with saturated aqueous NH4Cl solution (5 mL), 
MTBE (5 mL) and H2O (5 mL), extracted with MTBE (3×10 mL). Combined extract was 
washed with brine (15 mL), dried over MgSO4, concentrated. After flash chromatographic 
purification (hexane/AcOEt 8:1, Rf = 0.17-0.20) 13.2 mg (79%) of a colorless oil was 
obtained. According to 1H NMR the product was a 2.8:1.0 diastereomeric mixture. The 
signals of the CH3 group were found at δ1.91 ppm (132b) and δ1.93 ppm (133b), respectively 
(in C6D6). 
1.0 M TBAF solution in THF (0.13 mL, 0.13 mmol, 3 equiv) was added to the solution of the 
above 2.8:1.0 diastereomeric mixture (11.0 mg, 0.044 mmol) in THF (9 mL) at rt. After 3 h at 
rt the reaction mixture was quenched with saturated aqueous NH4Cl solution (5 mL) and 
extracted with AcOEt (3×10 mL). Combined extract was washed with brine (15 mL), dried 
over MgSO4 and concentrated. The crude product was purified by flash chromatography on 
silica gel with hexane/AcOEt 8:1, Rf = 0.17-0.20 to give 133b (6.7 mg, 61%) as a colorless 
oil. According to 1H and 13C NMR the product was diastereomerically pure with the chemical 
shift of the CH3 group at δ1.93 ppm (in C6D6). 
1H-NMR (C6D6, 500 MHz): δ3.96 (q, J = 7.1 Hz, 1H), 3.95 (q, J = 7.1 Hz, 1H), 2.88 (dddd, 
J = 2.9, 5.2, 10.9, 8.2 Hz, 1H), 2.49 (ddd, J = 3.2, 8.7, 8.7 Hz, 1H), 2.21 (dd, J = 5.2, 15.2 Hz, 
1H), 1.93 (s, 3H), 1.85 (dd, J = 10.9, 15.2 Hz, 1H), 1.73-1.68 (m, 1H), 1.65 (ddd, J = 6.2, 8.5, 
12.1 Hz, 1H), 1.61-1.53 (m, 2H), 1.48-1.42 (m, 1H), 1.19 (ddd, J = 11.8, 11.8, 9.0 Hz, 1H), 
1.20-1.13 (m, 1H), 0.98 (t, J = 7.1 Hz, 3H), 0.97-0.90 (m, 2H), 0.96-0.88 (m, 1H), 0.81 (m, 
1H), 0.75 (dddd, J = 2.6, 11.3, 13.0, 12.2 Hz, 1H). 
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13C-NMR (C6D6, 125 MHz): δ208.26 (C=O), 173.12 (O-C=O), 60.54 (CH2), 56.95 (CH), 
48.16 (CH), 43.41 (CH), 39.97 (CH), 36.86 (CH2), 35.93 (CH2), 32.49 (CH2), 29.12 (CH3), 
28.05 (CH2), 26.80 (CH2), 26.64 (CH2), 14.64 (CH3). 
HRMS ESI: Calcd. for [C15H24O3 + Na]: 275.1623, for [C15H24O3 + CH3CN + Na]: 
316.1889; found: 275.1653, 316.1885. 
Lactones 134 and 135 
134 (major) 135 (minor)
dr = 5 : 1
H
H
H
H
CH3
O
O
OBn
H
H
H
H
CH3
O
O
OBn
C23H32O3
Mol. Wt.: 356,50  
Preparation of the 0.2 M solution of the Grignard reagent:134 
The solution of benzyl 3-brompropyl ether (458 mg, 2 mmol, 1.0 equiv) in THF (2 mL) was 
added over 10 min via a syringe to a suspension of Mg turningsp (100 mg, 4 mmol, 2.0 equiv) 
in THF (1 mL) at rt. The exothermic reaction has an induction period of ca. 10 min, but when 
the reaction starts, the color of the reaction mixture changes to yellow-green and the 
temperature may rise up to 40-50 °C. After the reaction mixture was stirred for 45 min at rt it 
was diluted with THF (7 mL) to provide 0.2 M solution of the Grignard reagent. 
 
The Grignard reaction: 
0.2 M solution (1 mL, 0.2 mmol) of the Grignard reagent was dropwise added to the solution 
of the methyl ketone 132a (26.3 mg, 0.10 mmol, 0.5 equiv) in THF (1 mL) at rt. After 1 h at rt 
EtOH (3 mL) was added and the reaction mixture was stirred for additional 30 min. Solvents 
were removed under reduced pressure and the rest was diluted with MTBE (10 mL). The grey 
suspension was quenched with saturated aqueous NH4Cl solution (10 mL), extracted with 
MTBE (3 × 15 mL) and concentrated to furnish a pale oil. The crude product was purified by 
flash chromatography on silica gel with hexane/AcOEt 8:2 as eluent giving two fractions: 
135: 3.6 mg (10%) with an Rf = 0.20-0.21 and 134: 18 mg (48%) with an Rf = 0.17-0.19. 134 
                                                 
p) Ground to generate a fresh surface. 
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required additional purification by flash chromatography with hexane/MTBE 3:1 (134: 
Rf = 0.21-0.24, impurity Rf = 0.25-0.27, “Vanillin”). 
Lactone 135 (minor): 
135 (minor)
H
H
H
H
CH3
O
O
OBn
C23H32O3
Mol. Wt.: 356,50  
1H-NMR (CDCl3, 400 MHz): δ7.43-7.26 (m, 5H, Ar), 4.48 (s, 2H), 3.54-3.42 (m, 2H), 2.66 
(dd, J = 16.39, 8.19 Hz, 1H), 2.33 (dd, J = 16.56, 4.95 Hz, 1H), 2.30-2.23 (m, 1H), 2.04 
(dddd, J = 10.84, 10.84, 8.19, 5.04 Hz, 1H), 1.91-1.80 (m, 3H), 1.79-1.59 (m, 6H), 1.32 (s, 
3H), 1.23-1.08 (m, 4H), 1.03-0.90 (m, 2H), 0.82 (dddd, J = 10.84, 10.84, 10.84, 3.07 Hz, 1H). 
13C-NMR (CDCl3, 100 MHz): δ172.90 (Cq, C=O), 138.43 (Cq, Ar), 128.35 (2×CH, Ar), 
127.58 (2×CH, Ar), 127.54 (CH, Ar), 84.49 (Cq), 72.84 (CH2), 70.04 (CH2), 53.65 (CH), 
44.70 (CH), 43.04 (CH), 39.09 (CH), 37.71 (CH2), 34.40 (CH2), 32.91 (CH2), 31.24 (CH2), 
30.25 (CH2), 26.05 (CH2), 26.05 (CH2), 23.78 (CH2), 23.62 (CH3). 
HRMS ESI: Calcd. for [C23H32O3 + H]: 357.2430, for [C23H32O3 + Na]: 379.2249; found: 
357.2445, 379.2262. 
IR (cm-1, neat): 2922 (s), 2850 (m), 1737 (s), 1447 (m), 1366 (s), 1274 (w), 1217 (s), 1096 
(m), 1028 (w), 988 (w), 953 (w), 737 (m), 698 (m). 
Lactone 134 (major): 
134 (major)
H
H
H
H
CH3
O
O
OBn
C23H32O3
Mol. Wt.: 356,50  
1H-NMR (CDCl3, 400 MHz): δ7.41-7.21 (m, 5H, Ar), 4.50 (s, 2H), 3.57-3.41 (m, 2H), 2.69 
(dd, J = 16.38, 8.53 Hz, 1H), 2.35 (dd, J = 16.73, 2.73 Hz, 1H), 2.23 (ddd, J = 10.75, 10.75, 
7.17 Hz, 1H), 2.09 (dddd, J = 10.58, 10.67, 8.36, 2.39 Hz, 1H), 1.91-1.58 (m, 9H), 1.42 (s, 
3H), 1.23-1.05 (m, 4H), 1.02-0.90 (m, 2H), 0.77 (dddd, J = 10.80, 10.80, 10.80, 2.86 Hz, 1H). 
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13C-NMR (CDCl3, 100 MHz): δ172.74 (Cq), 138.40 (Cq), 128.30 (2×CH, Ar), 127.52 
(2×CH, Ar), 127.48 (CH, Ar), 83.92 (Cq), 72.82 (CH2), 70.22 (CH2), 53.40 (CH), 44.37 (CH), 
43.81 (CH), 38.39 (CH), 35.88 (CH2), 33.90 (CH2), 32.84 (CH2), 31.07 (CH2), 30.15 (CH2), 
26.05 (CH2), 25.98 (CH2), 25.12 (CH3), 23.79 (CH2). 
HRMS ESI: Calcd. for [C23H32O3 + H]: 357.2430, for [C23H32O3 + Na]: 379.2249; found: 
357.2434, 379.2256. 
IR (cm-1, neat): 2921 (s), 2851 (m), 1731 (s), 1453 (m), 1347 (w), 1274 (m), 1213 (w), 1100 
(s), 1075 (m), 1014 (w), 971 (w), 950 (w), 737 (m), 698 (m). 
Neryl bromide 
Br
CH3 CH3
CH3
C10H17Br
Mol. Wt.: 217,15  
The substance was prepared according to a published procedure.123 Pyridine (1.0 mL, 
12.4 mmol, d = 0.978) was added to a stirred solution of nerol (19.0 g, 21.5 mL, 123 mmol, 
1 equiv, d = 0.877) in Et2O (150 mL) at 0 °C followed by a dropwise addition of a solution of 
PBr3 (14.4 g, 52.0 mmol, d = 2.88, 5.0 mL) in hexane (50 mL) at 0 °C, during which a white 
suspension formed and a weak exothermic effect was observed. The reaction mixture was 
stirred for 30 min, whereupon the solution had became clear and a pink precipitate of the 
phosphorous salts [Py·P(OH)3] had formed. TLC analysis indicated incomplete reaction (nerol 
was left). Additional portion of the solution of PBr3 (1 mL) in hexane (5 mL) was added so 
that the nerol was consumed. The yellow solution was decantated from the precipitate onto ice 
(200 mL), the precipitate was washed with hexane (20 mL) and the washings were combined 
with the main portion of the product. Organic layer was separated and the aqueous was 
extracted with MTBE (3×100 mL). Combined organic extract was washed with 5% aqueous 
NaHCO3 solution (2×100 mL) and brine (100 mL). The extract was dried over MgSO4 and 
concentrated to give 17.0 g (97%) of yellow oil. TLC (hexane): nerol Rf ca. 0, product 
Rf = 0.50. Important to note that a sample of the product decomposed during an attempted 
chromatographic purification on silica gel. The crude product was successfully purified by 
bulb to bulb distillation at 110-120 °C/0.2 mmHg. 
In general, isoprenyl bromides should be stored at 4 °C over Ag threads. In this way the 
substance may be stored over a month. 
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1H-NMR (CDCl3, 200 MHz): δ5.65-5.45 (m, 1H), 5.20-5.00 (m. 1H), 4.10-3.90 (d, 
J = 8.4 Hz, 2H), 2.13 (s, 3H), 1.85-1.65 (m, 4H), 1.68 (s, 3H), 1.61 (m, 3H). 
13C-NMR (100 MHz, CDCl3): δ143.31 (Cq), 132.30 (Cq), 123.45 (CH), 121.34 (CH), 31.73 
(CH2), 29.35 (CH2), 26.18 (CH2), 25.65 (CH3), 23.51 (CH3), 17.65 (CH3). 
The position of the signals corresponding to the CH3 groups (at δ25.65, 23.51 and 17.65 ppm) 
in 13C NMR suggests the cis- geometry of the double bond.124 
HRMS ESI: desired M+ was not found. 
IR (cm-1, neat): 3035 (w), 2968 (s), 2929 (s), 2859 (m), 1655 (m), 1447 (s), 1377 (m), 1200, 
1109, 985, 840 (s). 
2-(3,7-Dimethyl-octa-2,6-dienyl)-cyclohexanone (136) 
O
CH3
CH3
CH3
C16H26O
Mol. Wt.: 234.38  
2.5 M solution of n-BuLi (3.7 mL, 9.2 mmol) in hexanes was added to the solution of 
diisopropylamine (1.4 mL, 9.7 mmol) in THF (34 mL), at -78 °C. The so obtained LDA 
solution was warmed to 0 °C, stirred for 15 min and cooled to -78 °C. 
The solution of cyclohexanone (0.9 mL, d = 0.947, 0.903 g, 9.21 mmol) in THF (8 mL) was 
slowly added to the LDA solution at -78 °C. After 1 h at -78 °C the solution of neryl bromide 
(1.02 g, 4.61 mmol) in THF (1.6 mL) was dropwise added over 0.5 h at -78 °C. 
The reaction mixture was stirred at -78 °C over 12 h, warmed to rt and stirred over 4 h at 
ambient temperature (TLC with hexane/AcOEt 15:1: neryl bromide Rf = 0.7 (green-blue, 
“Vanillin”); cyclohexanone Rf = 0.35 (violet, “Vanillin”); product Rf = 0.45 (yellow-brown, 
“Vanillin”). When there was no starting neryl bromide, the reaction mixture was quenched 
with 1 M aqueous NaHSO4 solution (50 mL). Organic layer was separated, diluted with 
MTBE (20 mL) and washed with saturated aqueous NaHCO3 solution (50 mL) and brine 
(50 mL). Aqueous layer was extracted with MTBE (3×15 mL), the extract was washed with 
saturated aqueous NaHCO3 solution (20 mL) and brine (20 mL). The extract was dried over 
MgSO4 and concentrated to give 1.15 g of a yellow oil. Crude 136 was purified by flash 
chromatography with hexane/AcOEt 15:1 (Rf = 0.30-0.35) to furnish 539 mg (50%) of a 
colorless oil. 
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1H-NMR (CDCl3, 400 MHz): δ5.10-5.00 (m, 2H), 2.45-2.32 (m, 2H), 2.30-2.18 (m, 2H), 
2.15-2.05 (m, 1H), 2.05-1.95 (m, 4H), 2.00-1.85 (m, 2H), 1.85-1.75 (m, 1H), 1.70-1.50 (m, 
11H), 1.35-1.25 (m, 1H). 
13C-NMR (100 MHz, CDCl3): δ212.89 (C=O), 136.51 (Cq), 131.37 (Cq), 124.15 (CH), 
122.63 (CH), 51.127 (CH), 41.93 (CH2), 33.39 (CH2), 31.82 (CH2), 27.91 (CH2), 27.44 (CH2), 
26.40 (CH2), 25.60 (CH3), 24.94 (CH2), 23.32 (CH3), 17.51 (CH3). The position of the signals 
corresponding to the CH3 groups ( at δ25.60, 23.32 and 17.51 ppm) in 13C NMR spectrum 
suggests the cis- geometry of the double bond in the neryl rest.124 
HRMS ESI: Calcd. for [C16H26O + Na]: 257.1881, for [C16H26O + Na + CH3CN]: 298.2147; 
found: 257.1890, 298.2151. 
IR (cm-1, neat): 2930 (s), 2859 (m), 1712 (m), 1448 (m), 1376, 1313, 1225, 1127, 1068, 960, 
831, 740. 
1-(3,7-Dimethyl-octa-2,6-dienyl)-2-methoxymethylene-cyclohexane (137) 
CH3
CH3
CH3
OCH3
C18H30O
Mol. Wt.: 262.43  
2.5 M n-BuLi solution in hexanes (5 mL, 12.5 mmol) was dropwise added to the solution of 
diisopropylamine (2.0 mL, 13.6 mmol) in THF (10 mL) at -60 °C. After 15 min at -60 °C the 
reaction mixture was warmed to 0 °C and stirred for 30 min. 
Methoxymethyl triphenylphosphonium bromide (3.50 g, 10.2 mmol) was added to the above 
solution of LDA as suspension in THF (60 mL) while stirred at 0 °C forming a red solution. 
After 30 min at 0 °C the mixture was cooled to -60 °C. The solution of the ketone 136 (1.72 g, 
7.34 mmol) in THF (10 mL) was added over 30 min at -60 °C. The reaction mixture was 
warmed to rt and stirred for 12 h. According to the TLC the reaction was complete (starting 
material Rf = 0.30-0.35, product has an Rf = 0.7). The reaction mixture was poured into 
saturated aqueous NH4Cl solution (50 mL), extracted with MTBE (3×15 mL). Combined 
extract was washed with brine (25 mL), dried over MgSO4 and concentrated to give the 
residue of the solid Ph3PO and the oily product. This was triturated with hexane/AcOEt 15:1 
and the cloudy solution was filtered. Evaporation gave 2.35 g of yellow oil. Bulb to bulb 
distillation (0.2 mm, 120 °C) allows to some extent to separate 137 from the byproduct, 
Ph3PO. A portion of 137 (224 mg) was purified by flash chromatography with hexane/AcOEt 
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100:1 to give 152.5 mg (68%) of the purified product. TLC product Rf = 0.15 (hexane); 0.45 
(hexane/AcOEt 50:1); 0.7 (hexane/MTBE 10:1); 0.25 (hexane/AcOEt 100:1). 
1H-NMR (CDCl3, 400 MHz): δ5.80-5.70 (m, 1H), 5.20-5.05 (m, 2H), 3.54 (s, 3H), 2.20-1.15 
(complex m, 24H). From the 1H NMR spectra it is clearly seen that the product is a mixture of 
the two π-diastereomers. Signals at δ7.2-7.3 suggest that Ph3PO could not be completely 
separated even after chromatographic purification with hexane/AcOEt 100:1. 
13C-NMR (100 MHz, CDCl3): δ139.34 (CH), 138.93 (CH), 137.22 & 137.11 (Cq), 135.46 
(Cq), 135.19 (Cq), 133.80 (CH), 133.61 (CH), 131.45 (Cq), 131.33 (Cq), 128.66 (CH), 128.49 
(CH), 128.42 (CH), 124.52 (s, CH), 124.39 (CH), 124.27 (CH), 121.26 (Cq), 120.86 (Cq), 
59.28 (CH3), 59.14 (CH3), 39.86 (CH), 33.38 (CH), 33.18 (CH2), 32.14 (CH2), 32.11 (CH2), 
30.40 (CH2), 30.09 (CH2), 29.53 (CH2), 28.35 (CH2), 27.34 (CH2), 26.81 (CH2), 26.65 (CH2), 
26.54 (CH2), 25.70 (CH3), 25.69 (CH3), 24.12 (CH2), 23.77 (CH2), 23.42 (CH3), 23.40 (CH3), 
21.63 (CH2), 17.62 (CH3), 17.60 (CH3). 
Total are: 12CH, 7×Cq, 14×CH2, 8×CH3 = 41 signals. Total need: 8×CH, 6×Cq, 14×CH2, 
8×CH3 = 36 carbon atoms. The admixture of OPPh3 is the reason for 3 additional CH signals 
(one of which is a doublet) between δ120-140 and one Cq (137.22 & 137.11, d, J = 11 Hz on 
P). According to the NMR the product was obtained as E/Z-mixture. 
HRMS ESI: Calcd. for [C18H30O + Na]: 285.2194; found: 285.2187. 
IR (cm-1, neat): 2926 (s), 2853 (m), 1716 (v), 1680 (m), 1447 (m), 1376, 1234, 1199, 1128 
(s), 1089, 995, 834, 743, 697. 
GC, Rt, min (intensity): 10.43 (42%), 10.612 (49%). 
2-(3,7-Dimethyl-octa-2,6-dienyl)-cyclohexane carbaldehyde (138) 
C17H28O
Mol. Wt.: 248.40
CH3
CH3
CH3
O
 
5% aqueous HCl solution (2 mL) was added at 60 °C to the solution of the methylvinylether 
137 (1000 mg) in THF (16 mL). After the reaction mixture was refluxed for 20 min in was 
cooled to rt and poured into a mixture of ice (10 mL) and saturated aqueous NaHCO3 solution 
(5 mL), extracted with MTBE (3×15 mL), dried over MgSO4 and concentrated to give a 
yellow oil of crude 138. TLC: starting material Rf = 0.6 (hexane/AcOEt 15:1); 0.4 
(hexane/AcOEt 50:1). Product Rf = 0.5 (hexane/AcOEt 15:1); 0.3-0.25 (hexane/AcOEt 50:1). 
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The crude product was purified by flash chromatography with hexane/AcOEt 50:1 to give 
0.33 g (35%) of a pale oil of 138. 
The column was gradually washed with hexane/AcOEt 15:1 and 7:3 to obtain the two main 
byproducts: 0.127 g of a colorless oil (Rf = 0.15 in hexane/AcOEt 15:1) and 0.125 g of a pale 
oil (Rf = 0.35 in hexane/AcOEt 7:3). According to the IR both are alcohols. 
1H-NMR (400 MHz, CDCl3): δ9.77 (s, ½H), 9.52 (d, J = 3.92 Hz, ½H), the ratio of the 
integrals of the aldehyde protons is 1.2:1 (cis : trans), 5.13-5.05 (m, 2H), 2.41-2.47 (m, ½H), 
2.20-1.10 (m, 24H), 1.03-0.92 (m, ½H). 
13C-NMR (100 MHz, CDCl3): δ205.52 (CH), 205.17 (CH), 137.02 (Cq), 136.67 (Cq), 131.56 
(Cq), 131.51 (Cq), 124.17 (CH), 124.14 (CH), 123.45 (CH), 122.55 (CH), 55.33 (CH), 51.84 
(CH), 37.86 (CH), 37.50 (CH), 32.93 (CH2), 32.01 (CH2), 31.95 (CH2), 30.68 (CH2), 29.29 
(CH2), 26.43 (CH2), 26.35 (CH2), 26.10 (CH2), 25.66 (CH3), 25.20 (CH2), 24.72 (CH2), 24.00 
(w, CH2), 23.75 (CH2), 23.70 (w, CH2), 23.37 (CH3), 23.35 (CH3), 17.57 (CH3). Since both 
diastereomers of 138 are structurarly similar, not all signals in 13C has been resolved. CH3 and 
CH2 groups of the neryl side chain have very close δ values for both diastereomers. 
HRMS ESI: Calcd. for [C17H28O + Na]: 271.2038; found: 271.2033. 
IR (cm-1, neat): 2926 (s), 2855 (m), 1723 (s), 1448 (m), 1376 (w), 835. 
trans-2-(3,7-Dimethyl-octa-2,6-dienyl)-cyclohexane carbaldehyde (trans-138) 
CH3
CH3
CH3
O
C17H28O
Mol. Wt.: 248.40  
5% aqueous KOH solution (20 mL) was added to the solution of the aldehyde 138 (0.16 g) in 
MeOH (20 mL). The mixture was refluxed for 5 h under N2. The reaction mixture was cooled 
to rt, extracted with MTBE (3×10 mL), the extract was washed with brine (15 mL), dried over 
MgSO4 and concentrated to give 0.144 g of a yellow oil (92%). 
1H-NMR (200 MHz, CDCl3): δ9.79 (s, 1H), 9.54 (d, J = 3.88 Hz, 1H), the ratio of the 
integrals of the aldehyde protons is 1:8.5 (cis : trans), δ5.20-5.05 (m, 2H), δ2.20-0.80 (m, 
25H). 
HRMS ESI: Calcd. for [C17H28O + Na]: 271.2038; found: 271.2031. 
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3-[2-(3,7-Dimethyl-octa-2,6-dienyl)-cyclohexyl]-acrylic acid ethyl ester (120) 
CH3
CH3
CH3COOEt
C21H34O2
Mol. Wt.: 318.49  
The solution of diethyl ethoxycarbonylmethanephosphonate (915 mg, 4.08 mmol, 3.2 equiv) 
in THF (10 mL) was dropwise added at 0 °C to the suspension of 60% NaH in mineral oil 
(153.2 mg, 3.83 mmol, 3.0 equiv) in THF (10 mL) to form a clear colorless solution that was 
additionally stirred for 10 min at 0 °C. The reaction mixture was cooled to -78 °C and the 
solution of the aldehyde trans-138 (0.317 g, 1.276 mmol, 1.0 equiv) in THF (8 mL) was 
added over 5 min. The reaction mixture was slowly warmed to rt and stirred over 12 h at 
ambient temperature, then quenched with saturated aqueous NH4Cl solution (10 mL) and 
extracted with MTBE (3×15 mL). Combined extract was washed with saturated aqueous NaCl 
solution (10 mL), dried over MgSO4 and concentrated. The crude product was purified by 
flash chromatography with hexane/AcOEt 50:1 to provide 209.3 mg (52%) of a colorless oil 
of 120. The product 120 has an Rf = 0.25-0.3 in hexane/AcOEt 50:1 (permanganate). 
1H-NMR (400 MHz, CDCl3): δ7.20-7.05 (dd, J = 8.53, 15.69 Hz, 1H), 6.90-6.75 (dd, 
J = 9.47, 15.62 Hz, 1H), 5.85-5.77 (dd, J = 15.96, 1.13 Hz, 1H), 5.83-5.75 (d, J = 15.69 Hz, 
1H), 5.15-5.00 (m, 2H), 4.25-4.10 (q, J = 7.04 Hz, 2H), 2.10-1.50 (m, 21H), 1.30-1.20 (t, 
J = 7.04 Hz, 3H), 1.20-1.10 (m, 3H), 0.95-0.80 (m, 1H). 
Multiplets: δ7.20-7.05 (dd) and δ5.85-5.77 (dd) correspond to a minor (cis on the ring) 
isomer. Multiplets: δ6.90-6.75 (dd) and δ5.83-5.75 (d) correspond to a major (trans on the 
ring) isomer. The ratio cis : trans is 1:6. 
13C-NMR (100 MHz, CDCl3): δ166.70 (Cq), 153.71 (CH), 136.05 (Cq), 131.33 (Cq), 124.29 
(CH), 123.06 (CH), 120.60 (CH), 60.01 (CH2), 46.63 (CH), 42.03 (CH), 32.77 (CH2), 32.63 
(CH2), 31.97 (CH2), 31.27 (CH2), 26.42 (CH2), 25.99 (CH2), 25.62 (CH2), 25.58 (CH3), 23.40 
(CH3), 17.52 (CH3), 14.21 (CH3). 
HRMS ESI: Calcd. for [C21H34O2 + Na]: 341.2456; found: 341.2460. 
IR (cm-1, neat): 2925 (s), 2854 (m), 1721 (s), 1651 (m), 1447 (m), 1368, 1323, 1265, 1224, 
1163, 1131, 1040, 986, 840, 719. 
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3-{2-[3,7-Dimethyl-7-(2,2,2-trifluoro-acetoxy)-oct-2-enyl]-cyclohexyl}-acrylic acid ethyl 
ester (139) 
CH3
CH3
CH3
COOEt O
O
CF3
C23H35F3O4
Mol. Wt.: 432.52  
Trifluoroacetic acid (82 µL, 0.942 mmol, 15 equiv, d = 1.48) was added to the solution of the 
acrylate 120 (20 mg, 0.063 mmol) in CH2Cl2 (5 mL) at 0 °C. The reaction mixture was 
warmed to rt and stirred over 48 h at rt. The progress of the reaction was controlled by TLC. 
The starting material has an Rf = 0.25-0.3 in hexane/AcOEt 50:1 (permanganate) and the 
product an Rf = 0.10 in hexane/AcOEt 50:1 and Rf = 0.3 in hexane/AcOEt 15:1. 
The reaction mixture was quenched with 0.3 M aqueous K2CO3 solution (10 mL), stirred for 
20 min at rt, then extracted with CH2Cl2 (3×10 mL). Combined organic extract was washed 
with saturated aqueous NaCl solution (10 mL), dried over MgSO4 and concentrated to give a 
yellow oil of the crude product. Purification by flash chromatography with hexane/AcOEt 
30:1 furnished 8.3 mg (30%) of 139. 
1H-NMR (200 MHz, CDCl3): δ6.90-6.70 (dd, J = 15.56, 9.03 Hz, 1H), 5.90-5.70 (d, 
J = 15.18 Hz, 1H), 5.35-5.20 (m, 1H), 4.35-4.10 (q, J = 7.11 Hz, 2H), 2.20-0.70 (m, 30H). 
HRMS ESI: Calcd. for [C23H35F3O4 + H]: 433.2566, for [C21H34O2 + H]: 319.2632, for 
[C21H34O2 + Na]: 341.2451, for [C21H34O2 + CH3CN + Na]: 382.2716; found: 319.2735, 
341.2601, 382.2783. Elimination of trifluoroacetic acid took place during the acquisition. 
IR (cm-1, neat): 2930 (m), 2856, 2255 (w), 1777 (CF3-CO, s), 1715 (m), 1651, 1449, 1372, 
1270, 1221, 1167 (C-F, s), 1124, 1041, 988, 911 (s), 736 (s), 650. 
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(R)-(-)-4-Benzyl-3-propionyl-oxazolidin-2-one (170) 
O N
O O
CH3
C13H15NO3
Mol. Wt.: 233.26 
2.5 M n-BuLi solution (11.4 mL, 28.5 mmol) in hexanes was added over 10 min to a solution 
of (R)-4-benzyl-oxazolidine-2-one (5.00 g, 28.2 mmol) in THF (85 mL) at -78 °C, followed 
by propionyl chloride (2.8 mL, d = 1.059, 32 mmol) added in one portion while stirring at 
-78 °C. The reaction mixture was stirred over 30 min at -78 °C then slowly warmed to rt and 
quenched with saturated aqueous NH4Cl solution (20 mL). Organic solvent was removed 
under reduced pressure and the rest was extracted with CH2Cl2 (3×20 mL). Combined organic 
extract was washed with 1 M NaOH solution (20 mL), brine (20 mL), dried over MgSO4 and 
concentrated to give 7.11 g of a yellow oil. 
The crude product was cooled with liquid nitrogen and left overnight to crystallize in the 
refrigerator. The crystals were triturated with cold hexane, filtered off and dried on air to 
afford 6.42 g (97.6%) of a white solid (mp 42-45 °C). Lit. mp 44-46 °C, 91% yield.125 
1H-NMR (400 MHz, CDCl3): δ7.45-7.15 (m, 5H, Ar), 4.75-4.60 (dddd, J = 9.81, 6.46, 3.51, 
3.51 Hz, 1H), 4.30-4.10 (m, 2H), 3.40-3.25 (dd, J = 13.30, 3.26 Hz, 1H), 3.10-2.85 (dq, 
J = 2.79, 7.40 Hz, 2H), 2.85-2.70 (dd, J = 13.30, 9.66 Hz, 1H), 1.30-1.10 (t, J = 7.34 Hz, 3H). 
HRMS ESI: Calcd. for [C13H15NO3 + Na]: 256.0950, for [C13H15NO3 + CH3CN + Na]: 
297.1215; found: 256.0956, 297.1220. 
[ ]20Dα (EtOH, c = 1.01) = -104° (98% ee). 
4(R)-Benzyl-3-(3(S)-hydroxy-2(R)-methyl-pent-4-enoyl)-oxazolidin-2-one (146)99 
O N
(R)
O O
(R)
(S)
OH
C16H19NO4
Mol. Wt.: 289.33 
1.0 M solution of dibutylboryltriflate in CH2Cl2 (29.7 mL, 29.7 mmol, 1.1 equiv) was 
dropwise added to the solution of the imide 170 (6.3 g, 27 mmol, 1 equiv) in CH2Cl2 (80 mL, 
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in a 250 mL flask) at 0 °C. Diisopropylethylamine (5.66 mL, d = 0.742, 32.41 mmol, 
1.2 equiv) was added to the reaction mixture at such a rate that internal temperature was 
bellow 3 °C. After the resulting clear colorless solution was cooled to -78 °C, acrolein 
(9.01 mL, 135.04 mmol, d = 0.843) was added over 5 min. After being stirred 30 min at 
-78 °C the solution was allowed to warm to 0 °C and quenched by addition of 1.0 M pH 7.0 
phosphate buffer (30 mL) and MeOH (100 mL). A mixture of MeOH (60 mL) and 30% 
aqueous H2O2 (30 mL) was carefully added, so as to keep the internal temperature bellow 
5 °C. Volatiles were removed under reduced pressure and water (100 mL) was added. The 
mixture was extracted with MTBE (3×200 mL). Combined extract was washed with 5% 
aqueous NaHCO3 solution (50 mL), brine (50 mL), dried over MgSO4, filtered and 
concentrated to give 9.0 g of pale oil. 
Rf = 0.15-0.20 (hexane/AcOEt 7:3). Flash chromatography with hexane/AcOEt 7:3 on a 6×30 
cm column afforded 5.85 g (75%) of 146 as a pale oil. 
1H-NMR (200 MHz, CDCl3): δ7.40-7.15 (m, 5H, Ar), 5.95-5.75 (ddd, J = 17.19, 10.54, 
5.14 Hz, 1H), 5.45-5.30 (ddd, J = 17.25, 1.57, 1.57 Hz, 1H), 5.30-5.15 (ddd, J = 10.51, 1.54, 
1.54 Hz, 1H), 4.80-4.60 (dddd, J = 9.81, 6.46, 3.39, 3.39 Hz, 1H), 4.60-4.45 (dddd, J = 5.02, 
1.60, 1.60, 1-2 Hz, 1H), 4.30-4.15 (m, 2H), 3.95-3.80 (dq, J = 3.39, 7.03 Hz, 1H), 3.35-3.20 
(dd, J = 13.36, 3.33 Hz, 1H), 2.95-2.85 (br s, 1H), 2.85-2.70 (dd, J = 13.36, 9.47 Hz, 1H), 
1.30-1.20 (d, J = 7.15 Hz, 3H). 
HRMS ESI: Calcd. for [C16H19NO4 + CH3CN + Na]: 353.1477; found: 353.1470. 
25
Dα (CHCl3, c = 1.42) = -68.6°, 
25
Dα  (CH2Cl2, c = 0.97) = -83.4°. 
Acetic acid 1-[2-(4-benzyl-2-oxo-oxazolidin-3-yl)-1-methyl-2-oxo-ethyl]-allyl ester (163) 
O N
(R)
O O
(R)
(S)
O
O
C18H21NO5
Mol. Wt.: 331.36 
Et3N (0.21 mL, 1.5 mmol, 4.3 equiv) and Ac2O (0.10 mL, 1.1 mmol, 3.2 equiv) were added to 
the solution of 146 (100 mg, 0.346 mmol, 1 equiv) in CH2Cl2 (2 mL) at rt followed by DMAP 
(10 mg, 0.081 mmol, 0.23 equiv). After 30 min at rt the reaction mixture was diluted with 
AcOEt (10 mL), organic layer was washed with 2% aqueous HCl solution (10 mL), by 
saturated aqueous NaHCO3 solution (15 mL) and brine (15 mL). Aqueous washings were 
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extracted with AcOEt (20 mL) and washed as before. Combined extract was dried over 
MgSO4 and concentrated to give a pale oil. The crude product was purified by flash 
chromatography (hexane/AcOEt 8:2) to afford 97.4 mg (85%) of a colorless oil. The product 
has an Rf = 0.20 in hexane/AcOEt 8:2 and 0.40-0.45 in hexane/AcOEt 7:3; the starting 
material has an Rf = 0.20-0.30 in hexane/AcOEt 7:3. 
1H-NMR (400 MHz, CDCl3): δ7.40-7.15 (m, 5H, Ar), 5.84 (ddd, J = 17.10, 10.76, 5.87 Hz, 
1H), 5.66-5.61 (m, 1H), 5.32 (dt, J = 17.23, 1.29 Hz, 1H), 5.23 (dt, J = 10.62, 1.19 Hz, 1H), 
4.63-4.55 (m, 1H), 4.27-4.21 (m, 1H), 4.19-4.13 (m, 1H), 4.11-4.03 (m, 1H), 3.26 (dd, 
J = 13.30, 3.26 Hz, 1H), 2.77 (dd, J = 9.66, 13.43 Hz, 1H), 2.07 (s, 3H), 1.12 (d, J = 7.03 Hz, 
3H). 
13C-NMR (100 MHz, CDCl3): δ173.41 (Cq), 170.08 (Cq), 153.46 (Cq), 135.23 (Cq), 134.01 
(CH), 129.36 (2×CH-Ar), 128.84 (2×CH-Ar), 127.26 (CH), 117.52 (CH2), 73.97 (CH), 66.25 
(CH2), 55.58 (CH), 41.63 (CH), 37.84 (CH2), 20.82 (CH3), 10.93 (CH3). 
HRMS ESI: Calcd. for [C18H21NO5 + Na]: 354.1312, for [C18H21NO5 + CH3CN + Na]: 
395.1583; found: 354.1317, 395.1587. 
IR (cm-1, in CH2Cl2): 3029 (w), 2986 (w), 2941 (w), 2360 (w), 1777 (s), 1739 (m), 1699 (m), 
1647(w), 1605(w), 1498, 1455 (w), 1386 (m), 1371 (m), 1350, 1291, 1230 (s), 1100, 1047, 
1020 (m), 973 (m), 945, 841, 763, 742, 704. 
25
Dα  (CH2Cl2, c = 1.0) = -90.5°. 
Propionic acid 1-[2-(4-benzyl-2-oxo-oxazolidin-3-yl)-1-methyl-2-oxo-ethyl]-allyl ester 
(164) 
O N
(R)
O O
(R)
(S)
O
O
C19H23NO5
Mol. Wt.: 345.39  
Et3N (0.19 mL, 4 equiv) and propionic acid anhydride (0.18 mL, 1.4 mmol, 4 equiv) were 
added to the solution of the aldol 146 (100 mg, 0.346 mmol, 1 equiv) and DMAP (8.5 mg, 
0.069 mmol, 0.2 equiv) in CH2Cl2 (3 mL) at rt. The reaction mixture was stirred for 3 h at rt. 
The reaction was complete judging by TLC. The reaction mixture was diluted with AcOEt 
(10 mL), organic layer was washed with 2% aqueous HCl solution (20 mL) then by saturated 
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aqueous NaHCO3 solution (20 mL) and brine (20 mL). Inorganic rests were extracted with 
AcOEt (20 mL) and washed as before. Combined extract was dried over MgSO4 and 
concentrated to give a pale oil. Crude product was purified by flash chromatography with 
hexane/AcOEt 8:2 to afford 116.2 mg of colorless oil (97.2 %). The product has an Rf = 0.25 
in hexane/AcOEt 8:2 and 0.45-0.50 in hexane/AcOEt 7:3 (permanganate); the starting 
material has an Rf = 0.20-0.30 in hexane/AcOEt 8:2. 
1H-NMR (400 MHz, CDCl3): δ7.40-7.15 (m, 5H, Ar), 5.90-5.79 (ddd, J = 17.19, 10.67, 
5.65 Hz, 1H), 5.68-5.62 (m, 1H), 5.35-5.28 (dt, J = 17.23, 1.35 Hz, 1H), 5.25-5.20 (dt, 
J = 10.58, 1.32 Hz, 1H), 4.62-4.55 (m, 1H), 4.28-4.21 (m, 1H), 4.18-4.14 (m, 1H), 4.12-4.04 
(m, 1H), 3.26 (dd, J = 13.30, 3.26 Hz, 1H), 2.77 (dd, J = 9.66, 13.30 Hz, 1H), 2.35 (dq, 
J = 1.69, 7.55 Hz, 3H), 1.21 (d, J = 6.90 Hz, 3H), 1.14 (t, J = 7.59 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ173.46 (Cq), 173.41 (Cq), 153.47 (Cq), 135.25 (Cq), 134.13 
(CH), 129.35 (2×CH-Ar), 128.84 (2×CH-Ar), 127.25 (CH), 117.39 (CH2), 73.65 (CH), 66.25 
(CH2), 55.59 (CH), 41.67 (CH), 37.83 (CH2), 27.56 (CH2), 10.89 (CH3), 9.05 (CH3). 
HRMS ESI: Calcd. for [C19H23NO5 + Na]: 368.1468, for [C19H23NO5 + CH3CN + Na]: 
409.1734; found: 368.1487, 409.1791. 
IR (cm-1, in CH2Cl2): 3030 (w), 2983 (w), 2944 (w), 2360 (w), 1778 (s), 1735 (m), 1700 (m), 
1647(w), 1605(w), 1498, 1456 (w), 1387 (m), 1351 (m), 1269, 1239, 1211, 1182 (s), 1099, 
1081, 1010, 982, 935, 807, 762, 743, 704. 
25
Dα  (CH2Cl2, c = 1.0) = -90.9°. 
5-Methyl-6-vinyl-dihydro-pyran-2,4-dione (165) 
O
(R)
(S)
O
O
C8H10O3
Mol. Wt.: 154.16 
A solution of the acetate 163 (50 mg, 0.1509 mmol) in THF (5 mL) was added to a stirred 
solution of LiHMDS (0.45 mL of 1.0 M solution in hexanes, 3 equiv, 0.453 mmol) in THF 
(1 mL) at -78 °C. After 3 h at -78 °C the reaction mixture was quenched while cold by 
addition of saturated aqueous NH4Cl solution (4 mL), MeOH (3 mL) and H2O (3 mL). AcOEt 
(10 mL) and water (10 mL) were added. The organic layer contained the chiral auxiliary. The 
aqueous basic layer (pH 9-10) was titrated with 0.3 N aqueous HCl solution to pH 2-3 and 
then extracted with CH2Cl2 (3×10 mL). The extract was dried over MgSO4 and concentrated 
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to give 9.4 mg (40%) of the crude product as a yellow oil. The product has an Rf = 0.10-0.15 
in hexane/AcOEt 7:3 and Rf = 0.15-0.20 in hexane/AcOEt 1:1 (UV, permanganate, 
“Vanillin”). Purification by flash chromatography with hexane/AcOEt 1:1 afforded 4.3 mg 
(18.5%) of a pale solid. 
1H-NMR (400 MHz, CDCl3): δ5.90-5.70 (ddd, J = 17.10, 10.76, 5.30 Hz, 1H), 5.50 (dd, 
J = 0.88, 17.07 Hz), 5.44 (dd, J = 0.69, 10.73 Hz), 5.20-5.10 (m, 1H), 3.52 (d, J = 20.20 Hz, 
1H), 3.42 (d, J = 20.33 Hz, 1H), 2.85 (dq, J = 4.52, 7.15 Hz, 1H), 1.17 (d, J = 7.15 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ201.94 (Cq), 167.11 (Cq), 130.73 (CH), 120.21 (CH2), 78.78 
(CH), 46.46 (CH), 45.45 (CH2), 9.46 (CH3). 
HRMS ESI: Calcd. for [C8H10O3 + Na]: 177.0528; found: 177.0537. 
3,5-Dimethyl-6-vinyl-dihydro-pyran-2,4-dione (166) 
O
(R)
(S)
O
O
H3C
C9H12O3
Mol. Wt.: 168.19 
Freshly prepared solution of KHMDS (1.2 mL of 0.5 M solution in toluene, 0.580 mmol, 
4.0 equiv) was added to the solution of the propionate 164 (50 mg, 0.145 mmol) in THF 
(5 mL) at -78 °C and the reaction mixture was stirred for 3 h at this temperature. The reaction 
mixture was quenched with saturated aqueous NH4Cl solution (4 mL), MeOH (3 mL) and 
H2O (3 mL) while cold. AcOEt (10 mL) and H2O (10 mL) were added. Aqueous layer was 
acidified with 1.0 M aqueous HCl solution to pH ca. 2 and extracted with AcOEt (3×15 mL). 
Combined extract was washed with brine (20 mL), dried over MgSO4 and concentrated to 
give 13.8 mg of a white solid (57%). Chromatographic purification with hexane/AcOEt 1:1 
afforded 5.6 mg (23%) of a white solid. The product has an Rf = 0.10-0.15 in hexane/AcOEt 
7:3 and Rf = 0.25-0.30 in hexane/AcOEt 1:1 (UV, permanganate, “Vanillin”). 
1H-NMR (400 MHz, CDCl3): δ5.91-5.77 (m, 1H), 5.57-5.39 (m, 2H), 5.32-3.24 (m, 1H), 
3.59 (q, J = 6.73 Hz) & 3.31 (q, J = 7.28 Hz) 1H, 2.79-2.70 (m, 1H), 1.44 (d, 
J = 7.15 Hz) + 1.38 (d, J = 6.78 Hz) 3H, 1.12 (d, J = 7.53 Hz, 3H). 
HRMS ESI: Calcd. for [C9H12O3 + Na]: 191.0684; found: 191.0691. 
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3(S)-Hydroxy-2(R)-methyl-pent-4-enoic acid methoxy-methyl-amide (145)99 
N
O
(R)
(S)
OH
O
C8H15NO3
Mol. Wt.: 173.21 
2.0 M Me3Al solution in heptane (5.8 mL, 2 equiv) was added over 20 min to a suspension of 
N,O-dimethyl hydroxylamine hydrochloride (1.304 g, 11.485 mmol, 2 equiv) in CH2Cl2 
(25 mL) at 0 °C (caution: gas evolution!). After the clear reaction mixture was warmed to rt 
and stirred for 1 h it was cooled to -20 °C, and a solution of the aldol product 146 (1.662 g, 
5.744 mmol, 1 equiv) in CH2Cl2 (15 mL) was added via cannula (intense gas evolution!). 
Clear reaction mixture was slowly warmed to rt and stirred for 15 h at ambient temperature. 
Reaction mixture was cannulated into 1.0 M aqueous tartaric acid solution (50 mL) under 
vigorous stirring. Organic layer was separated and the aqueous was extracted with CH2Cl2 
(3×15 mL). Combined extract was washed with brine (20 mL), dried over MgSO4, and 
concentrated to give the crude product, which was purified by flash chromatography with 
hexane/MTBE 1:2 to afford 0.861 g (86.5%) of a yellow oil. The product has an Rf = 0.2 in 
hexane/AcOEt 1:1 and 0.20-0.25 in hexane/MTBE 1:2. Evans auxiliary has an Rf = 0.15 in 
hexane/AcOEt 1:1 and 0.10 in hexane/MTBE 1:2. 
1H-NMR (200 MHz, CDCl3): δ5.95-5.70 (ddd, J = 17.19, 10.54, 5.02 Hz, 1H), 5.45-5.25 (dt, 
J = 17.23, 1.66 Hz, 1H), 5.25-5.15 (dt, J = 10.50, 1.69 Hz, 1H), 4.50-4.40 (m, 1H), 3.71 (s, 
3H), 3.21 (s, 3H), 3.05-2.85 (m, 1H), 1.20-1.10 (d, J = 7.15 Hz, 3H). 
Elemental Analysis: Anal. C, 54.13%; H, 8.39%, N, 7.85%; calcd. for C8H15NO3: C, 
55.47%; H, 8.73%; N, 8.09%. 
HRMS ESI: Calcd. for [C8H15NO3 + Na]: 196.0950; found: 196.0937. 
5-Oxo-hexanoic acid methyl ester (140)126 
H3C
O O
OCH3
C7H12O3
Mol. Wt.: 144.17  
Methyl acrylate (45.0 mL, d = 0.956, 500 mmol) and acetylacetone (51.3 mL, 500 mmol, 
d = 0.975) were added to a solution of sodium methoxide prepared from absolute methanol 
(200 mL) and sodium metal (0.83 g), and the mixture was refluxed for 3 h. It was left at rt 
overnight. Glacial acetic acid (2.7 mL, 47.2 mmol) was added and organic solvents were 
removed under reduced pressure. The rest was solved in MTBE (100 mL), washed with water 
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(3×25 mL) and concentrated. The residue was distilled at 93-98 °C/11-12 mmHg) to afford 
47.6 g (66%) of 140. 
1H-NMR (200 MHz, CDCl3): δ3.67 (s, 3H), 2.51 (t, J = 7.22 Hz, 2H), 2.34 (t, J = 7.15 Hz, 
2H), 2.14 (s, 3H), 1.89 (qui, J = 7.09 Hz, 2H). 
Low resolution MS (M+ (%)): 28.00 (100.00%), 31.99 (25.32%), 43.02 (29.28%), 55.02 
(5.83%), 59.03 (7.04%), 74.04 (8.57%), 85.07(5.33%), 112.05 (10.37%), 113.06 (6.70%). 
Elemental Analysis: Anal. C, 57.81%; H, 8.21%; calcd. for C7H12O3: C, 58.32%; H, 8.39%. 
6-Methyl-6-vinyl-tetrahydro-pyran-2-one (150) and 5-hydroxy-5-methyl-hept-6-enoic 
acid methyl ester (151) 
CH3
OO
C8H12O2
Mol. Wt.: 140.18
C9H16O3
Mol. Wt.: 172.22
H3CO
O HO CH3
 
CeCl3 · 7H2O (757 mg, 2.03 mmol, 1.5 equiv) was quickly ground in a mortar and placed into 
a 50 mL Schlenck flask. The flask was heated under vacuum (160 °C/0.01 mmHg) while 
stirred over 2 h. After the flask was cooled and the inert gas was introduced, THF (5 mL) was 
added. The flask was cooled to -78 °C and the solution of vinylmagnesium bromide was 
introduced (2.0 mL of 1.0 M solution, 2.0 mmol, 1.5 equiv). The mixture was stirred over 
10 min and the methyl 5-oxo-hexanoate (140) (0.195 g, 1.35 mmol, 1.0 equiv) was added as a 
solution in THF (5 mL). The reaction mixture was stirred for 1 h at -78 °C.  
The progress of the reaction was monitored by TLC. The reaction mixture was quenched by 
saturated aqueous NH4Cl solution (20 mL), warmed up and the organic layer was separated. 
The inorganic layer was extracted with MTBE (3×20 mL). Combined extract was washed 
with brine (20 mL), dried over MgSO4 and concentrated to give 0.276 g of yellow oil. The 
crude product was purified by flash chromatography with hexane/AcOEt 7:3 to afford 0.148 g 
(64%) of a pale oil. The product has an Rf = 0.2 in hexane/AcOEt 7:3. 
1H-NMR (200 MHz, CDCl3): δ6.00-5.70 (m, 1H), 5.35-5.00 (m, 2H), 3.66 (s, 3H), 2.60-1.50 
(m, 6H), 1.46 & 1.28 (s, 3H) (crude product is a mixture of 140, lactone 150 and alcohol 151). 
The product was used in the next step without further purification. 
HRMS ESI: desired M+ was not found. 
4. Experimental Part 
 
116
5-Hydroxy-5-methyl-hept-6-enoic acid methyl ester (151) 
C9H16O3
Mol. Wt.: 172.22
H3CO
O HO CH3
 
Method a): The solution of the mixture of 150 and 151 (0.1 g, 0.71 mmol) in MeOH (3 mL) 
was added to the solution of NaOMe obtained from Na metal (22 mg, 0.96 mmol) and MeOH 
(7 mL) at rt. The reaction mixture was stirred for 40 h at rt. 
Method b): Et3N (1 mL) was added to the solution of the mixture of 150 and 151 (0.1 g, 
0.71 mmol) in MeOH (5 mL). The reaction mixture was stirred for 40 h at rt. 
The workup is the same for both methods: The reaction mixture was quenched by addition of 
1.0 M aqueous solution of tartaric acid (20 mL), brine (20 mL) and MTBE (10 mL). Organic 
layer was separated and the rest was extracted with MTBE (3×20 mL). Combined organic 
extract was washed with brine (20 mL), dried over MgSO4 and concentrated to give 0.112 g 
(92% for Method a)) and 0.116 g (95% for Method b)) of 151 as a pale oil. 
1H-NMR (200 MHz, DMSO-d6): δ5.95-5.70 (dd, J = 17.25, 10.73 Hz, 1H), 5.20-5.00 (dd, 
J = 17.38, 2.07 Hz, 1H), 5.00-4.85 (dd, J = 10.60, 2.07 Hz, 1H), 4.46 (s, 1H), 3.57 (s, 3H), 
3.33 (s, 3H), 2.35-2.20 (t, J = 7.59 Hz, 2H), 1.65-1.30 (m, 4H), 1.12 (s, 3H). 
HRMS ESI: desired M+ was not found. 
5-Methyl-5-triethylsilanyloxy-hept-6-enoic acid methyl ester (144a) 
H3CO
O Et3SiO CH3
C15H30O3Si
Mol. Wt.: 286,48  
2,6-Lutidune (1.0 mL, 8.71 mmol, 2.2 equiv) and Et3SiOTf (1.12 mL, 1.31 g, 4.94 mmol, 
1.25 equiv) were added at rt to the solution of the alcohol 151 (680 mg, 3.948 mmol) in 
CH2Cl2 (5 mL). The reaction mixture was stirred for 1.5 h at rt and the progress of the 
reaction was monitored by TLC. The starting alcohol has an Rf = 0.2 in hexane/AcOEt 7:3 
and the product has an Rf = 0.7 in hexane/AcOEt 7:3. 
The reaction mixture was quenched with 1.0 M phosphate buffer (25 mL) and the organic 
layer was separated. The rest was extracted with CH2Cl2 (3×15 mL). Combined organic 
extract was washed with brine (15 mL), dried over MgSO4 and concentrated to give the oily 
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product. The crude product was purified by flash chromatography with hexane/AcOEt 50:1 to 
afford 0.849 g (75%) of a colorless oil. The product has an Rf = 0.15 in hexane/AcOEt 50:1. 
1H-NMR (200 MHz, CDCl3): δ5.90-5.75 (dd, J = 17.32, 10.79 Hz, 1H), 5.20-5.05 (dd, 
J = 1.51, 17.07 Hz, 1H), 5.05-4.95 (dd, J = 1.51, 10.54 Hz, 1H), 3.65 (s, 3H), 2.28 (t, 
J = 7.28 Hz, 2H), 1.75-1.55 (m, 2H), 1.55-1.40 (m, 2H), 1.29 (s, 3H), 0.93 (t, J = 7.78 Hz, 
9H), 0.65-0.50 (q, J = 7.78 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ174.10 (C=O), 145.24 (CH2), 111.93 (CH), 76.68 (Cq), 
51.34 (CH3), 43.16 (CH2), 34.39 (CH2), 27.27 (CH3), 19.72 (CH2), 7.05 (CH3), 6.76 (CH2). 
HRMS ESI: Calcd. for [C15H30O3Si + Na]: 309.1862; found: 309.1850. 
IR (cm-1, neat): 2954 (s), 2913, 2877, 1743 (s), 1459, 1436, 1415, 1370, 1240, 1173 (s), 
1119, 1045 (s), 1008 (s), 921, 873, 725. 
5-Methyl-5-triethylsilanyloxy-hept-6-enoic acid (152) 
HO
O Et3SiO CH3
C14H28O3Si
Mol. Wt.: 272,46  
Method a): 1.0 M aqueous LiOH solutionq (0.65 mL, 0.65 mmol, 4 equiv) was added to the 
solution of the ester 144a (46.5 mg, 0.163 mmol) in THF (2.5 mL) and MeOH (0.5 mL) at 
0 °C. The reaction mixture was warmed to rt and stirred at ambient temperature overnight. 
The progress of the reaction was monitored by TLC. The starting material has an Rf = 0.7 in 
hexane/AcOEt 7:3 and the product has an Rf = 0.3-0.4 in hexane/AcOEt 7:3. 
The reaction mixture was diluted with MTBE (10 mL) and quenched with 2% aqueous HCl 
solution (7 mL). Organic layer was separated and the inorganic rest was extracted with MTBE 
(3×10 mL). Combined extract was washed with saturated aqueous NaHCO3 solution (15 mL), 
brine (15 mL), dried over MgSO4 and concentrated to give 44.3 mg (99.7%) of pale oil. 
 
Method b): Ester 144a (482 mg, 1.682 mmol, 1 equiv) was refluxed with n-Bu2SnO (335 mg, 
1.346 mmol, 0.8 equiv) in toluene (10 mL) for 86 h. The progress of the reaction was 
monitored by TLC. 
 
                                                 
q) Obtained by the dissolution of LiOH·H2O (0.42 g) in H2O (10 mL). 
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The crude product was purified by flash chromatography with hexane/AcOEt 8:2 to afford 
0.296 g (65%) of the acid 152. The product has an Rf = 0.35-0.4 in hexane/AcOEt 7:3 and 
0.20-0.30 in hexane/AcOEt 8:2; the starting material has an Rf = 0.7 in hexane/AcOEt 7:3. 
1H-NMR (200 MHz, CDCl3): δ5.90-5.75 (dd, J = 10.68, 17.32 Hz, 1H), 5.20-5.10 (dd, 
J = 17.28, 1.48 Hz, 1H), 5.05-4.95 (dd, J = 10.64, 1.64 Hz, 1H), 2.40-2.30 (t, J = 7.34 Hz, 
2H), 1.75-1.55 (m, 2H), 1.55-1.45 (m, 2H), 1.30 (s, 3H), 0.94 (t, J = 7.84 Hz, 9H), 0.65-0.55 
(q, J = 7.91 Hz, 6H). The acidic proton is not seen. 
13C-NMR (100 MHz, CDCl3): δ179.81 (COOH), 145.17 (CH), 112.03 (CH2), 75.20 (Cq), 
43.01 (CH2), 34.29 (CH2), 27.29 (CH3), 19.45 (CH2), 7.05 (CH3), 6.74 (CH2). 
HRMS ESI: desired M+ was not found. 
IR (cm-1, neat): 3500-3000 (broad), 2955, 2912, 2877, 1709 (s), 1459, 1413, 1371, 1275, 
1236, 1175, 1119, 1045 (s), 1006 (s), 972, 921, 819, 724 (s). 
5-Methyl-5-triethylsilanyloxy-hept-6-enoic acid 1-[1-(methoxy-methyl-carbamoyl)-
ethyl]-allyl ester (143a) 
O
O
O Si
(S)
(R)
N
O
O
C22H41NO5Si
Mol. Wt.: 427.65  
The reaction is performed according to the general procedure described by Yamaguchi et al.94 
2,4,6-trichlorobenzoylchloride (47µL, 73.2 mg, d = 1.561, 0.3 mmol, 1 equiv) was added to a 
mixture of the acid 152 (81 mg, 0.3 mmol, 1 equiv) and Et3N (0.3 mmol, 42 µL) in THF 
(2 mL) and the mixture was stirred for 1 h at rt. The white precipitate formed was removed by 
filtrationr and the filtrate was concentrated under reduced pressure.s The mixed anhydride was 
solved in toluene (2 mL) and treated with the solution of the alcohol (51.9 mg, 0.3 mmol, 
1 equiv) in toluene (2 mL) and DMAP (73.3 mg, 0.6 mmol, 2 equiv) in toluene (2 mL). The 
reaction mixture was allowed to stir at rt for 3 h. The progress of the reaction was monitored 
by TLC. 
                                                 
r) Triethylammonium chloride started to appear after 10 min. After 1 h the precipitate was filtered off with the 
help of a 5 mL plastic syringe by placing a piece of cotton that served as a filter between a needle and a syringe. 
s) THF was removed while stirring at reduced pressure, without letting the solution to get in contact with the air. 
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The reaction mixture was diluted with MTBE (10 mL) and quenched by water (5 mL). 
Organic layer was separated, washed successively with 2% aqueous HCl solution (10 mL), 
saturated aqueous NaHCO3 solution (10 mL) and brine (10 mL). Aqueous layers were 
collected and extracted with MTBE (2×10 mL). Combined organic extract was dried over 
MgSO4 and concentrated to give 150.7 mg of a yellow oil. The crude product was purified by 
flash chromatography with hexane/AcOEt 7:3 to afford 102.45 mg (80%) of 143a as a 
colorless oil. The product has an Rf = 0.30-0.35 in hexane/MTBE 7:5 and 0.30-0.35 in 
hexane/AcOEt 7:3. 
1H-NMR (400 MHz, CDCl3): δ5.95-5.75 (m, 2H), 5.47-5.40 (t, J = 6.8 Hz, 1H), 5.30-5.20 
(dt, J = 17.16, < 1 Hz, 1H), 5.20-5.15 (dt, J = 10.52, < 1 Hz, 1H), 5.15-5.05 (dd, J = 17.28, 
1 Hz, 1H), 5.05-4.95 (dd, J = 10.68, 1 Hz, 1H), 3.66 (s, 3H), 3.20-3.14 (m, 4H), 2.29 (t, 
J = 7.64 Hz, 2H), 1.75-1.55 (m, 2H), 1.55-1.45 (m, 2H), 1.28 (s, 3H), 1.15-1.12 (d, 
J = 7.03 Hz, 3H), 0.92 (t, J = 8.03 Hz, 9H), 0.65-0.45 (q, J = 8.03 Hz, 6H). 
13C-NMR (100 MHz, CDCl3): δ174.30 (w, C=O), 172.57 (C=O), 145.24 & 145.23 (CH), 
134.56 (CH), 117.64 (CH2), 111.90 & 111.89 (CH2), 75.38 (CH), 75.37 (CH), 75.18 (Cq), 
61.43 (CH3), 43.14 (CH2), 39.33 (CH), 34.71 (CH3), 27.18 (CH3), 26.93 (CH3), 19.66 (CH2), 
13.43 (CH3), 7.04 (CH3), 6.71 (CH2). 
HRMS ESI: Calcd. for [C22H41NO5Si + Na]: 450.2652; found: 450.2640. 
IR (cm-1, neat): 3088 (w), 2957 (s), 2913, 2877(m), 2360 (w), 1739 (s), 1667 (s), 1461 (m) , 
1415 (m), 1377 (m), 1239 (m), 1173 (s), 1118 (m), 1047 (m), 1000 (s), 921 (m), 742, 725. 
25
Dα  (CH2Cl2, c = 0.95) = -10.21°. 
5-Hydroxy-5-methyl-hept-6-enoic acid 1-[1-(methoxy-methyl-carbamoyl)-ethyl]-allyl 
ester (143b) 
O
O
OH
(S)
(R)
N
O
O
C16H27NO5
Mol. Wt.: 313.39  
Glacial AcOH (1.4 mL) and H2O (0.6 mL) were added to the solution of the silyl ether 143a 
(6.8 mg, 0.0164 mmol) in THF (0.5 mL) and the reaction mixture was stirred for 2 h at rt. The 
progress of the reaction was monitored by TLC. 
The reaction mixture was poured into saturated aqueous NaHCO3 solution (15 mL) and 
extracted with AcOEt (3×15 mL). Combined extract was washed with brine (20 mL), dried 
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over MgSO4 and concentrated. The crude product was purified by flash chromatography with 
hexane/AcOEt 1:2 to afford 4.7 mg (94%) of a colorless oil. The product has an Rf = 0.3 in 
hexane/AcOEt 1:2. 
1H-NMR (400 MHz, CDCl3): δ5.97-5.78 (complex m, 2H), 5.57-5.45 (m, 1H), 5.35-5.15 (m, 
3H), 5.10-5.00 (ddd, J = 10.79, 4.77, 1.25 Hz, 1H), 3.68 (s, 3H), 3.16 (m, 4H), 2.50-2.25 (m, 
2H), 1.80-1.50 (m, 4H), 1.29-1.28 (2×s, 3H), 1.17-1.14 (d, J = 7.16 Hz, 3H). 
HRMS ESI: Calcd. for [C16H27NO5 + Na]: 336.1787; found: 336.1778. 
IR (cm-1, neat): 3447 (broad), 3087 (w), 2923 (s), 2854, 1735 (s), 1651 (s), 1461, 1416, 1378, 
1252, 1175 (s), 1116, 1053 (w), 993 (s), 922 (m), 740. 
5-Methyl-5-triethylsilanyloxy-hept-6-enoic acid 1-[2-(4-(R)-benzyl-2-oxo-oxazolidin-3-
yl)-1-(R)-methyl-2-(S)-oxo-ethyl]-allyl ester 
O
(R)
N
O O
(R)
(S)
O
O OSiEt3
C30H45NO6Si
Mol. Wt.: 543.77  
The reaction is performed according to the general procedure described by Yamaguchi et al.94 
2,4,6-trichlorobenzoylchloride (47µL, 73.2 mg, d = 1.561, 0.3 mmol, 1 equiv) was added to a 
mixture of the acid 152 (81 mg, 0.3 mmol, 1 equiv) and Et3N (0.3 mmol, 42 µL) in THF 
(2 mL) and the mixture was stirred for 1 h at rt. 
The white precipitate formed was removed by filtrationt and the filtrate was concentrated 
under reduced pressure.u The mixed anhydride was solved in toluene (2 mL) and treated with 
the solution of the aldol 146 (86.8 mg, 0.3 mmol, 1 equiv) in toluene (2 mL) and DMAP 
(73.3 mg, 0.6 mmol, 2 equiv) in toluene (2 mL). The reaction mixture was allowed to stir at rt 
for 3 h. 
The reaction mixture was diluted with MTBE (10 mL) and quenched with water (5 mL). 
Organic layer was separated, washed successively with 2% aqueous HCl solution (10 mL), 
saturated aqueous NaHCO3 solution (10 mL), brine (10 mL). Aqueous layers were collected 
                                                 
t) Triethylammonium chloride started to appear after 10 min. After 1 h the precipitate was filtered off with the 
help of a 5 mL plastic syringe by placing a piece of cotton that served as a filter between a needle and a syringe. 
u) THF was removed while stirring at reduced pressure, without letting the solution to get in contact with the air. 
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and extracted with MTBE (2×10 mL). Combined organic extract was dried over MgSO4 and 
concentrated to give 167 mg of colorless oil. The crude product was purified by flash 
chromatography with hexane/AcOEt 9:1 to afford 0.114 g (70%) of the product. The product 
has an Rf = 0.15 in hexane/AcOEt 10:1, 0.20 in hexane/AcOEt 9:1 and 0.45 in hexane/AcOEt 
8:2. 
1H-NMR (400 MHz, CDCl3): δ7.40-7.18 (m, 5H, Ar), 5.92-5.80 (m, 2H), 5.70-5.65 (m, 1H), 
5.37-5.31 (dt, J = 17.23, 1.35 Hz, 1H), 5.27-5.21 (dt, J = 10.62, 1.32 Hz, 1H), 5.19-5.12 (ddd, 
J = 17.29, 2.54, 1.60 Hz, 1H), 5.03-4.95 (dt, J = 10.71, 1.32 Hz, 1H), 4.65-4.55 (m, 1H), 4.35-
4.22 (m, 1H), 4.25-4.15 (dd, J = 8.97, 2.45 Hz, 1H), 4.15-4.05 (dq, J = 4.55, 6.88 Hz, 1H), 
3.35-3.25 (dd, J = 13.36, 3.20 Hz, 1H), 2.85-2.75 (dd, J = 13.36, 9.73 Hz, 1H), 2.40-2.30 (t, 
J = 7.28 Hz, 2H), 1.75-1.60 (m, 2H), 1.55-1.45 (m, 2H), 1.32 (s, 3H), 1.28-1.20 (d, 
J = 6.90 Hz, 3H), 0.96 (t, J = 7.91 Hz, 9H), 0.65-0.55 (q, J = 7.91 Hz, 6H). 
13C-NMR (100 MHz, CDCl3): δ173.36 (Cq), 172.74 (Cq), 153.49 (Cq), 145.23 (CH), 135.29 
(Cq, Ar), 134.22 (CH), 129.36 (2×CH, Ar), 128.84 (2×CH, Ar), 127.25 (CH), 117.34 (CH2), 
111.88 (CH2), 75.15 (Cq), 73.63 (CH), 66.25 (CH2), 55.65 (CH), 43.04 (CH2), 41.74 (CH), 
37.85 (CH2), 34.55 (CH2), 27.21 (CH3), 19.61 (CH2), 10.83 (CH3), 7.02 (CH3), 6.46 (CH2). 
HRMS ESI: Calcd. for [C30H45NO6Si + Na]: 566.2914; found: 566.2923. 
25
Dα  (CH2Cl2, c = 2.25) = -56.33°. 
Methyl ester of hexacyclinic acid 
13
25
11
12
26
14
9 7
19
OH
18
O27
CH3
16
HOOC
28
21
O
22
5
3OO 1
H
OH
8
CH3
23
CH3
H
H3C
O CH2N2 in MeOH 13
25
11
12
26
14
9 7
19
OH
18
O27
CH3
16
H3COOC
28
21
O
22
5
3OO 1
H
OH
8
CH3
23
CH3
H
H3C
O
C26H34O9
Mol. Wt.: 490.54
C27H36O9
Mol. Wt.: 504.57  
The solution of diazomethane in Et2O was added dropwise to the solution of hexacyclinic 
acidv (5.0 mg) solved in AcOEt (5 mL) until the color of the reaction mixture remained yellow 
and did not bleach after 3 min. The solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography with hexane/AcOEt 1:1 to afford 4.3 mg (84%) 
of the product. Hexacyclinic acid has an Rf = 0.40 in CHCl3/MeOH 9:1; the methyl ester has 
an Rf = 0.7 in CHCl3/MeOH 9:1, 0.23 in hexane/AcOEt 1:1 and 0.30 in hexane/AcOEt 1:2, 
                                                 
v) A sample of hexacyclinic acid was kindly granted by Prof. Zeeck, University of Göttingen. 
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UV. According to the TLC the product is stable over months. Biological tests have shown that 
the substance posses low or no cytotoxicity against the tested cell lines. 
1H-NMR (500 MHz, CD3OD, 300K): δ6.77-6.74 (t, J = 2.64 Hz, 1H), 4.68-4.62 (m, 1H), 
4.52-4.48 (m, 1H), 3.70 (s, 3H), 3.70-3.65 (m, 1H), 3.21 (s, 1H), 2.98-2.90 (m, 1H), 2.87-2.81 
(t, J = 10.74 Hz, 1H), 2.45-2.38 (m, 1H), 2.26-2.14 (m, 3H), 2.12 (s, 3H), 2.08-1.96 (m, 3H), 
1.89-1.80 (m, 1H), 1.78-1.71 (m, 1H), 1.55-1.44 (m, 2H), 1.33-1.27 (m, 2H), 1.16 (s, 3H), 
1.12-1.08 (d, J = 6.87 Hz, 3H), 1.05-1.01 (d, J = 6.10 Hz, 3H), 0.93-0.88 (m, 1H). 
13C-NMR (125 MHz, CD3OD, 300K): δ178.87, 172.81, 168.57, 140.67, 135.79, 95.91, 
80.88, 80.58, 80.41, 74.05, 53.57, 51.88, 46.84, 46.32, 45.69, 43.36, 42.69, 36.19, 32.75, 
32.28, 27.47, 24.21, 23.69, 20.94, 14.53, 14.42, 8.58. 
HRMS ESI: Calcd. for [C27H36O9 + Na]: 527.2257; found: 527.2249. 
2-(2-Bromoethyl)-1,3-dioxolane (171) 
O
O Br
C5H9BrO2
Mol. Wt.: 181.03  
The substance was prepared according to the known procedure82 using tetralin (0.825 mol), 
bromine (2.0 mol), acrolein (2.0 mol) and ethylene glycol (2.5 mol). The product was 
obtained as a pale heavy oil with a yield of 56% (201.67 g) after vacuum distillation (bp 53-
63 °C/2 mmHg). Lit. 82b bp 68-70 °C/5 mmHg; lit. 82a bp 68-70 °C/8 mmHg. 
1H-NMR (200 MHz, CDCl3): δ5.01 (t, J = 4.58 Hz, 1H), 4.05-3.80 (m, 4H), 3.47 (t, 
J = 7.09 Hz, 2H), 2.22 (dt, J = 4.61 Hz, 7.12 Hz, 2H). 
HRMS ESI: desired M+ was not found. 
IR (cm-1, neat): 2950 (s), 1409 (w), 1363 (m), 1262, 1210, 1030 (m), 877, 822 (w). 
Methyl 7-(1,3-dioxolan-2-yl)-5-hydroxy-5-methylheptanoate (173) 
H3CO
O HO CH3
O
O
C12H22O5
Mol. Wt.: 246,30  
Mg turnings (800 mg, 33 mmol, 3 equiv) were ground in a mortar (2-3 min) and transferred 
into a 50 mL Schlenk flask. The flask was evacuated and heated with the heat gun, the 
turnings were stirred for 30 min under vacuum. Then the vessel was fitted with an Ar balloon 
and THF (5 mL) was added. 
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A solution of 171 (2.00 g, 11.04 mmol, 1.0 equiv) in THF (5 mL) was added over 30 min to 
the Mg turnings while stirring and maintaining the temperature at 22-24 °C (cold water bath). 
The reaction has begun after 5 min. After the solution of 171 was added, the reaction mixture 
was stirred for 30 min at ambient temperature. 
The grey-colored solution of the organomagnesium compound (11.04 mmol, 1.0 equiv) in 
THF (10 mL) was separated from the rest of Mg turnings and dropwise added to the solution 
of 140 (1.59 g, 11.04 mmol, 1.0 equiv) in THF (10 mL) over 60 min at 0 - -10 °C (ice-salt 
bath). The reaction mixture was stirred for 4 h at 0 - -5 °C and the progress of the reaction was 
monitored by TLC. The starting material has an Rf = 0.50 in hexane/AcOEt 2:3; the product 
has an Rf = 0.20 in hexane/AcOEt 2:3; and the lactone has an Rf = 0.25 in hexane/AcOEt 2:3. 
The reaction mixture was diluted with MTBE (30 mL), quenched by saturated aqueous NH4Cl 
solution (10 mL) and water (10 mL) and extracted with MTBE (3×20 mL). Combined extract 
was washed with brine (20 mL), dried over MgSO4 and concentrated to give 1.85 g of pale 
oil. 
The crude product was solved in MeOH (10 mL) and this solution was added to the solution 
of Na metal (12 mg, 0.5 mmol) in MeOH (10 mL). The reaction mixture was stirred for 15 h 
at ambient temperature. 
The reaction mixture was diluted with MTBE (5 mL) and quenched by saturated aqueous 
NH4Cl solution (5 mL). Organic solvents were removed under reduced pressure and the rest 
was excessively extracted with MTBE (3×50 mL). Combined extract was dried over MgSO4, 
filtered and concentrated to give 1.91 g (70%) of a yellow-brown oil, which was bulb to bulb 
distilled to afford 1.64 g (60%) of a pale oil. The product has an Rf = 0.15-0.20 in 
hexane/AcOEt 1:1. 
1H-NMR (CDCl3, 400 MHz): δ4.82 (dt, J = 1.51, 4.45 Hz, 1H), 4.00-3.90 (m, 2H), 3.85-3.75 
(m, 2H), 3.61 (d, J = 1.51 Hz, 3H), 2.27 (dt, J = 1.05, 7.31 Hz, 2H), 1.75-1.40 (m, 8H), 1.12 
(d, J = 1.38 Hz, 3H). 
13C-NMR (CDCl3, 100 MHz): δ173.96 (C=O), 104.49 (CH), 71.66 (d, J = 0.58 Hz, Cq), 
64.77 (2×CH2), 51.39 (CH3), 41.19 (CH2), 35.22 (CH2), 34.20 (CH2), 28.03 (CH2), 26.46 
(CH3), 19.32 (CH2). 
HRMS ESI: Calcd. for [C12H22O5 + Na]: 269.1365; found: 269.1375. 
IR (cm-1, neat): 3600-3400 (br), 2959 (m), 2883 (m), 1784 (w), 1734 (s), 1437, 1417, 1373 
(m), 1238, 1207 (m), 1166, 1128 (m), 1039 (s), 1014, 984, 944, 917 (m), 885, 805. 
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Methyl 7-(1,3-dioxolan-2-yl)-5-methyl-5-(triethylsilyloxy)heptanoate (174) 
H3CO
O Et3SiO CH3
O
O
C18H36O5Si
Mol. Wt.: 360,56  
2,6-Lutidune (90 µL, 0.755 mmol, 2.0 equiv) and Et3SiOOTf (130 µL, 0.566 mmol, 
1.5 equiv) were added with a Hamilton syringe to the solution of 173 (93 mg, 0.378 mmol, 
1 equiv) in CH2Cl2 (5 mL) while stirred at -78 °C. Reaction mixture was stirred at -78 °C for 
6 h. The progress of the reaction was monitored by TLC: the starting material has an Rf = 0.10 
in hexane/AcOEt 1:1 while the product has an Rf = 0.60 in hexane/AcOEt 1:1. 
The reaction mixture was quenched while cold with 1.0 M pH 7.0 phosphate buffer (15 mL), 
extracted with CH2Cl2 (3×10 mL). Combined extract was washed with saturated aqueous 
NH4Cl solution (15 mL), brine (15 mL), dried over MgSO4, filtered, and concentrated to give 
a yellow oil. The crude product was purified by flash chromatography with hexane/AcOEt 5:1 
to afford 108.4 mg (80%) of a colorless oil. 
The product has an Rf = 0.20-0.25 in hexane/AcOEt 5:1, 0.55-0.60 in hexane/AcOEt 1:1, 
0.25-0.30 in hexane/AcOEt 4:1 and 0.15-0.20 in hexane/AcOEt 8:1. 
1H-NMR (CDCl3, 400 MHz): δ4.80 (t, J = 4.71 Hz, 1H), 4.00-3.90 (m, 2H), 3.85-3.75 (m, 
2H), 3.63 (s, 3H), 2.26 (t, J = 7.34 Hz, 2H), 1.70-1.35 (m, 8H), 1.16 (s, 3H), 0.90 (t, 
J = 7.97 Hz, 9H), 0.53 (q, J = 7.91 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ173.95 (C=O), 104.85 (CH), 74.64 (Cq), 64.77 (2×CH2), 
51.34 (CH3), 41.67 (CH2), 35.94 (CH2), 34.41 (CH2), 28.65 (CH2), 27.54 (CH3), 19.75 (CH2), 
7.07 (CH3×3), 6.76 (CH2×3). 
HRMS ESI: Calcd. for [C18H36O5Si + Na]: 383.2230, for [C18H36O5Si + CH3CN + Na + H]: 
425.2573; found: 383.2235, 425.2451. 
IR (cm-1, neat): 2955 (s), 2912, 2876, 1741 (s), 1459, 1437, 1414, 1375, 1237, 1197, 1171, 
1139, 1040, 1016, 944 (w), 889 (w), 724 (s). 
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Methyl 7-(1,3-dioxolan-2-yl)-5-methyl-5-(methylthiomethoxy)heptanoate (178) 
H3CO
O O CH3
O
O
S
CH3
C14H26O5S
Mol. Wt.: 306,42  
The transformation was conducted according to a published protocol.127 Ac2O (92 mL, 
d = 1.087, 0.9 mol) was added to the solution of the 173 (4.92 g, 19.98 mmol) in DMSO 
(140.0 mL, d = 1.101, 1.8 mol) at rt and the reaction mixture was stirred for 60 h at ambient 
temperature. The reaction mixture was poured into 500 mL of mixture of ice and saturated 
aqueous NaHCO3 solution (1:1 v/v). The emulsion was stirred until the evolution of the gas 
has ceased and was extracted with MTBE (5×50 mL). Combined extract was washed with 
saturated aqueous NaHCO3 solution (50 mL), brine (50 mL) and dried over MgSO4. Solvents 
were removed under reduced pressure (60 °C/up to 10 mar) and the oil obtained was further 
concentrated under high vacuum (rt/0.5 mmHg) to give 7.48 g of a brown-yellow oil. Bulb to 
bulb distillation (250 °C/0.5-1 mmHg) afforded a yellow oil with a typical smell, 5.23 g 
(85%). The product has an Rf = 0.55-0.60 in hexane/AcOEt 1:1 and 0.25-0.30 in 
hexane/AcOEt 2:3. 
1H-NMR (CDCl3, 400 MHz): δ4.82 (t, J = 4.45 Hz, 1H), 4.42 (s, 2H), 4.00-3.90 (m, 2H), 
3.85-3.75 (m, 2H), 3.62 (s, 3H), 2.27 (t, J = 7.15 Hz, 2H), 2.14 (s, 3H), 1.70-1.40 (m, 8H), 
1.14 (m, 3H). 
13C-NMR (CDCl3, 100 MHz): δ173.76 (C=O), 104.37 (CH), 77.54 (Cq), 66.04 (CH2), 64.79 
(2×CH2), 51.36 (CH3), 37.72 (CH2), 34.06 (CH2), 31.66 (CH2), 27.85 (CH2), 22.87 (CH3), 
18.98 (CH2), 14.46 (CH3). 
HRMS ESI: Calcd. for [C14H26O5S + Na]: 329.1412; found: 329.1336. 
IR (cm-1, neat): 2953 (s), 2881, 1737 (s), 1437, 1376, 1303, 1257, 1198, 1140, 1039, 946, 
911, 761, 688. 
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6-(2-(1,3-Dioxolan-2-yl)ethyl)-3,3-dibenzyl-6-methyl-tetrahydropyran-2-one (179) 
O
O
H3C
O
O
C25H30O4
Mol. Wt.: 394,50  
The reaction was conducted according to a published procedure.128 The solution of the alcohol 
173 (1.43 mmol, 352 mg, 1 equiv) in THF (3 mL) was added to the suspension of KHw 
(1.85 mmol, 1.29 equiv, 74 mg) in THF (2 mL) at 0 °C. A solution of BnBr (1.86 mmol, 
1.3 equiv, 320 mg) in THF (3 mL) was added. The reaction mixture was warmed to rt and 
stirred at ambient temperature over 12 h. As the reaction was not complete according to the 
TLC, additional portion of KH (0.9 mmol, 0.65 equiv, 35 mg) was added and the reaction 
mixture was stirred at rt for additional 3 h. Reaction mixture was diluted with MTBE (10 mL), 
quenched with H2O (10 mL) and extracted with MTBE (3×15 mL). Combined organic extract 
was washed with brine (20 mL), dried over MgSO4 and concentrated to give 395 mg of a 
brown emulsion. 
The crude product was purified by flash chromatography with hexane/AcOEt 7:3 to afford 
119 mg (21%) of a colorless oil that formed white crystals later. The product has an Rf = 0.25-
0.30 in hexane/AcOEt 7:3. 
1H-NMR (CDCl3, 400 MHz): δ7.40-7.20 (m, 10H, Ar), 4.60 (t, J = 4.71 Hz, 1H), 4.95-3.70 
(m, 4H), 3.55-3.35 (dd, J = 25.47, 13.05 Hz, 2H), 2.70-2.50 (dd, J = 39.90, 13.05 Hz, 2H), 
1.90-1.70 (m, 2H), 1.50-1.35 (m, 2H), 1.30-1.10 (m, 4H), 0.70 (s, 3H). 
13C-NMR (CDCl3, 100 MHz): δ175.85 (C=O), 137.02 (Cq, Ar), 136.93 (Cq, Ar), 130.64 
(2×CH, Ar), 130.49 (2×CH, Ar), 128.33 (2×CH, Ar), 128.24 (2×CH, Ar), 126.85 (CH, Ar), 
126.80 (CH, Ar), 103.98 (CH), 83.50 (Cq), 64.72 (CH2, dioxolane), 64.67 (CH2, dioxolane), 
47.82 (Cq), 46.67 (CH2, Bn), 46.12 (CH2, Bn), 35.27 (CH2), 29.9 (CH2), 27.76 (CH2), 25.42 
(CH3), 22.98 (CH2). 
HRMS ESI: Calcd. for [C25H30O4 + H]: 395.222, for [C25H30O4 + Na]: 417.2042; found: 
395.2185, 417.2023. 
                                                 
w) 35%-suspension of KH in mineral oil (150 mg) was transferred into a weighted Schlenk flask, washed with 
hexane over N2, the solvent was removed by a syringe and KH was dried under reduced pressure (0.1 mmHg). 
The flask was weighted. 
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IR (cm-1, neat): 3027(w), 2933, 2879, 1705(s), 1602(w), 1494, 1454, 1372, 1278, 1203, 
1132(s), 1108(s), 1031(s), 946, 766, 743, 702(s). 
4-Methoxybenzyl 2,2,2-trichloroacetimidate 
O CCl3
NH
O
C10H10Cl3NO2
Mol. Wt.: 282.55  
The compound was prepared according to the published procedure.129 A solution of PMBOH 
(22.65 g, 163.94 mmol, 1 equiv) in MTBE (25 mL) was added over 30 min to the stirred 
suspension of NaH (655 mg of 60% suspension in mineral oil, 16.38 mmol, 0.1 equiv) in 
MTBE (40 mL) at 0 °C. After the addition was complete, the reaction mixture was warmed to 
rt and stirred for 90 min at ambient temperature. The reaction mixture was cooled to -10 °C, 
and trichloroacetonitrile (26.0 g, 18.0 mL, 179.51 mmol, 1.1 equiv, d = 1.44) was added over 
30 min in small portions so that the temperature stayed bellow 5 °C. When the addition was 
complete the reaction mixture was stirred additional 15 min at -10 °C, then slowly warmed to 
rt and stirred for 1 h at ambient temperature. The reaction mixture was concentrated under 
reduced pressure (30 °C/15 mmHg). Hexane (70 mL), MeOH (1 mL) and celite (5 g) were 
added. The resulting mixture was stirred for 30 min at rt and filtered. Filtrate was concentrated 
to afford 47 g (100%) of a brown oil. 
1H-NMR (CDCl3, 200 MHz): δ8.36 (br s, 1H), 7.37 (d, J = 8.78 Hz, 2H), 6.91 (d, 
J = 8.78 Hz, 2H), 5.27 (s, 2H), 3.82 (s, 3H). 
Methyl 5-(4-methoxybenzyloxy)-7-(1,3-dioxolan-2-yl)-5-methylheptanoate (180) 
H3C
O
OCH3
O
O
O
OCH3
C20H30O6
Mol. Wt.: 366.45  
4-Methoxybenzyl 2,2,2-trichloroacetimidate (287 mg, 1.015 mmol, 2.5 equiv) and TfOH 
(0.108 µL, 0.003 equiv, 0.0012 mmol, d = 1.696)x were added to the solution of the alcohol 
173 (100 mg, 0.4060 mmol) in Et2O (10 mL) at rt. As there was no reaction progress after 1 h 
                                                 
x) 10 µL of the TfOH were solved in ether (10 mL). 0.1 mL of this solution was taken. 
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according to the TLC, additional portion of TfOH (0.216 µL, 0.006 equiv) was added. CSA 
monohydrate (20 mg, 20 mol%) was added. The reaction mixture was stirred for 15 h at rt. 
The reaction mixture was quenched by addition of saturated aqueous NaHCO3 solution 
(10 mL), followed by extraction with AcOEt (3×15 mL). Combined extract was dried over 
MgSO4 and concentrated. The crude product was purified twice by flashed chromatography 
with hexane/AcOEt 7:3 to afford 53.2 mg of a white solid on concentration. The product has 
an Rf = 0.2-0.3 in hexane/AcOEt 7:3. 
1H-NMR (CDCl3, 200 MHz): δ7.25 (d, J = 8.64 Hz, 2H), 6.85 (d, J = 8.76 Hz, 2H), 4.88 (t, 
J = 4.14 Hz, 1H), 4.30 (s, 2H), 4.00-3.82 (m, 4H), 3.79 (s, 3H), 3.66 (s, 3H), 2.32 (t, 
J = 7.09 Hz, 2H), 1.80-1.50 (m, 8H), 1.21 (s, 3H). 
HRMS ESI: Calcd. for [C20H30O6 + CH3CN + Na]: 430.2206; found: 430.2212. 
3-(Benzyloxy)propan-1-ol (181) 
OHO
C10H14O2
Mol. Wt.: 166.22  
3-(Benzyloxy)-1-propanol was prepared according to the published procedure130. Sodium 
(25 g, 1.09 mol) was added in small portions to vigorously stirred solution of 1,3-propanediol 
(240 mL, 250 g, 3.3 mol) in dry o-xylene (100 mL) at 50 °C. The temperature rose by itself up 
to 120°-140 °C, so that the reaction mixture refluxed. After all the sodium has been dissolved, 
benzyl chloride (139 mL, 150 g, d = 1.1 g/mL, 1.19 mol) was slowly added with stirring to the 
hot (120 °C) solution over a period of 2 h. The reaction mixture was heated for 1 h and then 
cooled to rt. Precipitated NaCl was removed by filtration and washed with toluene. Combined 
filtrate washings were concentrated under reduced pressure to provide a clear liquid (300 g), 
which was fractionated under vacuum using a Vigreux column. After a forerun of 1,3-
propanediol (185 g), bp 80-85 °C (2 mmHg), the γ-benzyloxopropanol (120 g, 65%) distilled 
as a clear colorless liquid, bp 95-100 °C (1-2 mmHg). Lit.130 yield: 65%, bp 95-100 °C (1-2 
mmHg), lit.131 bp 145-150 °C (13 mmHg). 
1H-NMR (CDCl3, 400 MHz): (Not calibrated) δ7.36 (m, 5H, Ar), 4.54 (s, 2H), 3.77 (t, 
J = 5.84 Hz, 2H), 3.67 (t, J = 5.90 Hz, 2H), 2.82 (br s, 1H), 1.88 (qui, J = 5.84 Hz, 2H). 
13C-NMR (CDCl3, 100 MHz): δ137.97 (Cq, Ar), 128.28 (2×CH, Ar), 127.54 (CH, Ar), 
127.50 (2×CH, Ar), 73.04 (CH2), 68.85 (CH2), 61.18 (CH2), 32.03 (CH2). 
HRMS ESI: desired M+ was not found. 
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IR (cm-1, neat): 3353 (br, s), 3031 (w), 2932, 2859, 1495, 1454, 1364, 1205, 1072 (s), 1026, 
972, 919, 735 (s), 696 (s). 
1-(Benzyloxy)-3-brompropane (182) 
O Br
C10H13BrO
Mol. Wt.: 229.11  
The substance was prepared according to a described procedure.132 N-bromosuccinimide 
(38.2 g, 0.215 mol) was added in small portions to the ice-salt cooled mixture of 181 (35.7 g, 
0.215 mol) and triphenylphosphine (56.4 g, 0.215 mol) under mechanical stirringy and at such 
a rate that the temperature of the reaction mixture did not exceed 10 °C.z 
After the reaction mixture was stirred over 20 h at rt it has been diluted with hexane (30 mL), 
filtered with suction and the precipitate was washed with hexane (2×50 mL) and MTBE 
(30 mL). The filtrate was concentrated under reduced pressure and the oily rest was diluted 
with MTBE (30-40 mL), washed with 10% aqueous Na2S2O3 solution (3×20 mL), 0.5 M 
aqueous NaOH solution (30 mL) and brine (30 mL). Inorganic rests were extracted with 
MTBE (3×30 mL) and the extract was washed as above. Combined organic extract was dried 
over MgSO4 and concentrated under reduced pressure (50 °C/8 mmHg) providing the crude 
product which was distilled bulb to bulb (150 °C/2 mmHg) to afford 31.31 g (64%) of a 
colorless liquid.aa Lit.132 yield: 33.2 g (67%), bp 128-130 °C/5 mmHg; lit.133 bp 159-160 °C/3 
mmHg. 
1H-NMR (CDCl3, 400 MHz): δ7.39 (m, 5H, Ar), 4.57 (s, 2H), 3.65 (t, J = 5.90 Hz, 2H), 3.58 
(t, J = 6.53 Hz, 2H), 2.19 (qui, J = 6.07 Hz, 2H). 
13C-NMR (CDCl3, 100 MHz): δ138.14 (Cq, Ar), 128.32 (2×CH, Ar), 127.56 (CH, Ar), 
127.54 (2×CH, Ar), 73.01 (CH2), 67.59 (CH2), 32.81 (CH2), 30.59 (CH2). 
HRMS ESI: desired M+ was not found. 
IR (cm-1, neat): 3496 (v, br), 3064, 3030, 2858, 1720 (w), 1495, 1453, 1363, 1255, 1205, 
1099 (s), 1069 (s), 1027, 909, 881, 735 (s), 696 (s). 
                                                 
y) Good mechanical stirring and inner temperature control are essential. 
z) The reaction has an induction period of ca. 30 min and is very exothermic! The addition of NBS must be slow 
enough. 
aa) The product, obtained after distillation contains an admixture (5%-10%) of the staring alcohol. From that 
reason it is advised to take 1.1-1.2 equiv of both PPh3 and NBS. 
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Methyl 8-(benzyloxy)-5-hydroxy-5-methyloctanoate (183) 
H3C
COOCH3
OH
O
C17H26O4
Mol. Wt.: 294.39  
3-(Benzyloxy)propylmagnesium bromide was prepared according to the published 
procedure.134 A solution of 182 (17.09 g, 74.59 mmol, 1.0 equiv) in THF (10 mL) was added 
over 30 min to a suspension of Mg turningsbb (3.58 g, 149 mmol, 2 equiv) in THF (10 mL) at 
22-24 °C (the flask was cooled on a cold water bath). The reaction is exothermic and has an 
induction period of approx. 15 min. When the reaction starts, the color of the reaction mixture 
becomes olive-green and the temperature may rise to 50-60 °C. 
After the addition of 182 was complete, the reaction mixture was stirred at ambient 
temperature for 2 h. Green-brown solution of the Grignard reagent was dropwise added to the 
solution of methyl 5-oxo-hexanoate (140) (4.33 g, 30 mmol, 0.4 equiv) in THF (10 mL) over 
30 min at rt. An exothermic effect was noticed during the addition. 
After the reaction mixture was stirred for 1 h at rt, MeOH (5 mL) was added. Then the 
reaction mixture was added to MeOH (100 mL) and stirred for 30 min at rt. Solvents were 
removed under reduced pressure and the rest was diluted with MTBE (50 mL). The grey 
suspension was filtered through sand and celite and the precipitate was washed with MTBE 
(2×40 mL) and CH2Cl2 (20 mL). 15.5 g of a yellow oil was obtained on concentration. 
The crude product was purified by bulb to bulb distillation (150 °C/0.1 mmHg) to afford the 
product as a yellow oil, 8.7 g (98.5%) as the rest in the distillation flask, and a colorless 
distillate. According to the NMR, the product is the mixture of the lactone and the methyl 
ester. It was used in the next step without further purification. 
 
NaOMe solution obtained from Na metal (220 mg, 9.18 mmol) and MeOH (25 mL) was 
added to the solution of the crude product (2.39 g, 9.10 mmol) in MeOH (50 mL) at rt. Pale 
cloudy solution was stirred for 2 h at rt. The reaction mixture was quenched by addition of 2% 
aqueous HCl solution (16 mL) at 0 °C (pH 2-3) and 1.0 M pH 7.0 phosphate buffer (2 mL). 
After volatiles were removed under reduced pressure H2O (20 mL) was added (pH should be 
neutral) and the mixture was extracted with MTBE (3×40 mL). Combined organic extract was 
washed with brine (20 mL), dried over MgSO4, filtered and concentrated to afford 2.23 g 
                                                 
bb) Ground to generate a fresh surface. 
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(83%) of 183 as a yellow oil. The product was used in the next step without further 
purification. It has an Rf = 0.3 in hexane/AcOEt 1:1. 
1H-NMR (CDCl3, 400 MHz): δ7.40-7.20 (m, 5H, Ar), 4.55-4.48 (m, 2H), 3.67 (s, 3H), 3.50 
(t, J = 6.14 Hz, 2H), 2.33 (t, J = 7.34 Hz, 2H), 1.75-1.65 (m, 4H), 1.60-1.54 (m, 2H), 1.51-
1.45 (m, 2H), 1.17 (s, 3H). 
HRMS ESI: Calcd. for [C17H26O4 + Na]: 317.1729; found: 317.1744. 
8-Benzyloxy-5-methyl-5-triethylsilanyloxy-octanoic acid methyl ester (184) 
H3C OSiEt3
O
C23H40O4Si
Mol. Wt.: 408,65
OCH3
O
 
2,6-Lutidune (4.7 mL, 4.30 mg, 40.10 mmol, 2.0 equiv) and Et3SiOTf (6.3 mL, 7.42 g, 
28.07 mmol, 1.4 equiv) were added to the solution of the alcohol 183 (5.90 g, 20.05 mmol) in 
CH2Cl2 (40 mL) at -95 °C over 2 min. The reaction mixture was stirred for 2 h at -78 °C until 
the reaction was complete according to the TLC. Reaction mixture was quenched by the 
addition of H2O (10 mL) and saturated aqueous NH4Cl solution (10 mL) while cold. The 
mixture was warmed to rt and extracted with CH2Cl2 (3×30 mL). The combined organic 
extract was washed with brine (20 mL), dried over MgSO4 and concentrated. The crude 
product was purified by flash chromatography with hexane/AcOEt 10:1 to afford 4.60 g 
(56%) of 184 as a colorless oil as a product. It has an Rf = 0.55-0.60 in hexane/AcOEt 3:2 and 
0.20-0.25 in hexane/AcOEt 10:1. 
1H-NMR (CDCl3, 400 MHz): δ7.40-7.20 (m, 5H, Ar), 4.53 (s, 2H), 3.69 (s, 3H), 3.48 (t, 
J = 6.65 Hz, 2H), 3.32 (t, J = 7.47 Hz, 2H), 1.75-1.60 (m, 2H), 1.55-1.40 (m, 2H), 1.22 (s, 
3H), 0.97 (t, J = 7.91 Hz, 9H), 0.59 (q, J = 7.91 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ174.05 (Cq), 138.62 (Cq), 128.27 (2×CH), 127.53 (2×CH), 
127.39 (CH), 74.99 (Cq), 72.74 (CH2), 70.90 (CH2), 51.37 (CH3), 41.63 (CH2), 38.56 (CH2), 
34.47 (CH2), 27.64 (CH3), 24.58 (CH2), 19.78 (CH2), 7.12 (3×CH3), 6.83 (3×CH2). 
HRMS ESI: Calcd. for [C23H40O4Si + Na]: 431.2594; found: 431.2608. 
IR (cm-1, neat): 2951 (s), 2911, 2874, 1739 (s), 1496, 1455, 1435, 1415, 1360, 1238, 1196, 
1170, 1100, 1008 (s), 722 (s), 697. 
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8-Hydroxy-5-methyl-5-triethylsilanyloxy-octanoic acid methyl ester (185) 
H3C OSiEt3
HO
C16H34O4Si
Mol. Wt.: 318.52
OCH3
O
 
The solution of the benzyl ether 184 (1000 mg, 2.45 mmol) in MeOH (5 mL) was added to the 
suspension of Ni* Raney (W2)135 catalyst (ca. 4 mL of the sedimented suspension that 
corresponds to ca. 2.4 g of dry catalyst) in MeOH (5 mL). The flask was evacuated and 
attached to H2-line (1 atm). The reaction mixture was vigorously stirred over 6 h while the 
hydrogenation was controlled by TLC. 
When the reaction was complete, the reaction mixture was filtered through celite and 
concentrated to give 0.768 g (98.5%) of 185 as a colorless oil. The product was used without 
further purification in the next step. It has an Rf = 0.15-0.20 in hexane/AcOEt 7:3. 
1H-NMR (CDCl3, 400 MHz): δ3.64 (s, 3H), 3.60-3.55 (m, 2H), 2.27 (t, J = 7.47 Hz, 2H), 
1.99 (s, 1H), 1.70-1.50 (m, 4H), 1.50-1.40 (m, 4H), 1.18 (s, 3H), 0.91 (t, J = 7.91 Hz, 9H), 
0.54 (q, J = 7.99 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ174.09 (CO), 75.14 (Cq), 63.31 (CH2), 51.41 (CH3), 41.56 
(CH2), 38.25 (CH2), 34.36 (CH2), 27.69 (CH3), 27.48 (CH2), 19.80 (CH2), 7.06 (3×CH3), 6.76 
(3×CH2). 
HRMS ESI: Calcd. for [C16H34O4Si + Na]: 341.2124; found: 341.2296. 
IR (cm-1, neat): 3388 (br), 2951 (s), 2911, 2875, 1740 (s), 1458, 1436, 1415, 1374, 1237, 
1196, 1169, 1120, 1053 (s), 1010 (s), 720 (s), 671. 
Methyl 5-methyl-8-oxo-5-(triethylsilyloxy)octanoate (169)136 
O
H3C OSiEt3
C16H34O4Si
Mol. Wt.: 318.52
OCH3
O
 
DMSO (334 µL, 368 mg, 4.71 mmol, 5 equiv, d = 1.101) was added to a solution of 
oxalylchloride (164 µL, 239 mg, 1.88 mmol, 2.0 equiv, d = 1.455) in CH2Cl2 (5 mL) at 
-78 °C. The reaction mixture was stirred 25 min at -78 °C. Solution of the alcohol 185 
(307 mg, 0.942 mmol, 1 equiv) in CH2Cl2 (5 mL) was dropwise added over 2 min. The 
reaction mixture was stirred for 15 min at -78 °C. 
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Pr2EtN (1000 µL, 742 mg, 5.74 mmol, 6 equiv, d = 0.742) was added and the reaction mixture 
was allowed to warm to rt. 
After the reaction mixture was stirred for 1.5 h at rt it was quenched with saturated aqueous 
NaHCO3 solution (10 mL) and extracted with CH2Cl2 (3×15 mL). The extract was washed 
with brine (20 mL), dried over MgSO4 and concentrated to give the oily product.cc The crude 
product was purified by flash chromatography with hexane/AcOEt 5:1 to afford 0.244 g 
(81%) of a light yellow oil. The product has an Rf = 0.22-0.27 in hexane/AcOEt 5:1 and 0.42 
in hexane/AcOEt 7:3. 
1H-NMR (CDCl3, 400 MHz): δ9.75 (t, J = 1.69 Hz, 1H), 3.65 (s, 3H), 2.55-2.40 (m, 2H), 
2.29 (t, J = 7.28 Hz, 2H), 1.90-1.70 (m, 2H), 1.70-1.55 (m, 2H), 1.50-1.40 (m, 2H), 1.19 (s, 
3H), 0.91 (t, J = 7.91 Hz, 9H), 0.55 (q, J = 7.99 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ202.71 (C=O), 173.83 (C=O), 74.46 (Cq), 51.46 (CH3), 
41.78 (CH2), 39.10 (CH2), 34.25 (CH2), 33.85 (CH2), 27.45 (CH3), 19.90 (CH2), 7.05 
(3×CH3), 6.70 (3×CH2). 
HRMS ESI: desired M+ was not found. 
IR (cm-1, neat): 2954 (s), 2912, 2876 (s), 2719 (w), 1738 (s), 1727 (s), 1459, 1437, 1416, 
1377, 1239, 1195, 1170, 1135, 1121, 1043 (s), 1008 (s), 971, 888 (w), 722 (s), 672 (w). 
Methyl (8S,9R)-10-[(4R)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]-8-hydroxy-5,9-dimethyl-10-
oxo-5-[(triethylsilyl)oxy]decanoate (186) 
O N
O O
CH3
Ph
OH
H3C OSiEt3
C29H47NO7Si
Mol. Wt.: 549.77
OCH3
O
 
1.0 M solution of dibutylboryltriflate (n-Bu2BOSO2CF3) in CH2Cl2 (5.40 mL, 5.40 mmol, 
2.2 equiv) and diisopropylethylamine (1.10 mL, 6.13 mmol, 2.5 equiv) were dropwise added 
to a solution of the imide 170 (1.14 g, 4.91 mmol, 2.0 equiv) in CH2Cl2 (75 mL) at -78 °C. 
After the reaction mixture was stirred for 10 min at -78 °C, it was warmed to 0-5 °C (ice bath) 
and stirred for 2 h at this temperature. 
The light yellow solution was cooled to -15 °C (ice/salt bath) and the aldehyde 169 (753 mg, 
2.38 mmol, 0.97 equiv) was added as a solution in CH2Cl2 (25 mL) at -10- -15 °C over 5 min. 
                                                 
cc) The product should not be subjected to heating during concentration. Otherwise the crude product becomes 
dark and the yield will be diminished. 
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After the reaction mixture was stirred for 3 h at -10- -15 °C it was quenched by addition to 
0.5 M pH 7.0 phosphate buffer (100 mL) and MeOH (10 mL) at -5-0 °C. A 2:1 mixture of 
MeOH and 30% aqueous H2O2 (30 mL) was carefully added so as to keep the internal 
temperature bellow 5 °C (occasional cooling in an ice/salt bath). Volatiles were removed 
under reduced pressure (50 °C/60 mmHg) and the rest was extracted CH2Cl2 (4×25 mL). 
Combined extract were washed with 5% aqueous NaHCO3 solution (20 mL) and brine 
(30 mL), dried over MgSO4, filtered and concentrated. Purification of the crude product by 
flash chromatography with hexane/AcOEt 7:3 afforded 935 mg (72% yield) the desired 
product (Rf = 0.12-0.17) as a pale oil and 868 mg of the Evans auxiliary. 
1H-NMR (CDCl3, 400 MHz): δ7.40-7.15 (m, 5H, Ar), 4.80-4.65 (m, 1H), 4.23 (dddd, 
J = 9.14, 7.45, 1.24, 0.61 Hz, 1H), 4.21 (dd, J = 9.03, 3.01 Hz, 1H), 3.95-3.85 (m, 1H), 3.79 
(dq, J = 3.01, 9.03 Hz, 1H), 3.66 (s, 3H), 3.28 (dd, J = 13.49, 3.33 Hz, 1H), 2.99 (dd, 
J = 17.44, 3.14 Hz, 1H), 2.81 (dd, J = 13.30, 9.54 Hz, 1H), 2.32 (t, J = 7.40 Hz, 2H), 1.75-
1.40 (m, 8H), 1.29 (dd, J = 7.03, 0.75 Hz, 3H), 1.22 (d, J = 2.01 Hz, 3H), 0.95 (t, J = 7.65 Hz, 
9H), 0.59 (q, J = 7.95 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ177.21 (C=O), 174.00 (C=O), 152.95 (O-C=O), 135.00 (Cq, 
Ar), 129.35 (2×CH, Ar), 128.87 (2×CH, Ar), 127.32 (CH, Ar), 75.07 & 75.04 (Cq), 72.05 & 
71.95 (CH), 66.07 (CH2), 55.05 (CH), 51.37 (CH3), 42.20 & 42.17 (CH), 41.73 & 41.43 
(CH2), 38.24 & 38.17 (CH2), 37.68 (CH2), 34.35 (CH2), 28.46 & 28.37 (CH2), 27.73 & 27.53 
(CH2), 19.78 & 19.76 (CH2), 10.54 & 10.46 (CH3), 7.08 (3×CH3), 6.76 (3×CH2). 
The doubling of some signals is due to the fact that the product is a mixture of two 
diastereomers. 
HRMS ESI: Calcd. for [C29H47NO7Si + Na]: 572.3020; found: 572.3036. 
IR (cm-1, neat): 3527 (br), 2951 (s), 2875 (s), 1779 (s), δ1736 (s), 1696 (s), 1455, 1375 (s), 
1289, 1207 (s), 1106, 1045 (s), 1007 (s), 971, 722 (s), 701 (s). 
[ ]20Dα (CHCl3, c = 1.23) = -32.3°. 
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4-Benzyl-3-[2-(5-methyl-9-oxo-5-triethylsilanyloxy-oxonan-2-yl)-propionyl]-oxazolidin-
2-one (187) 
O N
O O
CH3
O
OSiEt3H3C
O
C28H43NO6Si
Mol. Wt.: 517,73
"diastereomer I"
and
"diastereomer II"  
Method a): The solution of the methyl ester 186 (50 mg, 0.091 mmol) and bis(tri-n-
butyltin(IV)) oxide (5 µL, 5.85 mg, 9.8 µmol, ca. 0.1 equiv, d = 1.17) in toluene (5 mL) was 
refluxed over 48 h under argon. The progress of the reaction progress was monitored by TLC. 
The reaction mixture was quenched with saturated aqueous NH4Cl solution (15 mL), extracted 
with AcOEt (3×20 mL). Combined organic extract was washed with brine (15 mL), dried over 
MgSO4 and concentrated. The crude product was flashed with hexane/AcOEt 6:4 to give 
34.1 mg of a pale oil. This was additionally purified by flash chromatography with 
hexane/AcOEt 5:1 to afford 10.0 mg (21%) of 187 as a colorless oil. The starting material has 
an Rf = 0.12-0.17 in hexane/AcOEt 7:3; the product has an Rf = 0.7 in hexane/AcOEt 6:4 and 
0.20-0.30 in hexane/AcOEt 5:1, “Vanillin”. 
 
Method b): The solution of the methyl ester 186 (50 mg, 0.091 mmol) and bis(tri-n-
butyltin(IV)) oxide (5 µL, 5.85 mg, 9.8 µmol, ca. 0.1 equiv, d = 1.17) in toluene (3 mL) was 
heated in the microwave oven over 90 min (300W, 120 °C, stirring ON, cooling ON) followed 
by reflux over 12 h under conventional heating. The progress of the reaction was monitored 
by TLC. The reaction mixture was quenched with saturated aqueous NH4Cl solution (15 mL), 
extracted with AcOEt (3×20 mL). Combined organic extract was washed with brine (15 mL), 
dried over MgSO4 and concentrated. The crude product was flashed with hexane/AcOEt 10:1 
to afford two fractions 5.3 mg (11%, diastereomer I with an Rf = 1.10-1.11) and 3.1 mg (7%, 
diastereomer II with an Rf = 0.09-0.10). 
Diastereomer I: 
1H-NMR (CDCl3, 400 MHz): δ7.30-7.18 (m, 5H, Ar), 5.35-5.25 (m, 1H), 4.63-4.56 (t, 
J = 11.09 Hz, 1H), 4.29-4.23 (ddd, J = 10.92, 5.80, 2.05 Hz, 1H), 4.24-4.18 (dd, J = 11.44, 
4. Experimental Part 
 
136
4.61 Hz, 1H), 3.22-3.14 (dd, J = 13.31, 8.19 Hz, 1H), 3.08-3.01 (dd, J = 13.48, 7.68 Hz, 1H), 
2.81-2.72 (dq, J = 6.06, 7.00 Hz, 1H), 2.38-2.28 (m, 1H), 2.28-2.20 (m, 1H), 1.84-1.72 (m, 
2H), 1.70-1.35 (m, 7H), 1.21 (s, 3H), 1.12-1.09 (d, J = 6.83 Hz, 3H), 0.94-0.88 (t, J = 7.85 Hz, 
9H), 0.57-0.50 (q, J = 8.02 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ172.90 (Cq), 171.29 (Cq), 149.60 (Cq), 136.87 (Cq), 129.23 
(2×CH), 128.52 (2×CH), 126.82 (CH), 78.98 (CH), 74.28 (Cq), 62.72 (CH2), 52.42 (CH), 
41.81 (CH2), 39.13 (CH), 37.73 (CH2), 35.82 (CH2), 34.96 (CH2), 29.86 (CH3), 23.01 (CH2), 
20.66 (CH2), 10.30 (CH3), 7.09 (3×CH3), 6.78 (3×CH2). 
HRMS ESI: Calcd. for [C28H43NO6Si + CH3CN + Na]: 581.3023; found: 581.3011. 
[ ]20Dα (CHCl3, c = 1.33) = +5.26°. 
Diastereomer II: 
1H-NMR (CDCl3, 400 MHz): δ7.30-7.18 (m, 5H, Ar), 5.33-5.23 (m, 1H), 4.62-4.54 (dd, 
J = 10.24, 11.61 Hz, 1H), 4.35-4.29 (m, 1H), 4.24-4.18 (dd, J = 11.61, 4.44 Hz, 1H), 3.26-
3.19 (dd, J = 13.48, 8.36 Hz, 1H), 3.10-3.03 (dd, J = 13.65, 7.85 Hz, 1H), 2.81-2.73 (dq, 
J = 5.89, 7.11 Hz, 1H), 2.42-2.33 (m, 1H), 2.25-2.17 (m, 1H), 1.95-1.86 (m, 1H), 1.72-1.60 
(m, 1H), 1.56 (s, 3H), 1.55-1.34 (m, 6H), 1.14 (s, 3H), 1.11 (d, J = 7.17 Hz, 3H), 0.96-0.90 (t, 
J = 8.02 Hz, 9H), 0.59-0.51 (q, J = 7.68 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ172.79 (Cq), 171.30 (Cq), 149.53 (Cq), 136.96 (Cq), 129.23 
(2×CH), 128.54 (2×CH), 126.82 (CH), 78.28 (CH), 74.41 (Cq), 62.97 (CH2), 52.65 (CH), 
42.14 (CH2), 39.05 (CH), 36.74 (CH2), 35.95 (CH2), 34.81 (CH2), 27.35 (CH3), 24.44 (CH2), 
19.74 (CH2), 10.42 (CH3), 7.10 (3×CH3), 6.84 (3×CH2). 
HRMS ESI: Calcd. for [C28H43NO6Si + CH3CN + Na]: 581.3023; found: 581.3011. 
[ ]20Dα (CHCl3, c = 0.53) = -8.3°. 
(2R,3S)-3-hydroxy-10-methoxy-2,6-dimethyl-10-oxo-6-(triethylsilyloxy)decanoic acid 
(188)137 
HO
O
CH3
OH
OSiEt3H3C
OCH3
O
C19H38O6Si
Mol. Wt.: 390,59  
35% aqueous H2O2 solution (41 µL, d = 1.11, 13.82 mg, 0.7276 mmol, 4 equiv) and a solution 
of LiOH·H2O (9.2 mg, 0.2183 mmol, 1.2 equiv) in water (1 mL) were added to the solution of 
the methyl ester 186 (100 mg, 0.1819 mmol, 1 equiv) in THF/water 4:1 mixture (10 mL) at 
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0 °C. After the reaction mixture was stirred for 1 h at 0 °C, it was quenched by addition of a 
solution of Na2SO3 (92 mg, 0.7276 mmol, 4 equiv) in H2O (3 mL). The mixture was stirred 
for 15 min at 0 °C and 2% aqueous HCl solution (3 mL) was added so that the pH was neutral 
or slightly acidic. The mixture was extracted with AcOEt (3×20 mL). The extract was dried 
over MgSO4 and concentrated. The crude product was purified by flash chromatography with 
hexane/AcOEt 1:1 to afford 50 mg (70%) of 188 as a colorless oil. The product has an 
Rf = 0.20 in hexane/AcOEt 1:1. 
1H-NMR (CDCl3, 200 MHz): δ3.84 (br s, 1H), 3.68 (s, 3H), 2.75-2.55 (m, 1H), 2.31 (t, 
J = 6.71 Hz, 2H), 1.75-1.40 (m, 8H), 1.26 (s, 3H), 1.22 (s, 3H). 
HRMS ESI: Calcd. for [C19H38O6Si + Na]: 413.2335; found: 413.2347. 
IR (cm-1, neat): 3600-3000 (br), 2953 (s), 2912 (s), 2875 (s), 1706 (s), 1457, 1414, 1374, 
1198, 1170, 1119, 1005 (s), 720 (s). 
[ ]20Dα (CHCl3, c = 1.05) = +6.10°. 
 (2R,3S)-Dimethyl 3-hydroxy-2,6-dimethyl-6-(triethylsilyloxy)decanedioate (191)102 
OH
CH3 OSiEt3H3C
C20H40O6Si
Mol. Wt.: 404,61
H3CO
O
OCH3
O
 
The solution of LiOH·H2O (17 mg, 0.40 mmol, 11 equiv) in H2O (0.8 mL) was added to the 
solution of the ester 186 (20.3 mg, 0.036 mmol) in THF/MeOH 1:1 (4 mL) at 0 °C. The 
progress of the reaction was controlled by TLC. When there was no starting material, AcOEt 
(10 mL) was added and the organic layer was separated. Aqueous layer was acidified with 
1.0 M aqueous NaHSO4 solution to pH 1-2 and extracted with AcOEt (2×10 mL). Combined 
organic extract was washed with brine (15 mL), dried over MgSO4 and concentrated. The 
crude product was purified by flash chromatography with hexane/AcOEt to afford 5.0 mg 
(34%) of 191 as a colorless oil. It has an Rf = 0.3 in hexane/AcOEt 7:3. 
1H-NMR (CDCl3, 200 MHz): δ3.87 (br s, 1H), 3.75 (s, 3H), 3.71 (s, 3H), 2.80-2.50 (m, 2H), 
2.34 (t, J = 7.14 Hz, 2H), 1.80-1.40 (m, 8H), 1.30 (s, 3H), 1.24 (s, 3H), 0.98 (t, J = 7.64 Hz, 
9H), 0.63 (q, J = 7.78 Hz, 6H). 
HRMS ESI: Calcd. for [C20H40O6Si + Na]: 427.2492; found: 427.2472. 
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3-Hydroxy-2,6-dimethyl-6-triethylsilanyloxy-decanedioic acid diallyl ester and 3-
hydroxy-2,6-dimethyl-6-triethylsilanyloxy-decanedioic acid 1-allyl ester 10-methyl 
ester138 
O
O
CH3
OH
OSiEt3H3C
O
O
C24H44O6Si
Mol. Wt.: 456,69
O
O
CH3
OH
OSiEt3H3C
OCH3
O
C22H42O6Si
Mol. Wt.: 430,65  
LiBr (79 mg, 0.91 mmol, 5 equiv) was premixed with the methyl ester 186 (100 mg, 
0.182 mmol) neat, and left for 15-20 min.dd Allyl alcohol (2 mL, 29.4 mmol, 162 equiv, 
d = 0.854) and DBU (13.6 µL, 0.5 equiv, d = 1.018) were added and the reaction mixture was 
stirred at rt. The progress was monitored by TLC. According the TLC there was no starting 
material after 15 min. After 2 h at rt the reaction mixture was quenched by addition of 
saturated aqueous NH4Cl solution (5 mL), MTBE (5 mL) and water (5 mL). The mixture was 
extracted with MTBE (3×20 mL), combined organic extract was washed with brine (15 mL), 
dried over MgSO4 and concentrated. The crude product was flushed with hexane/AcOEt 8:1 
to afford two fractions: “fraction I”: 9.7 mg with Rf = 0.11-0.10 and “fraction II”: 6.5 mg with 
Rf = 0.10-0.09. 
 
 
 
 
 
 
 
 
 
                                                 
dd) The methyl ester was added as a solution in THF (1 mL) to the LiBr and the solvent was removed under 
reduced pressure. 
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Fraction I, 3-Hydroxy-2,6-dimethyl-6-triethylsilanyloxy-decanedioic acid diallyl ester 
O
O
CH3
OH
OSiEt3H3C
O
O
C24H44O6Si
Mol. Wt.: 456,69  
1H-NMR (CDCl3, 400 MHz): δ5.95 (ddd, J = 10.42, 5.77, 2.26 Hz, 1H), 5.89 (ddd, 
J = 10.45, 5.74, 2.16 Hz, 1H), 5.34 (ddd, J = 7.72, 3.07, 1.51 Hz, 1H), 5.30 (ddd, J = 7.72, 
3.07, 1.51 Hz, 1H), 5.25 (ddd, J = 7.81, 2.54, 1.22 Hz, 1H), 5.23 (ddd, J = 7.84, 2.57, 1.25 Hz, 
1H), 4.61 (ddd, J = 5.80, 2.16, 1.10 Hz, 2H), 4.57 (ddd, J = 5.77, 1.38, 1.38 Hz, 2H), 3.90-
3.80 (m, 1H), 2.68 (dd, J = 22.15, 4.58 Hz, 1H), 2.56 (ddd, J = 14.40, 7.18, 3.86 Hz, 1H), 2.32 
(t, J = 7.34 Hz, 2H), 1.71-1.62 (m, 2H), 1.61 (s, 3H), 1.51-1.41 (m, 4H), 1.22 (d, J = 1.00 Hz, 
1H), 1.20-1.18 (m, 4H), 0.93 (t, J = 7.91 Hz, 9H), 0.56 (dq, J = 1.63, 7.91 Hz, 6H). 
HRMS ESI: Calcd. for [C24H44O6Si + Na]: 479.2805; found: 479.2796. 
[ ]20Dα (CHCl3, c = 0.94) = -4.89°. 
Fraction II: 3-hydroxy-2,6-dimethyl-6-triethylsilanyloxy-decanedioic acid 1-allyl ester 
10-methyl ester 
O
O
CH3
OH
OSiEt3H3C
OCH3
O
C22H42O6Si
Mol. Wt.: 430,65  
1H-NMR (CDCl3, 400 MHz): δ5.92 (ddd, J = 22.96, 10.42, 5.77 Hz, 1H), 5.33 (ddd, 
J = 17.19, 3.01, 1.51 Hz, 1H), 5.25 (ddd, J = 10.42, 2.45, 1.19 Hz, 1H), 4.62 (dd, J = 1.95, 
1.07 Hz, 1H), 4.60 (dd, J = 2.20, 1.07 Hz, 1H), 3.85 (m, 1H), 3.66 (s, 3H), 2.68 (dd, J = 22.52, 
4.58 Hz, 1H), 2.56 (ddd, J = 14.40, 7.18, 3.86 Hz, 1H), 2.29 (t, J = 7.34 Hz, 2H), 1.71-1.61 
(m, 2H), 1.60 (s, 3H), 1.51-1.39 (m, 4H), 1.22-1.21 (d, J = 1.00 Hz, 1H), 1.20-1.18 (m, 4H), 
0.93 (t, J = 8.09 Hz, 9H), 0.56 (dq, J = 1.63, 7.88 Hz, 6H). 
HRMS ESI: Calcd. for [C22H42O6Si + Na]: 453.2648; found: 453.2657. 
[ ]20Dα (CHCl3, c = 0.67) = -5.37°. 
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(E)-Methyl-10-((R)-1-hydroxy-3-phenylpropan-2-ylamino)-5,9-dimethyl-10-oxo-5-
(triethylsilyloxy)dec-8-enoate (190) 
HO HN
O
CH3 OSiEt3H3C
OCH3
O
C28H47NO5Si
Mol. Wt.: 505,76  
The solution of the methyl ester 186 (51.8 mg, 0.094 mmol, 1 equiv) in Et2O (5 mL) was 
added to the slurry of potassium trimethylsilanolate (13.4 mg, 0.104 mmol, 1.11 equiv) in 
Et2O (8 mL) at rt. The reaction mixture was stirred for 20 h at rt. The progress was controlled 
by TLC. The reaction mixture was quenched by the addition of saturated aqueous NH4Cl 
solution (10 mL) followed by extraction with AcOEt (3×10 mL). Combined organic extract 
was dried over MgSO4 and concentrated. Purification by chromatography with hexane/AcOEt 
1:1 afforded 12 mg (25%) of 190. The product has an Rf = 0.3 in hexane/AcOEt 1:1 
(permanganate). 
1H-NMR (CDCl3, 400 MHz): δ7.40-7.15 (5H, Ar), 6.22 (t, J = 6.82 Hz, 1H), 5.92 (d, 
J = 6.84 Hz, 1H), 4.30-4.05 (m, 2H), 3.72 (m, 1H), 3.67 (s, 3H), 3.11 (br s, 1H), 3.00-2.80 (m, 
2H), 2.30 (t, J = 7.34 Hz, 2H), 2.20-2.05 (m, 2H), 1.77 (d, J = 0.67 Hz, 3H), 1.70-1.40 (m, 
6H), 1.19 (s, 3H), 0.94 (q, J = 8.02 Hz, 9H), 0.56 (t, J = 7.85 Hz, 6H). 
HRMS ESI: Calcd. for [C28H47NO5Si + Na]: 528.3121; found: 528.3110. 
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9-(1-Benzyl-2-hydroxy-ethylcarbamoyl)-8-hydroxy-5-methyl-5-triethylsilanyloxy-
decanoic acid (189) 
HO HN
O
CH3
OH
OSiEt3H3C
OH
O
C27H47NO6Si
Mol. Wt.: 509,75  
The solution of the methyl ester 186 (50 mg) in MeOH (5 mL) was added to Ba(OH)2·8H2O 
(1.60 g) and the resulting suspension was stirred at rt. According to the TLC the reaction was 
complete in 30 min. Reaction mixture was quenched by the addition of 2% aqueous HCl 
solution (10 mL) (acidic pH). The mixture was extracted with AcOEt (3×10 mL). Combined 
organic extract was washed with brine (15 mL), dried over MgSO4 and concentrated to afford 
189. The product has an Rf = 0.20-0.30 in hexane/AcOEt 1:1. 
HRMS ESI: Calcd. for [C27H47NO6Si + Na]: 532.3070; found: 532.3058. 
8-Hydroxy-9-(methoxy-methyl-carbamoyl)-5-methyl-5-triethylsilanyloxy-decanoic acid 
methyl ester (194) 
N
O
CH3
O
OH
O
H3C OSiEt3 OCH3
C21H43NO6Si
Mol. Wt.: 433,65  
The experiment was conducted according to a published procedure.50b,139 A stirred suspension 
of N,O-dimethyl hydroxylamine hydrochlorideee (445 mg, 4.56 mmol, 3.4 equiv) in THF 
(5 mL) was treated slowly with 2.0 M Me3Al in heptane (2.3 mL, 4.56 mmol, 3.4 equiv)ff at 0 
°C and the mixture was allowed to warm to 25 °C. The solution was stirred for 30 min before 
being cooled to 0 °C and treated slowly with the solution of the hydroxy imide 186 (737 mg, 
1.34 mmol) in THF (5 mL). The solution was allowed to warm to 25 °C and stirred for 2.5 h 
(time is important!). According to the TLC only a small amount of the starting material was 
left after 1 h and after 2.5 h the reaction was complete. 
The reaction mixture was added to saturated aqueous NH4Cl solution (10 mL) and 2% 
aqueous HCl solution (10 mL) while stirred at 0 °C. Resulting mixture was extracted with 
                                                 
ee) After the N,O-dimethyl hydroxylamine was transferred to the Schlenk flask it was stirred over 5 min under 
reduced pressure. Ca. 1 mL of toluene was added and removed under reduced pressure to dry the substance. 
ff) Fresh Me3Al of good quality should be used. 
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AcOEt (3×15 mL). Combined organic extract was dried over MgSO4 and concentrated to give 
the crude product. It was purified by flash chromatography on silica gel with hexane/AcOEt 
1:1 to afford 437 mg (75%) of 194 as a colorless oil after concentration. 
1H-NMR (CDCl3, 400 MHz): δ3.78 (m, 2H), 3.67 (s, 3H), 3.63 (s, 3H), 3.16 (s, 3H), 2.85 (br 
s, 1H), 2.26 (t, J = 7.3 Hz, 2H), 1.70-1.50 (m, 4H), 1.50-1.35 (m, 4H), 1.17 & 1.16 (2×s, 3H), 
1.14 (d, J = 6.8 Hz, 3H), 0.91 (2×t, J = 7.5 Hz, 9H), 0.53 (2×q, J = 7.8 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ178.24, 174.00 & 173.98, 75.08 & 75.07, 72.09 & 72.02, 
61.42, 51.35, 41.91, 41.29, 38.54 & 38.43, 38.28, 34.40 & 34.39, 28.47 & 28.39, 27.77 & 
27.42, 19.76 & 19.74, 10.17 & 10.12, 7.07, 6.77. 
HRMS ESI: Calcd. for [C21H43NO6Si + Na]: 456.2757; found: 456.2747. 
8-Hydroxy-9-(methoxy-methyl-carbamoyl)-5-methyl-5-triethylsilanyloxy-decanoic acid 
(195) 
N
O
CH3
O
OH
O
H3C OSiEt3 OH
C20H41NO6Si
Mol. Wt.: 419,63  
The experiment was conducted according to a described procedure.102 The solution of 
LiOH·H2O (18.3 mg, 0.43 mmol, 3.6 equiv) in H2O (1 mL) was added to the solution of the 
Winereb amide 194 (52 mg, 0.12 mmol) in THF/MeOH 1:1 (3 mL). The mixture was stirred 
for 3 h at rt while the progress of the reaction was monitored by TLC. 
The reaction mixture was diluted with brine (10 mL) and extracted with AcOEt (3×10 mL). 
Aqueous layer was acidified to pH 1-2 with 0.1 M aqueous NaHSO4 and extracted with 
AcOEt (2×10 mL). The combined organic extract was washed with brine (10 mL), dried over 
MgSO4 and concentrated, providing the crude product as a colorless oil. The crude product 
was purified by flash chromatography on a 18×120 mm silica gel column with CH2Cl2 → 
CH2Cl2-MeOH 10:1 to afford 43 mg (85%) of the seco-acid as a colorless oil. 
The product has an Rf = 0.31-0.28 in hexane/AcOEt 1:1, 0.52-0.47 in AcOEt, 0.50-0.45 in 
CH2Cl2/MeOH 10:1 and ca. 0 in pure CH2Cl2. The starting material has an Rf = 0.11-0.09 in 
hexane/AcOEt 1:1 and 0.22-0.18 in AcOEt. 
1H-NMR (CDCl3, 400 MHz): δ3.79 (m, 1H), 3.69 (s, 3H), 3.18 (s, 3H), 2.88 (br s, 1H), 2.31 
(t, J = 7.2 Hz, 2H), 1.70-1.50 (m, 4H), 1.50-1.35 (m, 4H), 1.19 & 1.18 (2×s, 3H), 1.16 (d, 
J = 7.2 Hz, 3H), 0.92 (2×t, J = 7.5 Hz, 9H), 0.55 (2×q, J = 7.8 Hz, 6H). 
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13C-NMR (CDCl3, 100 MHz): δ178.89 (Cq), 178.18 (Cq), 124.23 (CH), 75.11 (Cq), 72.22 & 
72.15 (CH), 61.48 (CH3), 41.82 & 41.19 (CH2), 38.42 & 38.26 (CH2), 34.38 (CH2), 31.87 
(CH3), 28.50 & 2843 (CH2), 27.82 & 27.47 (CH3), 19.55 & 19.53 (CH2), 10.28 & 10.22 
(CH3), 7.11 (CH3), 6.80 (CH2). 
HRMS ESI: Calcd. for [C20H41NO6Si + Na]: 442.2601; found: 442.2604. 
N-Methoxy-N-methyl-2-(5-methyl-9-oxo-5-triethylsilanyloxy-oxonan-2-yl)-propionamide 
(196) 
N
O
CH3
O
O
O
H3C
OSiEt3
C20H39NO5Si
Mol. Wt.: 401,61  
The cyclization was conducted according to a reported procedure.94 The solution of the seco-
acid 195 (169 mg, 0.403 mmol, 1 equiv) in THF (2 mL) was added at room temperature to a 
flask containing a solution prepared by dissolving Et3N (184 µL, 1.32 mmol, d = 0.728 g/mL, 
3 equiv) and 2,4,6-trichlorobenzoyl chloride (186 µL, 1.20 mmol, d = 1.561 g/mL, 3 equiv) in 
THF (10 mL). The resulting cloudy solutiongg was stirred at room temperature for 5 h and 
then dissolved in toluene (10 mL). This solution was added over 8.5 hhh via syringe pumpii to 
a solution of DMAP (296 mg, 2.42 mmol, 6 equiv) in toluene (400 mL) at reflux. The reaction 
mixture was stirred for additional 3.5 hjj, then cooled to room temperature, diluted with ethyl 
acetate (100 mL), washed with 0.1 M aqueous NaHSO4 (50 mL) and brine (50 mL), dried 
over MgSO4, filtered, and concentrated. Chromatographic purification with hexane/ethyl 
acetate 3:1 afforded a mixture of diastereomers as a yellow oil (163.8 mg, quant. yield, ca. 1:1 
by GC). 
1H-NMR (CDCl3, 400 MHz): δ5.09 (m, 1H), 3.69 & 3.68 (s, 3H), 3.17 (s, 3H), 3.05 (br s, 
1H), 2.32-2.15 (m, 2H), 2.0-1.20 (m, 8H), 1.17 & 1.16 (d, J = 6.8 Hz, 3H), 1.14 & 1.11 (s, 
3H), 0.91 & 0.88 (t, J = 8.0 Hz, 9H), 0.53 & 0.50 (q, J = 8.0 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ175.58 & 175.51 (Cq), 175.16 & 175.00 (Cq), 77.10 (CH), 
76.48, 76.40, 61.53 & 61.44 (CH3), 46.51 (CH2), 41.94 (CH2), 39.28 (CH), 37.37, 37.06, 
                                                 
gg) Precipitated Et3N·HCl was noticed in ca. 30 min after the addition of the reagents. 
hh) Time can be reduced to 5 h. 
ii) At a speed of 0.045 mL/min. 
jj) This time can be reduced to 30 min. 
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36.28 (CH2) & 36.23 (CH2), 34.75, 32.08 (CH), 29.59 (CH), 29.15 (CH3), 27.59, 26.92, 21.38 
(CH), 20.32 (CH2), 14.39 & 14.27 (CH3), 7.06 & 7.05 (CH3), 6.81 & 6.80 (CH2). 
HRMS ESI: Calcd. for [C20H39NO5Si + CH3CN + Na]: 465.2761; found: 465.2758. 
IR (cm-1, neat): 2951 (s), 2875 (m), 2362, 1736 (s), 1661 (s), 1459 (m), 1416, 1376, 1353, 
1285, 1246 (m),.1168, 1149, 1130, 1114, 1082, 1055, 1036, 993 (s), 917, 855, 742 (s).  
GC, Rt, min (intensity):15.015 (48%), 15.192 (50%). 
Reaction of the lactone 196 with LDA 
Preparation of 0.9 M LDA solution in hexanes/THF: 
Diisopropylamine (700 µL, 5 mmol, d = 0.722) was added to a flask containing 
2.5 M solution of n-BuLi (2 mL, 5 mmol) in hexanes in THF (3 mL) at -78 °C. Clear colorless 
solution was stirred for 10 min at -78 °C, warmed up to 0 °C and stirred 30 min at 0 °C. 
 
0.9 M LDA solution (550 µL, 0.5 mmol, 2.0 equiv) was added to the solution of the lactone 
196 (100 mg, 0.25 mmol) in THF (3 mL) at -78°C. After the reaction mixture was stirred for 
1.5 h at -78 °C (reaction control by TLC), it was quenched by the addition of aqueous 
0.1 M NaHSO4 solution (15 mL), warmed to rt and extracted with AcOEt (3×10 mL). 
Combined organic extract was washed with brine (10 mL), dried over MgSO4, filtered and 
concentrated. Chromatographic purification with hexane/AcOEt 1:1 on silica gel afforded four 
fractions: fraction I with Rf = 0.37-0.32, 13.3 mg (13%); fraction II with Rf = 0.26-0.32, 12.2 
mg; (approx. 12%) fraction III with Rf = 0.24-0.28, 12.8 mg (approx. 13%) and fraction IV 
with Rf = 0.18-0.24, 16.0 mg (17%). The column afterwards flushed with hexane/AcOEt 1:2 
to provide two additional fractions: fraction V with Rf = 0.17-0.22, 6.5 mg and fraction VI 
with Rf = 0.10-0.15, 2.5 mg. Fractions were investigated using spectroscopic methods and 
HRMS-ESI. Fraction I was characterized a diastereomer of 199; the structure of the substance 
constituting fraction II could not be identified, fraction III was identified as a mixture of the 
unidentified compound with 198 and fraction IV was characterized as a diastereomer of 198. 
4. Experimental Part 
 
145
N-Methyl-2-(5-methyl-9-oxo-5-triethylsilanyloxy-oxonan-2-yl)-propionamide (198) 
O
O
H3C
OSiEt3
CH3
N
H
O
H3C
C19H37NO4Si
Mol. Wt.: 371,59
(single diastereomer)  
1H-NMR (CDCl3, 400 MHz): δ5.74 (br s, 1H), 5.03 (m, 1H), 2.81 (d, J = 4.77 Hz, 3H), 2.37 
(dq, J = 7.00, 7.09 Hz, 1H), 2.32-2.20 (m, 2H), 1.94-1.81 (m, 1H), 1.79-1.54 (m, 5H), 1.47-
1.37 (m, 1H), 1.37-1.26 (m, 1H), 1.19 (d, J = 7.03 Hz, 3H), 1.16 (s, 3H), 0.90 (t, J = 7.84 Hz, 
9H), 0.52 (q, J = 7.82 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ175.88 (Cq), 173.74 (Cq), 77.09 (CH), 76.41 (Cq), 45.43 
(CH), 37.10 (CH2), 36.23 (CH2), 34.88 (CH2), 29.16 (CH3), 27.41 (CH2), 26.31 (CH3), 20.31 
(CH2), 14.24 (CH3), 7.09 (3×CH3), 6.83 (3×CH2). 
HRMS ESI: Calcd. for [C19H37NO4Si + CH3CN + Na]: 435.2655; found: 435.2662. 
IR (cm-1, neat): 3294 (br), 2951 (s), 2876 (m), 2361 (m), 1737 (s), 1645 (s), 1558 (s), 1457 
(m), 1413, 1374, 1349, 1284, 1241 (s), 1149 (s), 1128, 1114, 1055, 1003 (s), 978, 854, 743, 
722. 
N-Methoxymethyl-2-(5-methyl-9-oxo-5-triethylsilanyloxy-oxonan-2-yl)-propionamide 
(199) 
O
O
H3C
OSiEt3
CH3
N
H
O
O
H3C
C20H39NO5Si
Mol. Wt.: 401,61
(single diastereomer)  
1H-NMR (CDCl3, 400 MHz): δ6.35 (br s, 1H), 5.11 (m, 1H), 4.70 (d, J = 6.76 Hz, 2H), 3.33 
(s, 3H), 2.46 (dq, J = 6.96, 6.96 Hz, 1H), 2.26 (m, 2H), 2.0-1.85 (m, 2H), 1.70-1.40 (m, 4H), 
1.30-1.20 (m, 2H), 1.25 (d, J = 7.03 Hz, 3H), 1.14 (s, 3H), 0.93 (t, J = 7.84 Hz, 9H), 0.55 (q, 
J = 7.82 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ175.80 (Cq), 174.06 (Cq), 77.02 (CH), 76.76 (CH), 76.23 
(Cq), 71.30 (CH2), 56.05 (CH3), 45.58 (CH), 37.47 (CH2), 36.27 (CH2), 29.59 (CH3), 26.24 
(CH2), 21.69 (CH2), 13.95 (CH3), 7.12 (3×CH3), 6.83 (3×CH2). 
HRMS ESI: Calcd. for [C20H39NO5Si + Na]: 424.2495, for [C20H39NO5Si + CH3CN + Na]: 
465.2761; found: 424.2509, 465.2767. 
4. Experimental Part 
 
146
IR (cm-1, neat): 3307 (br), 2950 (s), 2876 (m), 1737 (s), 1661 (s), 1538 (s), 1456 (s), 1374, 
1354, 1283, 1227 (s), 1167 (m), 1129 (m), 1056 (s), 1000 (s), 915 (m), 740 (s), 722 (s). 
8-(4-Methoxy-benzyloxy)-9-(methoxy-methyl-carbamoyl)-5-methyl-5-triethylsilanyloxy-
decanoic acid methyl ester (202) 
N
O
O
CH3
O
OCH3
OSiEt3H3C O
OCH3
C29H51NO7Si
Mol. Wt.: 553,80  
The experiment was conducted according to a known procedure.140 
Ph3CBF4 (12 mol%, 5 mg) was added to the solution of the alcohol 194 (50 mg, 0.12 mmol, 
1 equiv) and 4-methoxybenzyl 2,2,2-trichloroacetimidate (102 mg, 0.36 mmol, 3.0 equiv) in 
CH2Cl2 (5 mL). The reaction mixture was stirred for 18 h at rt and the progress was monitored 
by TLC. 
When the reaction was complete, the reaction mixture was quenched by the addition of the 
saturated aqueous NaHCO3 solution (5 mL). The mixture was extracted with CH2Cl2 
(3×10 mL) and the combined organic extract was washed with brine (15 mL), dried over 
MgSO4 and concentrated. The crude product was purified by flash chromatography on silica 
gel with hexane/MTBE 2:1 affording 40 mg (63%) of 202 as a colorless oil. 
1H-NMR (CDCl3, 400 MHz): δ7.30-7.20 (d, J = 7.40 Hz, 2H), 6.90-6.80 (d, J = 8.68 Hz, 
2H), 4.47 (d, J = 10.79 Hz, 1H), 4.43 (d, J = 10.92 Hz, 1H), 3.77 (s, 3H), 3.64 (s, 3H), 3.63 (s, 
3H), 3.61-3.55 (br m, 1H), 3.14 (s, 3H), 3.11-3.00 (br m, 1H), 2.25 (t, J = 7.40 Hz, 2H), 1.64-
1.52 (m, 4H), 1.50-1.34 (m, 4H), 1.22 (d, J = 6.78 Hz, 3H), 1.14 & 1.12 (2×s, 3H), 0.90 (t, 
J = 7.84 Hz, 9H), 0.53 (q, J = 7.91 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ176.23 (Cq, weak), 174.01 (Cq), 159.13 (Cq, Ar), 130.70 
(Cq, Ar), 129.55 (CH, Ar), 129.54 (CH, Ar), 113.71 (2×CH, Ar), 80.63 & 80.62 (CH), 75.05 
& 75.02 (Cq), 72.28 & 72.22 (CH2), 61.36 (CH3), 55.22 (CH3), 51.37 (CH3), 41.98 & 41.39 
(CH2), 39.86 & 39.73 (CH, weak), 37.02 (CH2), 34.50 & 34.48 (CH2), 32.06 (CH3, weak), 
27.75 & 27.42 (CH3), 27.09 & 26.89 (CH2), 19.79 & 19.71 (CH2), 14.55 & 14.50 (CH3), 7.15 
(3×CH3), 6.84 (3×CH2). 
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HRMS ESI: Calcd. for [C29H51NO7Si]: 553.3435, for [C29H51NO7Si + CH3CN + Na]: 
617.3598; found: 617.3607. 
IR (cm-1, neat): 2953 (s), 2910 (s), 2875 (s), 2385 (w), 1738 (s), 1661 (s), 1613 (w), 1514 (s), 
1460 (m), 1377 (w), 1248 (s), 1173 (m), 1064 (m), 1037 (m), 1004 (m), 778 (s), 743 (s), 631 
(s). 
10-(4-Benzyl-2-oxo-oxazolidin-3-yl)-8-(4-methoxy-benzyloxy)-5,9-dimethyl-10-oxo-5-
triethylsilanyloxy-decanoic acid methyl ester (203) 
CH3
O
OCH3
OSiEt3H3C O
OCH3
O N
OO
C37H55NO8Si
Mol. Wt.: 669,92  
The experiment was conducted according to a known procedure.140 
Ph3CBF4 (12 mol%, 5 mg) was added to the solution of the alcohol 186 (73 mg, 0.13 mmol, 
1 equiv) and 4-methoxybenzyl 2,2,2-trichloroacetimidate (112 mg, 0.40 mmol, 3.0 equiv) in 
CH2Cl2 (5 mL) at rt. According to the TLC there was no starting material after the reaction 
mixture was stirred for 15 min at rt. 
The reaction mixture was quenched by the addition of saturated aqueous NaHCO3 solution 
(5 mL) and extracted with CH2Cl2 (3×10 mL). Combined organic extract was washed with 
brine (15 mL), dried over MgSO4 and concentrated. Chromatographic purification on silica 
gel with hexane/AcOEt 6:1 afforded 58 mg (67%) of 203 as a colorless oil. 
1H-NMR (CDCl3, 400 MHz): δ7.40-7.20 (m, 7H, Ar), 6.85 (d, J = 7.51 Hz, 2H), 4.57-4.38 
(m, 3H), 4.14-3.96 (m, 3H), 3.77 & 3.76 (s, 3H), 3.65 & 3.66 (s, 3H), 3.64-3.59 (m, 1H), 3.28 
(dd, J = 13.31, 3.07 Hz, 1H), 2.74 (dd, J = 12.80, 10.07 Hz, 1H), 2.29 (t, J = 7.34 Hz, 2H), 
1.67-1.54 (m, 6H), 1.45-1.39 (m, 2H), 1.27 & 1.26 (d, J = 6.83 Hz, 3H), 1.18 (s, 3H), 0.94 (t, 
J = 7.85 Hz, 9H), 0.56 (q, J = 7.97 Hz, 6H). 
13C-NMR (CDCl3, 100 MHz): δ175.14 & 175.10 (N-C=O), 174.05 & 174.03 (O-C=O), 
159.16 & 159.15 (Cq, Ar), 153.08 & 153.06 (N-(O-)C=O), 135.46 & 135.45 (Cq, Ar), 130.67 
& 130.65 (Cq, Ar), 129.67 & 129.66 (2×CH, Ar), 129.40 (2×CH, Ar), 128.89 (2×CH, Ar), 
127.26 (CH, Ar), 113.65 & 113.63 (2×CH, Ar), 79.91 & 79.69 (CH), 75.07 & 75.06 (Cq), 
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71.56 & 71.48 (CH2), 65.95 (CH2), 55.71 & 55.69 (CH), 55.22 & 55.22 (CH3), 51.38 (CH3), 
41.82 & 41.51 (CH2), 41.15 (CH), 37.88 & 37.77 (CH2), 37.70 (CH2), 34.48 & 34.46 (CH2), 
27.78 & 27.63 (CH3), 26.25 (CH2), 19.85 & 19.80 (CH2), 12.58 & 12.35 (CH3), 7.17 (3×CH3), 
6.90 & 6.89 (3×CH2). 
HRMS ESI: Calcd. for [C37H55NO8Si]: 669.3697, for [C37H55NO8Si + CH3CN + Na]: 
733.3860; found: 669.3690, 733.3858. 
IR (cm-1, neat): 2952 (s), 2910 (s), 2875 (s), 2359 (w), 1779 (s), 1733 (s), 1699 (s), 1612 (w), 
1512 (s), 1456 (m), 1376 (w), 1245 (s), 1209 (s), 1175 (s), 1033 (s), 1004 (m), 823 (s), 742 
(m), 720 (m), 703 (m), 655 (m). 
2-(5-Methyl-9-oxo-5-triethylsilanyloxy-oxonan-2-yl)-propionaldehyde (201) 
O
CH3
O
OSiEt3H3C
O
C18H34O4Si
Mol. Wt.: 342,55  
1.5 M solution of DIBAL in toluene (66 µL, 4 equiv, 0.10 mmol) was added to a stirred 
solution of the Weinreb amide 196 (10 mg, 0.025 mmol) in THF (1 mL) at -78 °C. After 
30 min at -78 °C the excess of DIBAL was quenched by the addition of acetone (3 mL). The 
mixture was quenched with 1.0 M aqueous solution of tartaric acid (10 mL) and extracted 
with MTBE (3×10 mL). Combined organic extract was dried over MgSO4, filtered and 
concentrated. The crude product was purified by flash chromatography with hexane/AcOEt 
10:1 to afford 1.1 mg (13%) of 201. The product has an Rf = 0.2-0.3 in hexane/AcOEt 10:1. 
1H-NMR (CDCl3, 400 MHz): δ9.74-9.70 (d, J = 1.36 Hz, 1H), 5.40-5.30 (m, 1H), 2.65-2.55 
(m, 1H), 2.35-2.20 (m, 2H), 2.10-1.30 (m, 8H), 1.17 (d, J = 6.8 Hz, 3H), 1.16 (s, 3H), 0.95-
0.85 (t, J = 7.84 Hz, 9H), 0.62-0.48 (q, J = 7.84 Hz, 6H). 
HRMS ESI: Calcd. for [C18H34O4Si]: 342.2226; found: 342.2218. 
 
5. Literature 
 
149
5 Literature 
 
                                                 
[1] Collie, J. N.; Myers, W. S. J. Chem. Soc. 1893, 63, 122. 
[2] Sankawa, U. In Comprehensive natural products chemistry, Barton, D.; Nakanishi, K.; 
Meth-Cohn, O., Eds.; Elsevier Science Ltd.: Oxford, 1999; Vol. 1: Polyketides and other 
secondary metabolites including fatty acids and their derivatives, Chapter 1, pp 1-23. 
[3] (a) Katz, L.; Donadio, S. Annu. Rev. Microbiol. 1993, 47, 875. (b) O’Hagan, D. O. Nat. 
Prod. Rep. 1992, 9, 447. (c) O’Hagan, D. O. Nat. Prod. Rep. 1993, 10, 593. (d) Hutchinson, 
C. R.; Fujii, I. Annu. Rev. Microbiol. 1995, 49, 201. (e) O’Hagan, D. The Polyketide 
Metabolites; Ellis Horwood: Chichester, U.K., 1991. (f) a recent review on polyketyde 
biosynthesis: (a) Staunton, J.; Wiessman, K. J. Nat. Prod. Rep. 2001, 18, 380. 
[4] Shen, B. Curr. Opin. Chem. Biol. 2003, 7, 285. 
[5] The erythromycin gene cluster: (a) Cortes, J.; Haydock, S. F.; Roberts, G. A.; Bevitt, D. J.; 
Leadlay, P. F. Nature 1990, 348, 176. (b) Donadio, S.; Staver, M. J.; McAlpine, J. B.; 
Swanson, S. J.; Katz, L. Science 1991, 252, 657. 
[6] (a) Malpartida, F.; Hopwood, D. A. Nature 1984, 309, 462. (b) Motamedi, H.; Hutchinson, 
C. R. Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 4445. 
[7] Funa, N.; Ohnishi, Y.; Fujii, I.; Shibuya, M.; Ebizuka, Y.; Horinouchi, S. Nature 1999, 
400, 897. 
[8] Xue, Q.; Ashley, G.; Hutchinson, C. R.; Santi, D. V. Proc. Natl. Acad. Sci. U. S. A. 1999, 
96, 11740. 
[9] (a) Firn, R. D.; Jones, C. G. Mol. Microbiol. 2000, 37, 989. (b) Plaga, W.; Stamm, I.; 
Schairer, H. U. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 11263. 
[10] Bethe, B. Dissertation, Universität Göttingen, 1994. 
[11] OSMAC: (a) Grond, S.; Papastavrou, I.; Zeeck, A. Eur. J. Org. Chem. 2002, 19, 3237. 
(b) Bode, H. B.; Bethe, B.; Hofs, R.; Zeeck, A. ChemBioChem 2002, 3, 6197. (c) Bode, H. B.; 
Walker, M.; Zeeck, A. Eur. J. Org. Chem. 2000, 8, 1451. (d) Schiewe, H. J.; Zeeck, A. J. 
Antibiot. 1999, 52, 635. (e) Fuchser, J.; Zeeck, A. Liebigs Ann. Chem. 1997, 87. 
[12] Höfs, R.; Walker, M.; Zeeck, A. Angew. Chem. 2000, 112, 3400; Angew. Chem., Int. Ed. 
2000, 39, 3258. 
[13] Höfs, R. Dissertation, University of Göttingen, 1999. 
[14] Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092. 
[15] Meyer, S. W., Dissertation, University of Göttingen, 2003. 
[16] (a) Jackson, M.; Karwowski, J. P.; Theriault, R. J.; Rasmussen, R. R.; Hensey, D. M.; 
Humphrey, P. E.; Swanson, S. J.; Barlow, G. J.; Premachandran, U.; McAlpine, J. B. J. 
Antibiot. 1995, 48, 462. (b) Hochlowski, J. E.; Mullally, M. M.; Henry, R.; Whittern, D. M.; 
McAlpine, J. B. J. Antibiot. 1995, 48, 467. 
[17] Tanaka, M.; Nara, F.; Yamasato, Y.; Masuda-Inoue, S.; Doi-Yoshioka, H.; Kumakura, 
S.; Enokita, R.; Ogita, T. J. Antibiot. 1999, 52, 670. 
5. Literature 
 
150
                                                                                                                                                         
[18] Munakata, R.; Katakai, H.; Ueki, T.; Kurosaka, J.; Takao, K. and Tadano, K. J. Am. 
Chem. Soc. 2004, 126, 11254. 
[19] (a) Shindo, K.; Kawai, H. J. Antibiot. 1992, 45, 294. (b) Shindo, K.; Sakakibara, M.; 
Kawai, H.; Seto, H. J. Antibiot. 1996, 49, 249. 
[20] (a) Shindo, K.; Matsuoka, M.; Kawai, H. J. Antibiot. 1996, 49, 241. (b) Shindo, K.; 
Iijima, H.; Kawai, H. J. Antibiot. 1996, 49, 244. 
[21] Dineen, T. A.; Roush, W. R. Org. Lett. 2004, 6, 2043. 
[22] Miao, S.; Anstee, M. R.; Baichwal, V.; Park, A. Tetrahedron Lett. 1995, 36, 5699. 
[23] (a) Muramatsu, H.; Miyauchi, M.; Sato, B.; Yoshimura, S. 40th Symposium on the 
Chemistry of Natural Products, Fukuoka, Japan, 1998, pp 487-492. (b) Sato, B.; Muramatsu, 
H.; Miyauchi, M.; Hori, Y.; Takase, S.; Hino, M.; Hashimoto, S.; Terano, H. J. Antibiot. 
2000, 53, 123. (c) Sato, B.; Nakajima, H.; Hori, Y.; Hino, M.; Hashimoto, S.; Terano, H. J. 
Antibiot. 2000, 53, 204. (d) Yoshimura, S.; Sato, B.; Kinoshita, T.; Takase, S.; Terano, H. J. 
Antibiot. 2000, 53, 615. 
[24] (a) Edler, M. C.; Buey, R. M.; Gussio, R.; Marcus, A. I.; Vanderwal, C. D.; Sorensen, E. 
J.; Díaz J. F.; Giannakakou, P. and Hamel, E. Biochemistry 2005, 44, 11525. (b) Edler, M. C.; 
Buey, R. M.; Gussio, R.; Marcus, A. I.; Vanderwal, C. D.; Sorensen, E. J.; Díaz J. F.; 
Giannakakou, P. and Hamel, E. Biochemistry 2006, 45, 5932 (Addition/Correction). (c) 
Adam, G. C.; Vanderwal, C. D.; Sorensen, E. J.; Cravatt, B. F. Angew. Chem., Int. Ed. 2003, 
42, 5480. 
[25] Desai, A.; Mitchison, T. J. Annu. Rev. Cell Dev. Biol. 1997, 13, 83. 
[26] (a) Jordan, M. A.; Toso, R. J.; Thrower, D.; Wilson, L. Proc. Natl. Acad. Sci. U. S. A. 
1993, 90, 9552. (b) Trielli, M. O.; Andreassen, P. R.; Lacroix, F. B.; Margolis, R. L. J. Cell 
Biol. 1996, 135, 689. (c) Wahl, A. F.; Donaldson, K. L.; Fairchild, C. Lee, F. Y. F.; Foster, S. 
A.; Demers, G. W.; Galloway, D. A. Nat. Med. 1996, 2, 72. 
[27] Höfle, G.; Bedorf, N.; Steinmetz, H.; Schomburg, D.; Gerth, K.; Reichenbach, H. Angew. 
Chem., Int. Ed. 1996, 35, 1567. 
[28] (a) Gunasekera, S. P.; Gunasekera, M.; Longley, R. E. J. Org. Chem. 1990, 55, 4912. (b) 
Gunasekera, S. P.; Gunasekera, M.; Longley, R. E. J. Org.Chem. 1991, 56, 1346 
(Addition/Correction). 
[29] Lindel, T.; Jensen, P. R.; Fenical, W.; Long, B. H.; Casazza, A. M.; Carboni, J.; 
Fairchild, C. R. J. Am. Chem. Soc. 1997, 119, 8744. 
[30] Bai, R. L.; Pettit, G. R.; Hamel, E. J. Biol. Chem. 1990, 265, 17141. 
[31] Smith, C. D.; Zhang, X. J. Biol. Chem. 1996, 271, 6192. 
[32] Leoni, L. M.; Hamel, E.; Genini, D.; Shih, H.; Carrera, C. J.; Cottam, H. B.; 
Carson, D. A. J. Natl. Cancer Inst. 2000, 92, 217. 
[33] Towle, M. J.; Salvato, K. A.; Budrow, J.; Wels, B. F.; Kuznetsov, G.; Aalfs, K. K.; 
Welsh, S.; Zheng, W.; Seletsky, B. M.; Palme, M. H.; Habgood, G. J.; Singer, L. A.; DiPietro, 
L. V.; Wang, Y.; Chen, J. J.; Quincy, D. A.; Davis, A.; Yoshimatsu, K.; Kishi, Y.; Yu, M. J.; 
Littlefield, B. A. Cancer Res. 2001, 61, 1013. 
[34] Hood, K. A.; West, L. M.; Rouwé, B.; Northcote, P. T.; Berridge, M. V.; Wakefield, St. 
J.; Miller, J. H. Cancer Res. 2002, 62, 3356. 
5. Literature 
 
151
                                                                                                                                                         
[35] Corley, D. G.; Herb, R.; Moore, R. E.; Scheuer, P. J.; Paul, V. J. J. Org. Chem. 1988, 53, 
3644. 
[36] Himes, R. H.; Kersey, R. N.; Heler-Bettinger, I.; Samson, F. E. Cancer Res. 1976, 36, 
3798. 
[37] Belotti, D.; Vergani, V.; Drudis, T.; Borsotti, P.; Pitelli, M. R.; Viale, G.; Giavazzi, R.; 
Taraboletti, G. Clin. Cancer Res. 1996, 2, 1843. (b) Vacca, A.; Iurlaro, M.; Ribatti, D.; 
Minischetti, M.; Nico, B.; Ria, R.; Pellegrino, A.; Dammacco, F. Blood 1999, 94, 4143. 
[38] Nicolaou, K. C.; Dai, W.-M.; Guy, R. K. Angew. Chem., Int. Ed. 1994, 33, 15. (b) 
Kingston, D. G. I. Chem. Commun. 2001, 867. 
[39] (a) Mühlradt, P. F.; Sasse, F. Cancer Res. 1997, 57, 3344. (b) Goodin, S.; Kane, M. P.; 
Rubin, E. H. J. Clin. Oncol. 2004, 22, 2015. 
[40] Yoshimura, S.; Sato, B.; Takase, S.; Terano, H. J. Antibiot. 2004, 57, 429. 
[41] Reviews on the biosynthesis of Diels-Alder-type natural products: (a) Ichihara, A.; 
Oikawa, H. Curr. Org. Chem. 1998, 2, 365. (b) Ichihara, A.; Oikawa, H. In Comprehensive 
Natural Products Chemistry; Sankawa, U.; Ed.; Barton, D. H. R.; Nakanishi, K.; Meth-Cohn, 
O.; Series Eds.; Elsevier: Oxford, 1999; Vol. 1, pp 367-408. (c) Williams, R. M.; Stocking, E. 
M. Angew. Chem., Int. Ed. 2003, 42, 3078. 
[42] Oikawa, H.; Kobayashi, T.; Katayama, K.; Suzuki, Y.; Ichihara, A. J. Org. Chem. 1998, 
63, 8748. 
[43] Auclair, K.; Sutherland, A.; Kennedy, J.; Witter, D. J.; Vanden Heever, J. P.; Hutchinson, 
C. R.; Vederas, J. C. J. Am. Chem. Soc. 2000, 122, 11519. 
[44] Watanabe, K.; Mie, T.; Ichihara, A.; Oikawa, H.; Honma, M. J. Biol. Chem. 2000, 275, 
38393. 
[45] Oikawa, H. Bull. Chem. Soc. Jpn. 2005, 78, 537. 
[46] (a) Wilson E. Chem. Eng. News 2005, 83, 38. (b) Guimaraes, C. R. W.; Udier-Blagovic, 
M.; Jørgensen, W. L. J. Am. Chem. Soc. 2005, 127, 3577. 
[47] Ose, T.; Watanabe, K.; Mie, T.; Honma, M.; Watanabe, H.; Yao, M.; Oikawa, H.; 
Tanaka, I. Nature 2003, 422, 185. 
[48] (a) Amontov, S.; Jaschke A. Nucleic Acids Res. 2006, 34, 5032. (b) Helm, M.; 
Petermeier, M.; Ge, B.; Fiammengo, R.; Jaschke, A. J. Am. Chem. Soc. 2005, 127, 10492. 
[49] Yoshimura, S.; Sato, B.; Kinoshita, T.; Takase, S.; Terano, H. J. Antibiot. 2002, 55, C1. 
[50] (a) Vanderwal, C. D.; Vosburg, D. A.; Weiler, S.; Sorensen, E. J. Org. Lett. 1999, 1, 645. 
(b) Vanderwal, C. D.; Vosburg, D. A.; Sorensen, E. J. Org. Lett. 2001, 3, 4307. 
[51] Vosburg, D. A.; Vanderwal, C. D.; Sorensen, E. J. J. Am. Chem. Soc. 2002, 124, 4552. 
[52] (a) Vanderwal, C. D.; Vosburg, D. A.; Weiler, S.; Sorensen, E. J. J. Am. Chem. Soc. 
2003, 125, 5393. (b) Sorensen, E. J. Bioorgan. Med. Chem. 2003, 11, 3225. 
[53] (a) Evans, D. A.; Starr, J. T. Angew. Chem., Int. Ed. 2002, 41, 1787. (b) Evans, D. A.; 
Starr, J. T. J. Am. Chem. Soc. 2003, 125, 13531. 
[54] (a) Clarke, P. A.; Cridland, A. P. Org. Lett. 2005, 7, 4221. (b) Clarke, P. A.; Davie, R. L.; 
Peace, S. Tetrahedron 2005, 61, 2335. 
5. Literature 
 
152
                                                                                                                                                         
[55] (a) Funel, J. A.; Prunet, J. J. Org. Chem. 2004, 69, 4555. (b) Funel, J. A.; Prunet, J. J. 
Org. Chem. 2004, 69, 5516 (Correction/Addition). (c) Toueg, J.; Prunet, J. Synlett 2006, 17, 
2807. 
[56] Funel, J. A.; Ricard, L.; Prunet, J. Chem. Commun. 2005, 38, 4833. 
[57] (a) Suzuki, T.; Tanaka, N; Matsumura, T.; Hosoya, Y.; Nakada, M. Tetrahedron Lett. 
2006, 47, 1593. (b) Suzuki, T.; Nakada, M. Tetrahedron Lett. 2002, 43, 3263. 
[58] Methot, J. L.; Roush, W. R. Org. Lett. 2003, 5, 4223. 
[59] (a) Clarke, P. A.; Grist, M.; Ebden, M.; Wilson, C. Chem. Commun. 2003, 1560. (b) 
Clarke, P. A.; Grist, M.; Ebden, M. Tetrahedron Lett. 2004, 45, 927. (c) Clarke, P. A.; Grist, 
M.; Ebden, M.; Wilson, C. and Blake, A. J. Tetrahedron 2005, 61, 353. (d) Clarke, P. A.; 
Black, R. J. G.; Blake, A. J. Tetrahedron Lett. 2006, 47, 1453. 
[60] (a) Trost, B. M.; Verhoeven, T. R. J. Am. Chem. Soc. 1979, 101, 1595. (b) Trost, B. M.; 
Verhoeven, T. R. J. Am. Chem. Soc. 1980, 102, 4743. (c) Trost, B. M.; Runge, T. A. J. Am. 
Chem. Soc. 1981, 103, 7550. 
[61] Armstrong, A.; Goldberg, F. W.; Sandham, D. A. Tetrahedron Lett. 2001, 42, 4585. 
[62] Macrocyclizations through Knoevenagel condensation are quite rare, and may only be 
limited to the formation of oligomers. For example, see: Zhang, Y.; Wada, T.; Sasabe, H. 
Chem. Commun. 1996, 621. 
[63] (a) Reich, H. J.; Reich, I. L.; Renga, J. M. J. Am. Chem. Soc. 1973, 95, 5813. (b) 
Sharpless, K. B.; Lauer, R. F. J. Am. Chem. Soc. 1973, 95, 2697. 
[64] Reviews: (a) Trost, B. M. Angew. Chem. 1989, 101, 1199; Angew. Chem., Int. Ed. 1989, 
28, 1173. (b) Tsuji, J. Palladium Reagents and Catalysts, John Wiley & Sons: Chichester, 
1995, pp 290-422. For an example of a macrolactonization using this reaction, see: (c) Trost, 
B. M.; Brickner, S. J. J. Am. Chem. Soc. 1983, 105, 568. 
[65] A review: Farina, V.; Krishnamurthy, V.; Scott, W. J. In Organic Reactions; Paquette, L. 
A., Ed.; John Wiley & Sons: New York: 1997; Vol. 50, Chapter 1, pp 1-652. 
[66] Evans, D. A.; Kaldor, S. W.; Jones, T. K.; Clardy, J.; Stout, T. J. J. Am. Chem. Soc. 1990, 
112, 7001. 
[67] (a) Holmquist, C. R.; Roskamp, E. J. Tetrahedron Lett. 1990, 31, 4991. (b) Holmquist, C. 
R.; Roskamp, E. J. Tetrahedron Lett. 1992, 33, 1131. 
[68] Gray, M.; Andrews, I. P.; Hook, D. F.; Kitteringham, J.; Voyle, M. Tetrahedron Lett. 
2000, 41, 6237. 
[69] (a) Stellfeld, T.; Bhatt, U.; Kalesse, M. Org. Lett. 2004, 6, 3889. (b) Stelmakh, A.; 
Stellfeld, T.; Kalesse, M. Org. Lett. 2006, 8, 3485. 
[70] Stellfeld, T., Dissertation, Freie Universität Berlin 2004. 
[71] James, P.; Landais, Y. Org. Lett. 2004, 6, 325. 
[72] James, P.; Felpin, F.-X.; Landais, Y.; Schenk, K. J. Org. Chem. 2005, 70, 7985. 
[73] (a) Stork, G.; Burgstahler, A. J. Am. Chem. Soc. 1951, 73, 3544. (b) Saha, N. N.; Bagchi, 
P. N. and Dutta, P. C. J. Amer. Chem. Soc. 1955, 77, 3408. (c) Ziegler, F. E.; Kloeck, J. A. 
Tetrahedron 1977, 33, 373. 
5. Literature 
 
153
                                                                                                                                                         
[74] (a) Andersen, N. H.; Uh, H. -S.; Smith, S. E. and Wuts, P. G. M. Chem. Commun. 1972, 
956. (b) Andersen, N. H.; Uh, H.-S. Tetrahedron Lett. 1973, 2079. 
[75] This reagent is very nearly that recommended by Edwards B. E. and Rao P. N. for the 
conversion of cyclic ketones to enol acetates: Edwards, B. E.; Rao, P. N. J. Org. Chem. 1960, 
31, 324. 
[76] Cooper, J. L.; Harding, K. E. Tetrahedron Lett. 1977, 3321. 
[77] Wightam, R., Research Report to W. S. Johnson, Stanford University, 1965. 
[78] Dastur, K. P. J. Am. Chem. Soc. 1974, 96, 2605. 
[79] Snider, B. B.; Rodini, D. J.; Straten, J. J. Am. Chem. Soc. 1980, 102, 5872. 
[80] Takakis, I. M.; Tsantali G. G. J. Org. Chem. 2003, 68, 6455. 
[81] (a) Horiguchi, Y.; Matsuzawa, S.; Nakamura, E., Kuwajima, I. Tetrahedron Lett. 1986, 
27, 4025. (b) Nakamura, E., Matsuzawa, S.; Horiguchi, Y.; Kuwajima, I. Tetrahedron Lett. 
1986, 27, 4029. 
[82] (a) Büchi, G., Wuest, H. J. Org. Chem. 1969, 34, 1122. (b) Mithran, S.; Subbaraman, A. 
S. Molecules 1999, 4, 159. 
[83] Hsung, R. P. Synth. Commun. 1990, 20, 1175. 
[84] (a) Sworin, M.; Neumann, W. L. Tetrahedron Lett. 1987, 28, 3217. (b) Helquist, P.; Bal, 
S.; Marfat, A. J. Org. Chem. 1982, 47, 5045. (c) Galemmo, R. A.; Paquette, L. A. J. Org. 
Chem. 1985, 50, 1768. 
[85] Steryzcki, R. Synthesis 1979, 724. 
[86] Ihara, M. J. Am. Chem. Soc. 1993, 115, 8107. 
[87] Examples for the diastereoselective Grignard reaction of similar methyl ketones are 
known: (a) Toda, N.; Ori, M.; Takami, K.; Tago, K.; and Kogen, H. Org. Lett. 2003, 5, 269. 
(b) Matsuya, Y.; Masuda, S.; Itoh, T.; Murai, T; Nemoto, H. J. Org. Chem. 2005, 70, 6898 
and references cited there. 
[88] (a) Macromodel, ver. 8.1; Schrodinger, Inc., 1500 SW First Ave. Suite 1180, Portland 
OR 97201. (b) Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R.; Lipton, M.; 
Caufield C.; Chang, G.; Hendrickson, T.; Still, W. C. J. Comput. Chem. 1990, 11, 440. 
[89] (a) Chang, G.; Guida, W. C.; Still, W. C. J. Am. Chem. Soc 1989, 111, 4379. (b) 
Saunders, M.; Houk, K. N.; Wu, Y. D.; Still, W. C.; Lipton, M.; Chang, G.; Guida, W. C. J. 
Am. Chem. Soc. 1990, 112, 1419. 
[90] (a) Halgren, T. A. J. Comput. Chem. 1996, 17, 490. (b) Halgren, T. A. J. Comput. Chem. 
1996, 17, 520. (c) Halgren, T. A. J. Comput. Chem. 1996, 17, 553. (d) Halgren, T. A. J. 
Comput. Chem. 1996, 17, 587. (e) Halgren, T. A.; Nachbar R. J. Comput. Chem. 1996, 17, 
616. (f) Halgren, T. A. J. Comput. Chem. 1999, 20, 720. (g) Halgren, T. A. J. Comput. Chem. 
1999, 20, 730. 
[91] (a) Mitsunobu, O.; Wada, M.; Sano, T. J. Am. Chem. Soc. 1972, 94, 679; Reviews: (b) 
Hughes, D. L. Org. Reactions 1992, 42, 335. (c) Hughes, D. L. Org. Prep. Proced. Int. 1996, 
28, 127. (d) Mitsunobu, O. Synthesis 1981, 1. 
[92] (a) Gao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune, H.; Sharpless, K. B. J. 
Am. Chem. Soc. 1987, 109, 5765. (b) Johnson, R. A.; Sharpless, K. B. In Catalytic 
Asymmetric Synthesis, Ojima, I., Ed.; VCH: New York, 1993; pp 103-158. 
5. Literature 
 
154
                                                                                                                                                         
[93] Imamoto, T.; Takiyama, N.; Nakamura, K.; Hatajima, T.; Kamiya, Y. J. Am. Chem. Soc. 
1989, 111, 4392. 
[94] Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn. 
1979, 52, 1989. 
[95] Review on chemistry of N-methoxy-N-methylamides and their application in synthesis: 
Sibi, M. P. Org. Prep. Proced. Int. 1993, 25, 15. 
[96] (a) Turner, J. A.; Jacks, W. A. J. Org. Chem. 1989, 54, 4229. (b) Jones, Jr., W. D.; 
Schnettler, R. A.; Huber, E. W. J. Heterocyclic Chem. 1990, 27, 511. 
[97] (a) Oster, T. A.; Harris, T. M. Tetrahedorn Lett. 1983, 24, 1851. (b) Jouin, P.; Poncet, J.; 
Dufour, M.-N.; Maugras, I.; Pantaloni, A.; Castro, B. Tetrahedorn Lett. 1988, 29, 2661. (c) 
DiMaio, J.; Gibbs, B.; Lefebvre, J.; Konishi, Y.; Munn, D.; Yue, S. Y. J. Med. Chem. 1992, 
35, 3331. 
[98] Sibi, M. P.; Christensen, J. W.; Kim, S.-G.; Eggen, M.-J.; Stessman, C.; Oien, L. 
Tetrahedron Lett. 1995, 36, 6209. 
[99] Evans, D. A.; Gage, J. R.; Leighton, J. L. J. Am. Chem. Soc. 1992, 114, 9434. 
[100] Otera, J. Chem. Rev. 1993, 93, 1449. 
[101] (a) Steliou, K.; Szczygielska-Nowosielska, A.; Favre, A.; Poupart, M. A.; Hanessian, S. 
J. Am. Chem. Soc. 1980, 102, 7579. (b) Steliou, K.; Poupart, M. A. J. Am. Chem. Soc. 1983, 
105, 7130. 
[102] Smith, A. B.; Chen, S. S.-Y.; Nelson, F. C.; Reichert, J. M.; Salvatore, B. A. J. Am. 
Chem. Soc. 1997, 119, 10935, on p. 10944. 
[103] (a) Graham, S. L.; Scholz, T. H.; Tetrahedron Lett. 1990, 31, 6269. (b) Graham, S. L.; 
Scholz, T. H. J. Org. Chem. 1991, 56, 4260. 
[104] (a) Lubell, W. D.; Jamison, T. F.; Rapoport, H. J. Org. Chem. 1990, 55, 3511. (b) 
Romo, D.; Johnson, D. D.; Plamondon, L.; Miwa, T.; Schreiber, S. L. J. Org. Chem. 1992, 57, 
5060. 
[105] Vul’fson, N. S.; Zaretskii, V. I. J. Gen. Chem. USSR 1959, 29, 2704. 
[106] (a) Waizumi, N.; Itoh, T.; Fukuyama, T. J. Am. Chem. Soc. 2000, 122, 7825. (b) 
Paquette, L. A.; Geng, F. J. Am. Chem. Soc. 2002, 124, 9199. 
[107] Santaniello, E.; Manzocchi, A. Synthesis 1977, 698. 
[108] Burkhardt, E.; Rieke, R. D. J. Org. Chem. 1985, 50, 416. 
[109] Inaba, S.-I.; Rieke, R. D. Tetrahedron Lett. 1985, 26, 155. 
[110] Orsini, F. J. Org. Chem. 1997, 62, 1159. 
[111] Imamoto, T.; Kusumoto, T.; Tawarayama, Y.; Sugiura, Y.; Mita, T.; Hatanaka, Y.; 
Yokoyama, M. J. Org. Chem. 1984, 49, 3904. 
[112] Kakiya, H.; Nishimae, S.; Shinokubo, H.; Oshima, K. Tetrahedron 2001, 57, 8807. 
[113] (a) Moriwake, T. J. Org. Chem. 1966, 31, 983. (b) Borno, A.; Bigley, D. B. J. Chem. 
Soc., Perkin Trans. 2 1983, 1311. 
[114] Kagoshima, H.; Hashimoto, Y.; Oguro, D.; Saigo, K. J. Org. Chem. 1998, 63, 691. 
[115] Shibata, I.; Suwa, T.; Sakakibara, H.; Baba, A. Org. Lett. 2002, 4, 301. 
5. Literature 
 
155
                                                                                                                                                         
[116] (a) Cintas, P. Synlett 1995, 1087. (b) Podlech, J.; Maier, T. C. Synthesis 2003, 633. (c) 
Nair, V.; Ros, S.; Jayan, C. N.; Pillai, B. S. Tetrahedron 2004, 60, 1959. (d) Araki, S.; 
Hirashita, T. Main Group Metals Org. Synth. 2004, 1, 323. (e) Chan, T. H.; Li, C.-J.; Lee, M. 
C.; Wei, Z. Y. Can. J. Chem. 1994, 72, 1181. (f) Loh, T.-P. Sci. Synth. 2004, 7, 413. (g) Babu, 
S. A.; Yasuda, M.; Shibata, I. and Baba, A. J. Org. Chem. 2005, 70, 10408. 
[117] Wessjohann, L.; Gabriel, T. J. Org. Chem. 1997, 62, 3772. 
[118] Parrish, J. D.; Shelton, D. R.; Little, R. D. Org. Lett. 2003, 5, 3615. 
[119] Kagayama, A.; Igarashi, K.; Shiina, I.; Mukaiyama, T. Bull. Chem. Soc. Jpn. 2000, 73, 
2579. 
[120] Fukuzawa, S.; Matsuzawa, H.; Yoshimitsu, S. J. Org. Chem. 2000, 65, 1702. 
[121] Molander, G. A.; Etter, J. B.; Harring, L. S. and Thorel, P.-J. J. Am. Chem. Soc. 1991, 
113, 8036. 
[122] Sato, T.; Kawara, T.; Sakata, K.; Fujisawa, T. Bull. Chem. Soc. Jpn. 1981, 54, 505. 
[123] Appendino, G.; Cravotto, G.; Nano, G. M. Synth. Commun. 1992, 22, 2205. 
[124] Steric compression results in a shielding effect for cis substituents: Trost, B. M.; 
Verhoeven, T. R. J. Am. Chem. Soc. 1980, 102, 4730. 
[125] Gage, J. R.; Evans, D. A. Org. Synth. 1993, Coll. Vol. 8, 339; Org. Synth. 1990, 68, 83. 
[126] Chong, R.; Clezy, P. S. Aust. J. Chem. 1967, 20, 123. 
[127] Jeong, J. U.; Guo, C.; Fuchs, P. L. J. Am. Chem. Soc. 1999, 121, 2083. 
[128] Aoyagi, S.; Wang, T. C.; Kibayashi, C. J. Am. Chem. Soc. 1993, 115, 11404, 
preparation of compounds 53 and 29. 
[129] Mickel, S. J.; Sedelmeier, G. H.; Niederer, D.; Daeffler, R.; Osmani, A.; Schreiner, K.; 
Seeger-Weibel, M.; Berod, B.; Schaer, K.; Gamboni, R. Org. Process Res. Dev. 2004, 8, 92, 
preparation of compound 8. 
[130] Kutney, J. P.; Abduraham, N.; Gletsos, C.; LeQuesne, P.; Piers, E. and Vlattas, I. J. Am. 
Chem. Soc. 1970, 92, 1727. 
[131] Smith, L.; Spring, J. J. Am. Chem. Soc. 1943, 65, 1271. 
[132] Heathcock, C. H.; Kleinman, E. F.; Binkley, E. S. J. Am. Chem. Soc. 1982, 104, 1064. 
[133] Fugie, Y. Yakugaku Zasshi 1961, 81, 693. 
[134] Shu, C.; Alcudia, A.; Yin, J.; Liebeskind, L. S. J. Am. Chem. Soc. 2001, 123, 12485, 
reference 28. 
[135] (a) Raney Ni W2 was prepared according to the procedure of Mozingo, R. Org. Synth. 
1955, Coll. Vol. 3, 181. (b) Pavlic, A. A.; Adkins, H. J. Am. Chem. Soc. 1946, 68, 1471. 
[136] Estieu, K.; Paugam, R.; Olliver, J.; Salaün, J.; Cordero, F. M.; Goti, A.; Brandi, A. J. 
Org. Chem. 1997, 62, 8276, preparation procedure for compound 6b in the supporting 
information. 
[137] Li, Z.-H.; Bulychev, A.; Kotra, L. P.; Massova, I.; Mobashery, S. J. Am. Chem. Soc. 
1998, 120, 13003, preparation procedure for compound 13a. 
[138] Seebach, D.; Thaler, A.; Blaser, D.; Ko, S. Y. Helv. Chim. Acta. 1991, 74, 1102. 
5. Literature 
 
156
                                                                                                                                                         
[139] Schnermann, M. J.; Boger, D. L. J. Am. Chem. Soc. 2005, 127, 15704, preparation 
procedure for compound S3, page 6. 
[140] Reddy, K. K.; Saady, M.; Falck, J. R.; Whited, G. J. Org. Chem. 1995, 60, 3385. 
 157 
3
.
9
2
0
4
1
.
9
9
8
2
2
.
0
2
4
8
3
.
0
0
0
0
I
n
t
e
g
r
a
l
7
.
2
6
0
0
3
.
9
4
9
4
3
.
9
3
6
8
3
.
4
5
4
1
3
.
4
1
5
2
3
.
3
7
1
3
2
.
3
0
3
5
2
.
2
6
0
9
2
.
2
2
0
7
1
.
3
2
9
1
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
O
O CH3
Br
200 MHz, CDCl3
127
 158 
0
.
9
9
7
6
0
.
1
0
0
7
4
.
1
2
4
9
0
.
8
3
5
7
1
.
0
6
4
2
1
.
1
9
1
7
1
4
.
3
9
7
3
.
6
2
6
9
0
.
9
3
9
1
8
.
6
5
9
5
I
n
t
e
g
r
a
l
7
.
1
6
0
0
6
.
1
8
5
7
5
.
5
8
8
5
3
.
5
6
6
6
3
.
5
4
2
8
2
.
5
1
3
0
2
.
2
0
2
5
1
.
9
5
7
7
1
.
9
4
7
4
1
.
6
0
2
8
1
.
3
3
0
6
1
.
2
9
9
9
0
.
1
4
5
6
0
.
1
1
0
6
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.0
 
(H3C)3SiO
O
OH3C
128
400 MHz, CDCl3
 159 
1
3
1
.
9
3
1
3
1
2
8
.
7
0
0
0
1
2
5
.
0
3
2
4
1
1
1
.
0
2
1
1
6
5
.
3
5
2
0
6
5
.
3
4
0
6
4
0
.
3
4
9
3
3
8
.
6
6
3
1
3
4
.
9
2
5
0
2
8
.
4
8
7
1
2
7
.
1
3
0
6
2
4
.
8
4
0
5
2
4
.
2
6
8
9
2
3
.
7
6
7
8
0
.
1
6
7
3
(ppm)
0102030405060708090100110120130140
 
(H3C)3SiO
O
OH3C
128
100 MHz, CDCl3
 160 
0
.
1
2
2
0
0
.
8
6
9
0
4
.
2
8
4
1
2
1
.
1
9
3
9
.
8
1
5
7
9
.
8
1
0
0
9
.
5
6
7
4
9
.
5
4
8
0
7
.
2
6
0
0
3
.
9
1
5
5
2
.
0
4
3
9
1
.
7
6
3
0
1
.
7
3
7
9
1
.
7
2
0
4
1
.
7
0
3
4
1
.
5
9
4
3
1
.
2
8
1
5
(ppm)
0.01.02.03.04.05.06.07.08.09.0
 
200 MHz, CDCl3
CHO
O
OH3C
trans-129 (cis : trans  1 : 7,1)
 161 
0
.
0
9
7
6
0
.
8
4
7
0
0
.
9
4
5
9
4
.
0
0
0
0
3
.
1
5
7
3
1
.
8
4
6
0
7
.
0
4
6
8
7
.
9
4
8
6
1
.
0
5
4
9
1
.
1
8
5
1
7
.
1
3
6
1
7
.
1
2
2
4
7
.
1
0
4
7
6
.
8
2
4
6
6
.
8
0
5
7
6
.
7
9
3
4
6
.
7
7
4
4
5
.
8
3
1
7
5
.
7
9
2
3
5
.
7
6
1
1
3
.
8
9
2
8
3
.
8
7
5
3
3
.
7
1
3
4
3
.
7
0
6
2
1
.
8
7
5
4
1
.
8
6
8
3
1
.
7
9
3
1
1
.
7
2
0
1
1
.
6
0
9
5
1
.
5
1
7
6
1
.
4
3
6
3
1
.
2
6
3
5
1
.
2
5
1
3
1
.
1
7
2
6
1
.
1
1
4
7
0
.
9
5
3
0
0
.
8
8
0
3
(ppm)
1.01.52.02.53.03.54.04.55.05.56.06.57.0
 
O
O
CH3
COOMe
500 MHz, CDCl3
O
O
CH3
COOMe
1 : 8.68
 162 
1
6
7
.
1
6
2
5
1
5
3
.
9
4
0
1
1
2
0
.
2
9
5
1
1
1
0
.
1
5
3
4
6
4
.
5
5
6
8
6
4
.
5
0
7
2
5
1
.
3
0
7
6
4
6
.
9
3
1
2
4
1
.
0
7
0
6
3
5
.
6
5
7
8
3
2
.
7
0
6
6
3
0
.
9
9
9
4
2
8
.
6
8
8
4
2
5
.
9
4
6
7
2
5
.
5
5
0
4
2
3
.
6
4
3
2
(ppm)
30405060708090100110120130140150160
 
O
O
CH3
COOMe
125 MHz, CDCl3
O
O
CH3
COOMe
1 : 8.68
 163 
0
.
1
3
5
2
0
.
8
8
6
3
0
.
9
9
9
8
2
.
0
0
0
0
3
.
9
0
5
6
8
.
3
7
1
5
1
1
.
0
3
2
1
.
0
3
0
5
I
n
t
e
g
r
a
l
7
.
2
6
0
0
7
.
1
2
2
0
7
.
0
9
9
7
7
.
0
8
2
8
7
.
0
6
0
9
6
.
7
9
3
0
6
.
7
6
9
2
6
.
7
5
3
8
6
.
7
3
0
0
5
.
8
0
3
9
5
.
8
0
1
1
5
.
7
6
1
3
5
.
7
5
9
4
5
.
7
2
2
1
5
.
7
2
0
2
4
.
1
4
4
0
4
.
1
2
6
1
3
.
8
6
5
2
3
.
8
5
1
7
1
.
7
9
9
2
1
.
4
6
3
6
1
.
4
3
6
3
1
.
4
1
5
0
1
.
2
4
3
8
1
.
2
2
5
9
0
.
9
0
4
8
0
.
8
3
8
6
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5
 
400 MHz, CDCl3
O
OH3C
cis : trans 1:6,6 - on the cyclohexane ring
CO2Et
129a
 164 
1
6
6
.
6
7
8
6
1
5
3
.
5
3
2
3
1
2
0
.
6
2
0
9
1
1
0
.
0
7
1
5
7
7
.
0
0
0
0
6
4
.
4
7
4
8
6
4
.
4
2
3
4
5
9
.
9
8
6
0
4
6
.
8
3
6
0
4
0
.
9
6
9
7
3
5
.
5
3
4
0
3
2
.
6
2
0
8
3
0
.
9
1
9
4
2
8
.
6
0
0
7
2
5
.
8
7
8
1
2
5
.
4
7
9
9
2
3
.
5
6
7
0
1
4
.
1
7
2
2
(ppm)
2030405060708090100110120130140150160
 
100 MHz, CDCl3
O
OH3C
cis : trans 1:6,6 - on the cyclohexane ring
CO2Et
129a
 165 
1
.
0
1
1
4
0
.
9
9
3
9
2
.
0
6
2
9
1
.
0
8
4
4
1
.
0
8
6
6
3
.
0
0
8
1
6
.
5
2
0
6
8
.
5
3
4
4
1
.
1
1
5
4
I
n
t
e
g
r
a
l
7
.
2
6
0
0
6
.
7
7
0
3
6
.
7
4
6
4
6
.
7
3
1
1
6
.
7
0
7
2
5
.
7
7
6
4
5
.
7
3
7
2
4
.
1
6
4
0
4
.
1
4
6
1
4
.
1
2
8
2
4
.
1
1
0
3
2
.
4
5
5
2
2
.
3
7
5
0
2
.
3
3
0
7
2
.
2
3
0
0
1
.
8
5
0
3
1
.
6
7
8
0
1
.
5
8
7
6
1
.
2
6
5
1
1
.
2
4
8
0
1
.
2
3
0
1
1
.
1
8
2
4
1
.
1
2
6
9
0
.
9
1
3
6
0
.
8
8
2
9
0
.
8
5
3
0
0
.
8
2
4
0
(ppm)
1.01.52.02.53.03.54.04.55.05.56.06.57.0
400 MHz, CDCl3
CH3
O
H
H
173 (HPLC purified)
C15H24O3
Mol. Wt.: 252,35
CO2Et
 166 
2
0
8
.
8
5
5
3
1
6
6
.
5
7
5
7
1
5
3
.
0
2
7
4
1
2
0
.
9
6
5
7
7
7
.
0
0
0
0
6
0
.
0
6
8
0
4
6
.
8
5
6
9
4
0
.
7
6
5
8
4
0
.
5
0
2
9
3
2
.
5
8
0
8
3
0
.
8
1
2
7
2
9
.
7
1
5
3
2
8
.
3
4
9
2
2
5
.
7
6
1
9
2
5
.
3
6
1
8
1
4
.
1
6
2
7
(ppm)
102030405060708090100110120130140150160170180190200210
 
100 MHz, CDCl3
CH3
O
H
H
173 (HPLC purified)
C15H24O3
Mol. Wt.: 252,35
CO2Et
 167 
2
.
0
0
0
0
0
.
7
9
0
5
1
.
8
2
3
0
1
.
0
2
4
4
0
.
8
0
1
3
3
.
6
0
9
2
2
.
9
6
5
0
3
.
2
5
0
6
3
.
5
3
2
0
8
.
6
2
4
5
I
n
t
e
g
r
a
l
7
.
1
6
0
3
4
.
0
2
5
6
4
.
0
1
1
2
3
.
9
8
5
6
3
.
9
7
1
2
3
.
0
3
1
3
3
.
0
2
0
7
2
.
3
6
8
6
2
.
3
4
9
9
1
.
9
5
0
2
1
.
9
2
4
0
1
.
8
4
7
2
1
.
8
2
9
9
1
.
7
0
6
1
1
.
6
4
5
6
1
.
4
2
4
5
1
.
0
8
7
1
1
.
0
7
0
9
1
.
0
0
0
7
0
.
9
8
6
6
0
.
9
7
2
2
0
.
2
1
0
3
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.0
 
CO2Et
CH3
OTMS
H
H
H
H
H
131a (kinetic)
500 MHz, C6D6
 168 
1
7
3
.
3
1
1
7
1
2
8
.
7
0
0
0
7
4
.
9
1
2
6
6
0
.
7
4
7
0
6
0
.
6
1
3
6
5
6
.
0
9
8
1
5
1
.
4
1
5
0
5
0
.
0
5
0
9
3
8
.
2
1
1
6
3
3
.
5
8
1
8
3
2
.
5
8
5
3
3
2
.
5
6
4
4
2
7
.
9
1
5
5
2
7
.
3
8
4
0
2
7
.
2
6
7
8
1
5
.
1
5
0
3
2
.
7
7
9
4
(ppm)
0102030405060708090100110120130140150160170
 
CO2Et
CH3
OTMS
H
H
H
H
H
131a (kinetic)
100 MHz, C6D6
 169 
2
.
0
0
0
0
0
.
9
9
4
8
0
.
9
7
0
1
0
.
9
9
4
3
1
.
0
2
8
5
1
.
0
4
8
8
3
.
0
7
9
0
1
.
1
1
0
9
3
.
0
8
0
8
9
.
4
0
1
8
8
.
8
9
5
4
I
n
t
e
g
r
a
l
7
.
1
6
0
9
4
.
0
7
6
0
4
.
0
5
8
0
4
.
0
4
8
7
4
.
0
4
0
1
4
.
0
3
0
7
4
.
0
2
2
2
4
.
0
1
2
8
4
.
0
0
6
0
3
.
9
9
4
9
3
.
9
8
8
1
3
.
9
7
8
7
3
.
9
7
0
2
3
.
9
6
0
8
3
.
9
5
2
3
3
.
9
4
2
9
3
.
9
2
5
0
2
.
9
9
9
3
2
.
9
8
2
3
2
.
8
8
3
3
2
.
8
6
5
4
2
.
8
5
1
7
2
.
8
3
4
7
2
.
3
6
5
5
2
.
3
4
5
0
2
.
3
2
5
4
2
.
1
9
4
0
2
.
1
7
7
8
2
.
1
6
2
4
2
.
1
4
6
2
1
.
9
6
3
6
1
.
9
2
9
5
1
.
6
6
5
9
1
.
6
5
0
5
1
.
4
4
7
5
1
.
1
1
6
5
1
.
1
0
6
2
1
.
0
1
4
1
0
.
9
9
6
2
0
.
9
7
8
3
0
.
2
3
8
6
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.0
 
400 MHz, C6D6
CO2Et
CH3
OTMS
H
H
H
H
H
131b (thermodynamic)
 170 
1
7
2
.
2
4
6
8
7
4
.
4
6
7
0
5
9
.
9
4
8
9
5
0
.
9
7
1
3
4
8
.
9
6
8
9
4
8
.
7
0
6
0
4
3
.
2
9
6
9
3
7
.
1
6
2
0
3
2
.
3
2
8
4
3
2
.
3
1
5
0
2
7
.
0
5
4
6
2
6
.
9
1
5
5
2
6
.
9
0
2
2
2
6
.
5
8
4
0
1
4
.
4
8
9
4
2
.
1
3
5
7
(ppm)
0102030405060708090100110120130140150160170
 
100 MHz, C6D6
CO2Et
CH3
OTMS
H
H
H
H
H
131b (thermodynamic)
 171 
3
.
5
1
2
3
0
.
2
7
8
6
0
.
3
0
5
0
1
.
0
0
0
0
1
.
0
0
6
4
3
.
5
4
5
2
I
n
t
e
g
r
a
l
4
.
1
4
0
4
4
.
0
7
9
6
3
.
1
1
0
5
3
.
0
9
3
3
2
.
9
9
3
6
2
.
9
7
5
7
2
.
9
6
2
2
2
.
4
7
3
6
2
.
4
5
1
6
2
.
4
3
3
1
2
.
3
0
4
6
2
.
2
8
8
3
2
.
2
7
2
6
2
.
2
5
6
3
2
.
0
7
4
1
2
.
0
4
1
1
1
.
2
3
4
5
1
.
1
0
5
6
0
.
3
9
8
8
0
.
3
4
8
3
-
0
.
4
7
7
4
(ppm)
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
CO2Et
CH3
OTMS
H
H
H
H
H
131b (thermodynamic)
400 MHz, C6D6
NOE irrad. at 1.66 ppm
 172 
1
.
0
3
1
0
0
.
0
5
5
4
1
.
0
2
2
9
I
n
t
e
g
r
a
l
7
.
2
6
6
1
4
.
0
9
9
3
4
.
0
8
1
5
3
.
0
9
0
5
2
.
9
7
7
3
2
.
9
6
3
8
2
.
3
0
3
3
2
.
2
8
7
3
2
.
2
7
1
6
2
.
2
5
5
3
1
.
5
5
7
9
1
.
2
2
6
7
1
.
2
1
7
3
1
.
1
9
7
2
1
.
1
9
5
0
1
.
1
0
7
5
0
.
3
4
8
6
-
0
.
4
7
7
4
(ppm)
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5
 
CO2Et
CH3
OTMS
H
H
H
H
H
131b (thermodynamic)
400 MHz, C6D6
NOE irrad. at 2.46 ppm
 173 
1
.
0
8
9
1
0
.
1
1
6
7
0
.
3
2
0
9
1
.
0
0
0
0
I
n
t
e
g
r
a
l
7
.
2
6
5
8
7
.
2
6
2
7
4
.
0
9
9
3
4
.
0
8
1
5
3
.
1
0
9
6
2
.
4
5
7
0
2
.
3
0
2
4
2
.
2
8
6
7
2
.
2
7
0
7
2
.
2
5
4
7
1
.
5
5
6
6
1
.
1
6
8
1
1
.
1
5
5
8
1
.
1
5
3
0
1
.
1
5
1
7
1
.
1
5
0
5
1
.
1
0
7
5
0
.
3
5
0
5
-
0
.
4
7
7
4
(ppm)
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5
CO2Et
CH3
OTMS
H
H
H
H
H
131b (thermodynamic)
400 MHz, C6D6
NOE irrad. at 2.97 ppm
 174 
7
.
2
6
9
3
7
.
2
6
6
1
7
.
2
6
4
3
6
.
1
7
5
1
4
.
1
4
0
4
4
.
1
2
2
5
2
.
9
5
9
1
2
.
9
4
5
3
2
.
4
5
4
5
2
.
4
3
3
5
2
.
3
0
3
0
2
.
2
8
7
0
2
.
2
7
1
0
2
.
2
5
5
0
1
.
6
6
5
4
1
.
5
5
6
9
1
.
1
8
5
9
1
.
1
5
4
6
1
.
1
5
3
3
1
.
1
5
2
1
1
.
1
0
7
5
0
.
6
0
2
3
0
.
3
4
8
6
-
0
.
4
7
7
4
(ppm)
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5
CO2Et
CH3
OTMS
H
H
H
H
H
131b (thermodynamic)
400 MHz, C6D6
NOE irrad. at 3.10 ppm
 175 
1
.
9
8
3
3
0
.
9
7
0
7
1
.
0
0
5
1
0
.
9
9
3
9
3
.
9
8
5
6
1
.
0
9
4
3
0
.
9
2
1
1
3
.
0
6
9
7
1
.
0
5
9
9
8
.
0
9
1
0
1
.
0
2
5
9
I
n
t
e
g
r
a
l
7
.
1
6
0
0
3
.
9
2
7
3
3
.
9
0
9
5
3
.
1
8
6
3
3
.
1
6
3
7
2
.
8
0
1
8
2
.
7
7
4
5
2
.
7
5
9
5
2
.
7
3
2
2
2
.
4
1
2
3
2
.
4
0
1
0
2
.
3
7
0
0
2
.
3
5
8
7
1
.
9
5
6
6
1
.
7
6
6
0
1
.
6
1
4
2
1
.
6
0
7
6
1
.
5
8
9
4
1
.
2
0
9
9
1
.
1
8
8
9
0
.
9
7
0
0
0
.
9
5
2
2
0
.
9
3
4
6
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5
H
CO2Et
CH3
OH
HH
132a
(CH3 at 1.96 ppm)
500 MHz, C6D6
 176 
2
1
1
.
6
0
0
8
1
7
3
.
9
1
0
9
1
2
8
.
4
0
0
0
6
0
.
3
8
0
3
5
0
.
5
0
3
5
5
0
.
4
2
3
4
4
6
.
1
1
7
5
4
4
.
3
7
8
0
3
6
.
9
3
0
4
3
4
.
0
8
2
0
3
2
.
1
6
1
5
3
2
.
1
2
7
2
3
0
.
7
9
1
6
2
6
.
9
8
8
7
2
6
.
5
4
6
7
1
4
.
6
3
1
2
(ppm)
2030405060708090100110120130140150160170180190200210
 
H
CO2Et
CH3
OH
HH
132a
125 MHz, C6D6
 177 
1
.
9
8
3
9
0
.
9
8
2
1
1
.
0
1
6
9
1
.
1
3
8
7
4
.
0
1
4
0
2
.
1
4
3
0
3
.
6
2
2
3
1
.
0
8
0
0
4
.
4
0
3
1
2
.
3
2
1
6
1
.
1
1
6
1
1
.
1
6
4
8
1
.
0
9
5
5
I
n
t
e
g
r
a
l
7
.
2
6
0
0
4
.
0
6
3
8
4
.
0
4
9
5
2
.
7
6
0
7
2
.
5
0
3
2
2
.
4
8
3
1
2
.
2
6
1
0
2
.
1
9
7
8
2
.
1
7
8
9
2
.
1
6
5
2
2
.
1
3
1
6
1
.
8
3
3
2
1
.
8
0
2
7
1
.
7
6
5
8
1
.
7
2
0
7
1
.
6
8
8
3
1
.
5
4
4
6
1
.
4
7
2
0
1
.
2
8
7
4
1
.
2
3
2
8
1
.
2
1
8
5
1
.
2
0
4
1
1
.
1
8
9
2
1
.
0
7
6
6
1
.
0
6
0
4
0
.
9
8
1
7
0
.
9
6
8
3
0
.
8
8
8
4
0
.
8
6
5
8
0
.
8
5
9
1
0
.
8
4
3
5
0
.
8
3
6
8
0
.
8
2
1
2
0
.
8
1
4
8
0
.
7
9
9
0
0
.
7
9
2
6
(ppm)
1.01.52.02.53.03.54.04.55.05.56.06.57.0
 
500 MHz, CDCl3
H
H
CH3
CO2Et
O
H
H
133a
 178 
2
1
7
.
1
4
8
9
2
1
0
.
7
6
2
5
1
7
6
.
0
1
6
3
1
7
2
.
9
4
3
1
8
6
.
8
2
9
2
7
7
.
0
0
0
0
6
0
.
3
0
8
0
5
5
.
3
9
8
2
5
1
.
7
2
1
0
4
4
.
5
2
3
0
4
2
.
9
4
5
4
3
7
.
8
6
6
0
3
4
.
7
1
2
8
3
1
.
4
8
7
2
2
9
.
8
6
0
1
2
9
.
0
7
3
2
2
5
.
9
5
0
5
2
5
.
9
2
1
9
1
4
.
1
4
9
3
(ppm)
020406080100120140160180200220
 
100 MHz, CDCl3
H
H
CH3
CO2Et
O
H
H
133a
 179 
-
1
0
0
.
0
0
0
0
1
.
8
6
5
7
6
.
9
5
1
6
5
.
8
4
3
1
1
.
8
2
9
6
I
n
t
e
g
r
a
l
7
.
2
6
0
0
2
.
7
6
1
4
2
.
1
6
4
9
1
.
5
2
0
5
1
.
4
9
5
8
0
.
8
4
3
5
0
.
8
3
6
8
0
.
8
2
1
2
0
.
8
1
4
8
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.0
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500 MHz, CDCl3
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(CH3 at 1.93 ppm)(CH3 at 1.91 ppm)
2.82 : 1.00
500 MHz, C6D6
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